Yaya tsawon lokacin da waɗannan alamun ke faruwa?
Kuma duk ciwon kirji da ke damun mutum ya kamata a bi da shi ta wannan hanyar, musamman ma idan ya yi daidai da shekarunsa.
Kuma har ma da zazzabi.
Kuma za ku bukaci a duba yawan cholesterol da kuma hawan jini.
Kuma yanzu kana da zazzabi?
Kuma yanzu kuna jin ciwon kirji?
Kuma kuna da wahalar numfashi?
Kuma za ku iya gaya mani ko akwai wasu alamun da kuke ji?
Kuma yawan zafin jikinka.
Kuma ina da tari.
Kuma ina da ɗan sanyi da tari.
Kuma a gaskiya, na ji ciwon kirji a zuciyata a yau.
Kuma shin lokaci ne mai kyau don samun furen ku?
Kuma hakan yana haifar da ciwon kirji.
Kuma ina ganin ina da zazzabi kadan.
Kuma ina so in ji daga gare ku inda ciwon kirji yake.
Kuma suna da zazzabi kaɗan.
Kuma tare da tarihin ciwon sukari.
Kuma ina jin kamar za a karya kirji na.
Kuma mutane suna tari a gabana a koyaushe.
Kuma kuna da ciwon kirji.
Kuma kun ce wannan shine matsa lamba a cikin kirjin ku.
Shin akwai wani a cikin iyalin da ke da ciwon zuciya, ciwon zuciya, bugun zuciya, yawan cholesterol, hawan jini?
Shin akwai wasu alamun ko matsaloli da kuka lura da su tare da ciwon tsoka?
Shin akwai wani marar lafiya a gidanku da yake da irin wannan alamun?
Shin kana da wasu alamun cutar?
Kana jin tsoro?
Shin har yanzu kuna ciwon kirji?
Tun da yake wannan lokacin mura ne.
Amma ba za mu manta da ciwon kirji ba.
Amma ciwon kirji ya zama matsala mafi girma.
Amma ina da wahalar numfashi.
Amma na san mutane da yawa sun yi tari a kaina.
Amma dole ne mu ɗauki kowace ciwo da ke cikin kirji da muhimmanci.
Amma, shin numfashinka yana da kyau?
Na yi baƙin ciki sosai don na manta da abin da na yi.
Kana jin cewa wani yana matsa maka a kirji?
Har ila kana jin kamar kana jin tsoro?
Shin sun taɓa yin gunaguni cewa sun yi rashin lafiya saboda waɗannan alamun?
Kana da wata cuta mai tsanani kamar hawan jini ko wata matsala dabam?
Kana da wata cuta mai tsanani kamar ciwon sukari?
Kana jin ciwon kirji da kuma jijiyoyi?
Kana da hawan jini?
Kana jin tsoro ne?
Shin kun san alamun da ta ke nunawa?
Kuna ganin wannan hoton?
Ka sha ruwa da yawa a yau.
Duk da haka, na yi gwajin ciwon sukari.
Amma tana da alamun da na ke da su.
Yaya yawan zafin jikinka yake?
Yaya yawan hawan jini naka yake?
Idan kana da zazzabi mai tsanani
Idan kana da zazzabi mai yawa ko fiye da haka,
Idan kun ga cewa akwai wata cuta ko wata cuta da kuke bukatar a lura da ita sosai.
Na yi zazzabi jiya.
Ina da zazzabi kaɗan.
Na yi zazzabi jiya.
Ina jin zafi sosai a cikin kirji a nan.
Ina kuma fama da numfashi.
Zan aiko muku da hotuna.
Ina jin ciwon kirji a yau.
Ina jin ciwon kai da zazzabi a yau.
Ina ganin akwai mura.
Ina ganin wannan ɗan mura ne.
Kana jin kamar wani yana zaune a kan kirjinka?
Ya fara da ciwon kai da zazzabi a lokaci guda.
Hakan ya sa na ji ciwo a tsakiyar kirji.
Wannan matsin lamba yana kama da ciwon kirji.
Yana cikin kirji na.
Yana tsakiyar kirji na.
Yana tsakiyar kirji.
Ina jin ciwon kirji.
Ina matukar damuwa da wannan ciwon kirji.
Ya kamata ku bayyana ciwon kirji dalla-dalla.
Wasu cututtuka kamar su hawan jini ko ciwon sukari.
Kamar dai a tsakiyar kirji.
Yanzu za ku iya samun takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin takalmin tak
Yanzu Mary, tsawon lokacin da kuka kasance kuna da alamun cutar?
Yanzu kun ce kuna da ciwon kirji.
Ina jin ciwon kirji a wasu lokatai.
To, ban da ciwo, shin akwai wasu alamun da kuke gani?
Ko kuwa wani yana zaune a kan kirjinka?
Haka ma za a iya cewa game da zazzabi da tari, ciwon kai da ciwon tsoka.
A tsakiyar kirji na.
Ka nuna mini inda kake ciwo a wannan hoton.
Idan kana da zazzabi.
Shin kana ganin wasu cikin waɗannan alamun suna da alaƙa da yin ciki?
Shin yaranku ma suna da irin wannan alamun?
Ka gaya mini game da ciwon kirjinka.
Ana yawan samun zazzabi da dare.
Na yi zazzabi a cikin kwanaki biyu da suka gabata.
Zazzabi ya fara tashi daga daren jiya.
Ni ne Dr. Porter daga Cibiyar Kula da gaggawa.
Don haka za ku iya gaya mani game da ciwon kirjinku?
Ina jin ciwo a gaba na kirji.
Na'am, amma na ji ciwo sosai a kirji.
A lokacin da na ji ciwon kirji,
Wane irin ciwo ne kake ji a kirji?
A wane lokaci ne wannan ciwon kirji ya soma?
A ina ne ƙirjinka yake ciwo?
Kuna iya sanin inda ƙirjinku yake ciwo.
Za ka iya jin ƙarancin kirji.
Na san ina da ciwon sukari da wasu matsaloli.
Ka ce kana da ciwon kirji.
Hadakar cututtukan cutar coronavirus (COVID-19) a cikin EU/European Economic Area da United Kingdom, suna ƙaruwa cikin sauri tsakanin 1 ga Janairu zuwa 15 ga Maris, 2020.
Hadadden adadin cututtukan cutar coronavirus (COVID-19) yana nuna kamanceceniya tsakanin ƙasashen EU/EU da Ingila, wanda ke tabbatar da cewa cutar COVID-19 tana ƙaruwa cikin sauri a duk ƙasashe, kodayake matakan sun bambanta daga ƙasa zuwa ƙasa.
Bisa ga kwarewar Italiya, ƙasashe, asibitoci da cibiyoyin kulawa da gaggawa dole ne su haɓaka shirye-shiryen su don yawan adadin marasa lafiya na COVID-19 da ke buƙatar kulawa da lafiya da kuma kulawa ta musamman.
A ranar 31 ga Disamba, 2019, an gano jerin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
A ranar 9 ga watan Janairun 2020, Cibiyar Kula da Cututtuka da Cututtuka ta kasar Sin ta ba da shawarar sabon coronavirus a matsayin mai daukar hoto, wanda yanzu ake kira SARS-CoV-2.
An kira shi cutar coronavirus (COVID-19) saboda cutar ta haifar da kamuwa da cutar SARS-CoV-2.
Shaidar da aka samu ya nuna cewa kashi 80% na mutanen da ke fama da COVID-19 suna da rashin lafiya mai sauƙi, wato, cututtukan numfashi tare da ko ba tare da cutar huhu ba kuma yawancin su sun warke.
A cikin kashi 14 cikin dari na masu cutar COVID-19 suna da mummunan ciwo wanda ke buƙatar asibiti, yayin da kashi 6 cikin dari na marasa lafiya ke da mummunan ciwo wanda ke buƙatar magani mai tsanani.
Yawan mutuwar marasa lafiya da ke kwance a asibiti saboda COVID-19 ya kai kashi 4 cikin dari.
A cikin wannan binciken, mun kimanta yanayin haɗuwa na COVID-19 a kowace ƙasa a cikin EU/EEA da United Kingdom (UK) kuma mun kwatanta su da lardin Hubei na China.
Mun kuma kwatanta adadin masu kamuwa da COVID-19 a cikin EU/EEA da UK da adadin masu kamuwa da cutar a Italiya tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Cutar COVID-19 a cikin EU/EEA da UK
Bayan China, COVID-19 ya kara yaduwa a duniya kuma sauran ƙasashen duniya yanzu suna bin yanayin COVID-19 a cikin ƙasar.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar EuroSurveillance 2020, Spiteri et al na 5 ga Maris, WHO ta ba da rahoton farkon yanayin COVID-19 a Turai kamar yadda ta bayyana.
A cikin EU/EEA, Faransa ta sanar da farko uku tabbatacce lokuta dawo daga Wuhan, lardin Hubei na kasar Sin a ranar 24 ga Janairu, 2020.
A ranar 15 ga Maris, 2020, an gano shari'o'in COVID-19 a duk ƙasashen EU/EEA 30 da Ingila (UK), tare da ba da rahoton shari'o'i 39,768 da mutuwar 1,727 a ranar 31 ga Disamba, 2019, tare da shari'o'i 17,750 da mutuwar 1,441 a Italiya kadai.
Samun adadin adadin masu cutar COVID-19 da kuma yawan abubuwan da suka faru.
Cibiyar Kula da Cututtuka ta Turai (ECDC) tana yin rikodin shari'ar COVID-19 ta kowace ƙasa a duniya, wanda ake sabunta bayanai a kowace rana da ƙarfe 8:00 na safe ta amfani da ma'aikatun kiwon lafiya na ƙasashe, hukumomin kiwon lafiya na ƙasa da na yanki da kuma tushen hukuma kamar WHO.
Ana amfani da wannan bayanan don tantance yanayin COVID-19 a cikin EU/EEA da UK da kwatanta su da shari'o'in a Italiya.
A matsayin samfurin yanayin yanayin COVID-19 mai aiki, mun lissafa jimlar kwanaki 14 na COVID-19 na lokuta, muna la'akari da yanayin yaduwar COVID-19 a kowace EU/EEA da Burtaniya a cikin lokacin Janairu 1 - 15 Maris 2020.
Mun kuma gabatar da adadin adadin wadanda aka ruwaito a kowace kasa da karfe 8:00 na safe a ranar 15 ga Maris, 2020 kuma mun kwatanta su da adadin wadanda aka ruwaito a Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Yanayin COVID-19 a cikin EU/EEA da UK
Tsarin gabaɗaya na kwanaki 14 na rarrabuwar kawunan COVID-19 a cikin ƙasashen EU/EEA da UK yayi kama da na lardin Hubei (China) (Figure 1).
A cikin EU/EEA gabaɗaya da UK, haɗuwa da shari'ar COVID-19 ya fara ƙaruwa a kusan 21 ga Fabrairu sannan ya fara ƙaruwa da sauri a kusan 28 ga Fabrairu, 2020 (abun da aka ƙara).
Wannan ya hada da yawan adadin wadanda aka ruwaito a cikin Italiya, amma duk sauran ƙasashen EU/EEA da UK suna nuna irin wannan yanayin na haɓaka na COVID-19 (abun da aka ƙara).
Figure 2 ya nuna yawan adadin masu kamuwa da COVID-19 a cikin EU/EEA da UK idan aka kwatanta da adadin masu kamuwa da cutar a Italiya tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Ya nuna cewa a ranar 15 ga Maris da karfe 8 na safe, an riga an samu adadin adadin masu cutar a cikin wasu kasashe 15 na EU/EEA da Burtaniya kamar yadda Italiya ta samu makonni 3 da suka gabata ko kuma ƙasa da haka.
Sakamakon bincikenmu ya nuna cewa cutar COVID-19 tana karuwa cikin sauri a cikin EU/EEA da UK.
Halin da aka lura a cikin hadadden lokuta na COVID-19 ya nuna cewa annobar tana ƙaruwa cikin sauri a cikin ƙasashe.
Bugu da kari, yayin da kasashe daban-daban ke cikin matakai daban-daban, bambance-bambance tsakanin martani na lafiyar jama'a na ƙasa da yiwuwar bambance-bambance tsakanin ƙasashe da kuma zaɓin haƙuri daban-daban ya kamata a bincika don tabbatar da COVID-19, gami da gwajin kama-da-wane.
A farkon watan Maris na 2020, likitoci a yankunan da cutar ta shafa na Italiya sun bayyana halin da ake ciki wanda ke buƙatar kulawar ICU don kashi 10% na marasa lafiya da ke fama da COVID-19, kuma kafofin watsa labarai sun nuna cewa asibitoci da cibiyoyin kula da marasa lafiya a waɗannan yankuna sun riga sun kai iyakar ƙarfin su.
Bayanai game da shigar da marasa lafiya na COVID-19 asibiti da/ko cibiyoyin kulawa na musamman a halin yanzu ana samun su ne kawai don kashi 6% da 1% na shari'o'i a matakin EU/EEA, bi da bi (ba a nuna bayanai ba).
Amma suna buƙatar tattara bayanan sa ido na yanzu ta hanyar da ta dace wanda ke mai da hankali kan adadin adadin rahotannin da aka bayar da rahoton da kuma yawan mutuwar.
Wani binciken da aka yi a 2010-11 ya nuna cewa akwai bambanci sosai tsakanin yawan gadajen kula da marasa lafiya a Turai, wanda ya kai gado 29.2 a Jamus da 4.2 a Portugal a kowace jama'a 100,000.
Wannan yana nufin cewa wasu ƙasashe suna da ƙasa ko fiye da albarkatu fiye da Italiya (akuwa 12.5 na ICU da gadajen kulawa na matsakaici a cikin 2010-11 ga kowane mutum 100,000).
Yawan adadin masu cutar COVID-19 da aka kwantar a asibiti a kowace EU/EEA da Burtaniya yanayin samfurin da ke da alaƙa da wadatar ƙarfin kiwon lafiya yana da alaƙa da haɗarin wucewa > 90% na ƙarfin gado mai mahimmanci, wanda aka bayar a cikin sabuntawa na shida na ECDC Rapid Risk Assessment of COVID-19.
Tun da har yanzu an iyakance adadin masu cutar ga wasu yankuna na EU/EEA da UK, kuma asibitoci da cibiyoyin kulawa da gaggawa suna ba da magani ga wasu yankuna, ya kamata a samar da bayanan shari'o'i da cibiyoyin kula da gaggawa a cikin ma'anar cibiyoyin yanki don ƙididdigar 2 (NUTS-2).
Kwarewar Italiya da halin da ake ciki a wasu ƙasashe ya nuna cewa cutar COVID-19 tana yaduwa cikin sauri a cikin EU/EEA da UK.
Saboda haka, ƙasashe, asibitoci da cibiyoyin kulawa na musamman suna buƙatar shirya kansu don ci gaba da kamuwa da cutar SARS-CoV-2 a cikin al'umma da kuma yawan marasa lafiya da ke fama da COVID-19 waɗanda ke buƙatar kula da kiwon lafiya da kuma musamman kulawar kulawa ta musamman, kamar yadda yanayin ya kasance a yankunan da ke fama da cutar a Italiya.
A cewar sabon tsarin hadarin ECDC, gaggawa, aiki da kuma cikakkiyar hanyar kawar da cutar SARS-CoV-2 tana da mahimmanci maimakon jinkirta hana yaduwar cutar, saboda idan ba a aiwatar da shi ba da wuri, saurin karuwar irin waɗannan shari'o'in ba zai ba masu yanke shawara da asibitoci damar fahimtar, karɓa da kuma karɓar martani ba.
Har ila yau, an lissafa matakan kiwon lafiyar jama'a a cikin saurin kimanta haɗarin don kawar da tasirin cutar.
Akwai ɗan gajeren lokaci na dama a nan lokacin da ƙasashe za su iya ƙara haɓaka ƙoƙarin su don rage yaduwar SARS-CoV-2 da rage matsin lamba kan ayyukan kiwon lafiya.
Idan wannan ya gaza, akwai yiwuwar sauran tsarin kiwon lafiya na EU/EEA na iya fuskantar karuwar marasa lafiya da ke buƙatar kulawa mai tsanani a cikin kwanaki ko makonni masu zuwa.
Cutar coronavirus ta 2019 (COVID-19) ta barke ne sakamakon mummunar cutar numfashi mai saurin kamuwa da cuta (SARS) Coronavirus 2 (SARS-CoV-2) wanda ya riga ya kashe mutane sama da 3,000 da kuma kamuwa da mutane sama da 80,000 a China da sauran wurare a duniya, kuma ya zama bala'i ga bil'adama.
Kamar SARS-CoV, wanda ya haifar da cutar SARS a cikin shekara ta 2003, SARS-CoV-2 mai yiwuwa ya kamu da cutar daga ƙuda kuma yana nuna alamun bayyanar cututtuka ta hanyar wannan hanyar.
Ko da yake cutar COVID-19 tana da rauni da mutuwar mutane fiye da SARS, amma tana da kamuwa da cuta kuma tana shafar tsofaffi fiye da matasa da maza fiye da mata.
A cikin martani ga yawan wallafe-wallafen da ke faruwa a cikin cututtukan da ke faruwa, wannan labarin yana ƙoƙari ya ba da cikakken bayani game da batun bincike da ke faruwa.
Mun magance abubuwan yau da kullun kamar ilimin annoba, ilimin halittu, ilimin kwayar cuta, ganewar asali, magani, tsinkaya da rigakafin cutar.
Ko da yake akwai tambayoyi da yawa da ba a amsa ba, muna fatan wannan bita zai taimaka wajen fahimtar wannan cuta mai haɗari da kuma magance ta.
Bikin bazara na ranar 25 ga Janairu, 2020 ya kasance abin ban mamaki da ba za a iya mantawa da shi ba ga duk Sinawa waɗanda aka umarce su da su zauna a gida a duk lokacin hutu da kuma makonni da yawa bayan barkewar sabuwar cutar.
Wannan kwayar cutar tana da alaƙa da kwayar cutar coronavirus (CoV) wacce ta haifar da barkewar cutar saurin kamuwa da cutar numfashi (SARS) a 2003, don haka a ranar 11 ga Fabrairun 2020, Hukumar Lafiya ta Duniya ta sake sanya mata suna SARS-CoV-2 da kuma cutar da ke tattare da ita COV Disease 19 (COVID-19).
Cutar ta fara ne a Wuhan, China kuma nan take ta bazu zuwa duk fadin kasar da kuma wasu kasashe 50 a duniya.
A ranar 2 ga Maris, 2020, kwayar cutar ta haifar da tabbataccen shari'o'in COVID-19 80,000, tare da sakin marasa lafiya sama da 40,000 da mutuwar marasa lafiya 3,000.
WHO ta yi gargadin cewa COVID-19 "maƙiyi na farko na mutane" ne kuma mai yiwuwa ya fi ta'addanci ƙarfi.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), an buga sama da takardu 200 kan COVID-19 a cikin watanni biyu da suka gabata, wanda ya haɗa da ilimin kwayoyin cuta, ilimin annoba, ilimin halittu, ganewar asali da magani tun lokacin da aka fara rahoton shari'ar farko a ranar 7 ga Janairu, 2020, wanda ya ba da damar tsara jerin cututtukan cutar ban da marasa lafiya daban-daban.
Wannan bita yana ƙoƙari ya taƙaita ci gaban bincike a cikin sababbin fannoni masu tasowa.
Idan za mu iya, za mu yi ƙoƙarin kwatanta COVID-19 da SARS da sauran cututtukan da ke haifar da CoV, cututtukan numfashi na Gabas ta Tsakiya (MERS, barkewar 2012).
Za mu kuma tattauna abin da muka koya game da rigakafin cututtuka da kuma tsinkayar su, da kuma wasu batutuwa masu muhimmanci da suka rage.
CoVs a al'adance ana ɗaukar su marasa cutarwa ga ɗan adam, suna haifar da kusan 15% na cututtukan mura.
Amma a wannan karni mun fuskanci mummunar cutar CoV guda biyu da ke kashe mutane, wato SARS-CoV da MERS-CoV, wanda ya fara bulla a China a 2003 da Saudiyya a 2012 kuma nan da nan ya yadu zuwa wasu ƙasashe tare da mummunan cututtuka da mutuwar mutane.
Don haka, COVID-19 na yanzu shine barkewar CoV na uku a tarihin ɗan adam.
Kamar yadda aka nuna a Figure 1.1, Hukumar Lafiya ta Kasa ta kasar Sin ta fara bayar da rahoton tarin cutar nimoniya da ba a san asalin ta ba a Wuhan a ranar 31 ga Disamba, 2019.
Bayan kwana bakwai, an fitar da jerin CoV.
A ranar 15 ga Janairun 2020, an samu mutum na farko da ya mutu a Wuhan.
A halin yanzu, annobar ta yadu cikin sauri zuwa garuruwa, larduna da ƙasashe maƙwabta.
A ranar 20 ga Janairu, an ba da rahoton masu ba da kiwon lafiya game da kamuwa da cutar wanda ya nuna yiwuwar yaduwar cutar daga mutum zuwa mutum.
A ranar 23 ga watan Janairu, an kafa dokar kulle a birnin Wuhan kuma an dakatar da zirga-zirgar jama'a.
A ranar 24 ga Janairu, binciken farko na likita game da cutar ya nuna cewa daga cikin shari'o'i 41 da aka tabbatar, 21 ne kawai suka zo daga hanyar kai tsaye zuwa kasuwar abincin teku ta Wuhan wanda aka ɗauka a matsayin cibiyar kamuwa da cuta ta farko daga asalin dabba da ba a sani ba.
A ranar 30 ga Janairu, WHO ta ayyana barkewar cutar a matsayin gaggawa ta kiwon lafiya a duniya.
A lokacin da aka buga wannan rahoton, cutar ta riga ta bazu ko'ina cikin China da ƙasashe 50 a duniya (Figure 2.2).
Har yanzu ba a san ainihin matsayin barkewar cutar ba saboda yanayin yana canzawa cikin sauri.
Nazarin cibiyar da ta hada da mutane 8,866 da suka hada da 4,021 da aka tabbatar da cutar COVID-19 a ranar 11 ga Fabrairu, 2020 ya gabatar da hoto na yau da kullun na cutar kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya kamu da mutane a duk shekaru, amma ya fi mayar da hankali ga masu shekaru 30 zuwa 65.
Rabin wadanda suka kamu da cutar (47.7%) sun kasance 'yan shekaru 50, kadan sun kasance' yan kasa da shekaru 20, kuma kawai 14 daga cikin wadanda suka kamu da cutar sun kasance 'yan kasa da shekaru 10.
SARS-CoV-2 ya kamu da maza da yawa (0.27/1,00,000) fiye da mata (0.31/1,00,000).
COVID-19 ya bazu ne a cikin Hubei da kuma biranen da ke kewaye.
Matsakaicin lokacin da cutar ta kamu da cutar COVID-19 ya kai kwanaki 5 (2-9) kafin a gano cutar.
Matsakaicin tsawon lokacin riƙewa ya kasance kwanaki 4.8 (3.0-7.2).
Matsakaicin lokacin kamuwa da cutar zuwa mutuwa ya kasance kwanaki 9.5 (4.8-13).
Ƙididdigar ƙididdigar ƙididdiga (R0) ta kasance 3.77 (95% CI: 3.51-4.05) kuma an daidaita R0 zuwa 2.23-4.82.
Yawan mutanen da suka kamu da cutar ya karu sosai kafin 23 ga Janairun 2020, wanda ya yi daidai da yaduwar cutar kafin bikin bazara a kasar Sin.
Yawan mutuwar marasa lafiya tare da tabbataccen lamari ya kasance 1.44% (95% CI: 1.10-1.86%) kuma yawan mutuwar marasa lafiya ya kasance 3.06% (95% CI: 2.02-4.59%).
Manyan abubuwan haɗari guda uku don COVID-19 sune jinsi (maza), shekaru (> 60), da kuma cutar nimoniya mai tsanani.
CoVs babban ƙananan ƙwayoyin cuta ne da ke ɗauke da zaren RNA guda ɗaya.
Ana iya raba su zuwa kwayoyin halittar guda hudu, wato alpha, beta, gamma da delta, daga cikinsu an san alpha- da beta CoVs suna shafar mutane.
Wannan spike mai rufi (S) glycoprotein yana ɗaure da masu karɓar salula na angiotensin-converting enzyme 2 (ACE2) da diapeptidyl peptidase 4 (DPP4) don SARS-CoV da MERS-CoV, bi da bi, sannan kuma ya haifar da haɗuwa da fata.
Ana sakin kwayoyin RNA masu kamuwa da cuta a cikin kwayar halitta; bayan kwayar cutar ta kwayar halitta ta kwayar halitta ta kwayar halitta ta RNA ta samar da kwayar halitta mai dauke da kwayar halitta tare da glycoproteins da nucleocapsid proteins, wanda daga bisani ya hada da membrane plasma don sakin kwayar cutar.
An fara yin rikodin tsarin halittar SARS-CoV-2 a ranar 10 ga Janairun 2020.
SARS-CoV-2 an gano sabon nau'in beta-CoV wanda aka gano 99.98% na gano kwayoyin halitta a cikin samfuran 10 da aka ɗauka daga asalin barkewar cutar, Hunan Seafood Market a Huan.
SARS-CoV-2 ya fi kama da MERS-CoV fiye da SARS-CoV.
Ta hanyar nazarin ƙananan ƙananan lantarki, an gano ƙwayoyin SARS-CoV-2 a cikin ƙananan ƙananan ƙwayoyin cuta na mutum.
An gano ACE2 na ɗan adam a matsayin mai karɓar SARS-CoV-2 da SARS-CoV.
Koyaya, sunadaran S na SARS-CoV-2 suna ɗaure da ACE2 na ɗan adam cikin rauni fiye da sunadaran S na SARS-CoV, wanda hakan ya haifar da rashin kamuwa da cuta mai tsanani ta SARS-CoV-2 fiye da SARS-CoV.
SARS-CoV-2 na iya samar da sabbin ƙananan furotin, waɗanda aka ɓoye ta hanyar orf3b, da furotin mai ɓoyewa wanda aka ɓoye ta hanyar orf8.
SARS-CoV-2 orf3b na iya taka rawa a cikin cututtukan cututtukan cututtuka da hana bayyanar IFNß; duk da haka, orf8 ba ya haɗa da wani yanki ko maƙasudin aiki da aka sani.
A ranar 18 ga Fabrairun 2020, Zhou, et al. sun ba da rahoton cewa cikakken tsarin cryo-EM na ɗan adam ACE2 a ƙudurin 2.9 Å ya haɗu da mai ɗaukar amino acid B0AT1.
Sun gano cewa tsarin kwayar cutar da ke buɗe da rufewa ya haɗu a matsayin dimer kuma ACE2-B0AT1 mai haɗuwa na iya ɗaure sunadarai biyu na S, wanda ke ba da tabbaci na gano CoV da kamuwa da cuta.
B0AT1 na iya zama maƙasudin magani don gwajin magani don shawo kan kamuwa da SARS-CoV-2.
Mai watsa shiri na asali da na tsakiya
An san cewa SARS-CoV da MERS-CoV duka sun samo asali ne daga gizo-gizo kuma sun isa ga mutane daga cats da raƙuma masu cin abinci, bi da bi.
Idan aka kwatanta tarihin SARS-CoV-2 da sauran CoVs, an ɗauka cewa bat yana da gidajen SARS-CoV-2 saboda sabon kwayar cutar tana da kamanceceniya da kashi 96% tare da SARS-like CoVs na bat-SL-CoVZX45 da bat-SL-CoVZX21.
Koyaya, ba a san irin matsakaitan masu ɗaukar hoto da suka taimaka wa kwayar cutar ta ƙetare shingen jinsuna don cutar da mutane ba kuma har yanzu ba a bayyana hanyar watsawa ba.
Ji, et al., sun ba da shawarar cewa macizai dole ne su kasance masu ɗaukar hoto don su isa ga mutane daga bats, tare da sake haɗuwa tsakanin S-protein.
Wani bincike da aka gudanar a Guangzhou, China ya nuna cewa dogon hanci, ants-eating eaten cats da ake amfani da su a cikin maganin gargajiya a China na iya zama mai yiwuwar matsakaiciyar rundunar SARS-CoV-2, wanda ya nuna cewa CoV da aka gano a cikin cats da SARS-CoV-2 suna da kamanceceniya ta hanyar kwayoyin halitta 99%.
Duk da haka, kashi 1 cikin dari na raba tsakanin kwayoyin halitta biyu har yanzu yana da nisa, don haka ana jiran tabbacin tabbaci don yanke shawara (Figure 33).
Har yanzu ba a san yawancin kaddarorin jiki na SARS-CoV-2 ba.
SARS-CoV da MERS-CoV na iya rayuwa a cikin yanayin bushewa har zuwa awanni 48 da rayuwa har zuwa kwanaki 5 a 20 ° C da zafi 40%-50%.
SARS-CoV-2 yana da irin wannan halaye.
An ba da rahoton cewa SARS-CoV-2 ba zai iya jurewa da hasken ultraviolet da zafin jiki na 56 ° C ba bayan minti 30, ether, 75% ethanol, chlorinated disinfectant, parasitic acid, chloroform, da sauran magungunan ruwa na madara ban da chlorhexidine na iya kawar da shi yadda ya kamata.
Yawancin lokaci, ɗan adam ba zai iya jurewa SARS-CoV-2 ba kuma saboda haka yana da rauni ga wannan sabon ƙwayar cuta.
A halin yanzu, babu wani cikakken nazari game da amsawar rigakafi ga SARS-CoV-2.
Don haka, zamu iya komawa ne kawai ga nazarin wasu CoVs, musamman: SARS-CoV da MERS-CoV (Figure 4).
A yadda aka saba, lokacin da kwayar cutar ta fara kai hari ga mai masaukin, ana gano ta ne ta hanyar karɓar karɓar karɓar karɓar karɓar (PRR), gami da C-type lectin-like receptors, Toll-like receptors (TLR), NOD-like receptors (NLR) da RIG-like receptors (RLR).
Ta hanyoyi daban-daban, kwayar cutar tana haifar da bayyanar abubuwan ƙonewa, balaga na ƙwayoyin dendritic da kuma tsangwama na nau'in I (INN), wanda ke iyakance yaduwar kwayar cutar da kuma saurin fashewar phagocytosis na kwayar cutar.
Amma, sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano cewa sun gano sun gano cewa sun gano sun gano sun gano sun gano sun sun gano sun sun sun san sun san sunan sun san sun kuma sun san sun kuma sun san sun sun sun sun sun sun san sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun sun
Ba da daɗewa ba, tsarin garkuwar jiki mai kyau zai shiga cikin gwagwarmayar da za a yi da kwayar cutar.
Tare da CD4 + da CD8 + T cells, T lymphocytes suna taka muhimmiyar rawa a cikin kariya.
Kwayoyin CD4+ T suna motsa kwayoyin B don samar da kwayoyin cutar da ke haifar da cutar, kuma CD8+ T suna kashe kwayoyin cutar kai tsaye.
Kwayoyin T masu taimakawa suna samar da cytokines masu saurin kumburi don taimakawa kwayoyin ceto.
Koyaya, COVID T zai iya hana aikin ta hanyar shiga cikin apoptosis na ƙwayoyin T.
Tsarin rigakafin cututtukan jiki wanda ya ƙunshi abubuwa da kwayoyin cuta kamar C3A da C5A suna da mahimmanci don yaƙar kamuwa da cutar.
Alal misali, ƙwayoyin cuta da aka samo daga marasa lafiya da suka warke sun kawar da MERS-CoV.
A gefe guda kuma, yawan aiki na tsarin garkuwar jiki yana haifar da tarin ƙwayoyin halitta na gida wanda zai iya haifar da mummunan lalacewar huhu da sauran gabobin jiki, kuma a mafi munin yanayin, lalacewar gabobin jiki da mutuwa.
Cutar SARS-CoV-2 da ke farawa a cikin al'umma tana iya faruwa ga tsofaffi da ke da cutar da kuma mata masu ciki.
Mutanen da ke da wasu cututtuka ko kuma waɗanda ke da tsarin garkuwar jiki da ya raunana suna iya kamuwa da cutar fiye da sauran mutane.
Matsakaicin lokacin da aka kiyasta na SARS-CoV-2 shine kwanaki 1-14, tare da kwanaki 3-7 a mafi yawan lokuta kamar yadda aka gano a cikin farkon lokuta 425 a Wuhan.
Koyaya, nazarin shari'o'i 1,099 ya nuna cewa matsakaicin lokacin tafasa ya kasance kwanaki 3 kuma ya kasance tsakanin 0 zuwa 24 days.
Kamar yadda aka bayyana a sama, binciken da aka yi kwanan nan ya nuna cewa lokacin intubation ya kasance kwanaki 4.8 (3.0-7.2) a cikin yawan mutane 8,866.
Don haka, yana da matukar mahimmanci ga jami'an kiwon lafiya su tsara lokacin keɓewa mai tasiri bisa ga mafi kyawun lokacin warkewa, don hana mutane masu kamuwa da cutar amma marasa alamun cutar daga watsa kwayar cutar ga wasu.
A matsayin matsakaiciyar hanya, mutanen da suka kamu da cutar ko kuma suka kamu da cutar za su iya zama a keɓe su na tsawon kwanaki 14.
Shin dole ne a keɓe mutum na kwanaki 24?
Zazzabi shine babban alama da farkon bayyanar COVID-19, wanda zai iya kasancewa ba tare da alamomi ba ko wasu alamomi kamar bushewar tari, tashin zuciya, jijiyoyin jiki, zazzaɓi, ciwon kai, ciwon makogwaro, rhinorrhea, ciwon kirji, zawo, tashin zuciya da amai.
Wasu marasa lafiya na iya samun dyspnea da/ko hypoxemia mako guda bayan kamuwa da cutar.
A cikin mawuyacin hali, marasa lafiya suna da saurin kamuwa da cututtukan numfashi, harin septic, acidosis na rayuwa da kuma coagulopathy.
Masu fama da zazzabi da / ko cututtukan numfashi da zazzabi mai tsanani suna buƙatar gwajin kwayar cutar don ganewar asali, koda kuwa ba a san su ba.
Wani binciken alƙaluma da aka yi a ƙarshen Disamba 2019 ya nuna cewa kashi 98 cikin ɗari na alamun cutar zazzabi ne, kashi 76 cikin ɗari na tari mai bushewa, kashi 55 cikin ɗari na dyspnea da kashi 3 cikin ɗari na zawo; kashi 8 cikin ɗari na marasa lafiya suna buƙatar taimakon iska.
Bincike biyu na kwanan nan da aka yi kan wani rukuni na mutane da ke da alaƙa da cutar da kuma wanda ba shi da alamun cutar sun nuna irin wannan binciken.
A kwatankwacin haka, binciken alƙaluma na 2012 ya nuna cewa marasa lafiyar MERS-CoV suma suna da zazzabi (98%), tari mai bushewa (47%) da dyspnea (55%) a matsayin manyan alamun bayyanar cututtuka.
Amma, kashi 80% daga cikinsu sun buƙaci taimakon iska, wanda ya fi na marasa lafiya na COVID-19 yawa kuma MERS ya fi na COVID-19 kisa.
Hakanan an gano zazzabi (26%) da ciwon makogwaro (21%) a cikin marasa lafiyar MERS.
A cikin marasa lafiyar SARS, an gano cewa zazzabi (99%-100%), tari mai bushewa (29%-75%), dyspnea (40%-42%), zawo (20-25%) da ciwon makogwaro (13-25%) sune manyan alamun bayyanar cututtuka, kuma kusan 14%-20% na marasa lafiyar suna buƙatar tallafin iska.
A ranar 14 ga watan Fabrairu, lokacin da aka tabbatar da adadin masu cutar a duniya ya kai 66,576, yawan mutuwar COVID-19 ya kai kashi biyu cikin ɗari.
Idan aka kwatanta, a watan Nuwamba na shekara ta 2002, mutuwar SARS ya kai kashi 10 cikin 100 na mutane 8,096 da aka tabbatar da cutar.
Ga MERS, yawan mutuwar ya kai kashi 37 cikin dari na mutane 2,494 da aka tabbatar da su, bisa ga binciken alƙaluma na Yuni 2012.
Nazarin da aka yi a baya ya nuna cewa SARS-CoV-2 yana da RO mafi girma 6.47 tare da 95% Confidence Interval (CI) na 5.71-7.23, yayin da SARS-CoV ke tsakanin 2 zuwa 4.
Kwatanta SARS-CoV-2 da MERS-CoV da SARS-CoV dangane da bayyanar cututtuka, yawan mutuwa da RO an nuna su a cikin tebur 1.1.
Bayanan da ke sama sun nuna cewa SARS-CoV-2 yana da ƙarfin watsawa fiye da MERS-CoV da SARS-CoV, amma ba su da haɗari.
Saboda haka, ya fi ƙalubale a sarrafa cutar SARS-CoV-2 fiye da MERS-CoV da SARS-CoV.
Yawancin lokaci, farawar ƙungiya tana farawa ne a cikin iyali ɗaya ko kuma a cikin bikin guda ɗaya ko kuma a cikin jirgin ruwa ɗaya kamar jirgin ruwa.
Marasa lafiya suna da tarihin tafiya ko zama a Wuhan ko wasu yankuna da ke fama da cutar, ko kuma sun kasance cikin hulɗa da mutanen da ke da cutar, ko kuma a cikin makonni biyu da suka gabata kafin barkewar cutar.
Koyaya, an ba da shawarar cewa mutane na iya ɗaukar kwayar cutar ba tare da alamomi ba har tsawon makonni biyu, kuma marasa lafiya da suka warke daga asibiti na iya sake ɗaukar kwayar cutar wanda ke ba da shawarar tsawaita lokacin keɓewa.
A farkon matakin, yawan marasa lafiya na al'ada ko raguwa suna da ƙwayoyin farin jini na waje (musamman: lymphocytes).
Misali, an gano marasa lafiya 1,099 na COVID-19 tare da cutar lymphopenia < 4×109/L tare da ƙididdigar ƙwayoyin cutar Lymphocyte < 1×109/L kuma an gano matakan aminotransferase da cutar ta viremia.
An sami karuwar matakan hanta da muscular enzymes da myoglobin a cikin jinin wasu marasa lafiya, kuma an sami karuwar furotin mai amsawa da kuma erythrocytes a cikin jinin yawancin marasa lafiya.
A cikin marasa lafiya masu tsanani, matakin D-dimer wanda ke haifar da lalacewar fibrin a cikin jini ya karu kuma ƙididdigar ƙwayoyin lymphocyte ya ragu sosai.
Yawancin marasa lafiyar COVID-19 sun sami rashin daidaito a cikin radiography na kirji kuma ana nuna su da inuwa ta filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen fila
Marasa lafiya galibi suna haɓaka cutar nimoniya mara kyau, mummunan rauni na huhu da mummunan ciwon numfashi (ARDS).
Lokacin da ARDS ya faru, ƙonewa mara kyau, tarin ruwa da ci gaba da duhu suna shafar musayar iska.
Rashin lalacewar nau'ikan 1 da nau'ikan 2 na ƙwayoyin cuta yana haifar da raguwar matakin farfajiya da haɓaka damuwa, wanda ke rage ƙarfin yaduwar huhu da haɓaka haɗarin cutar huhu.
Saboda haka, mafi munin sakamakon radiography yana iya zama mafi munin cututtuka.
Binciken farko na cutar COVID-19 a ranar 18 ga Fabrairu, 2020 ya nuna cewa decomposition na kwayoyin cuta, samar da murfin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Gano SARS-CoV-2 RNA ta hanyar juyawa-fassarar polymerase chain reaction (RT-PCR) an yi amfani da shi azaman babban ma'auni don gano COVID-19.
Duk da haka, saboda yawan ƙarancin ƙarancin cutar, an fara amfani da bayyanar cututtuka don ganewar asali a China a ranar 13 ga Fabrairu, 2020 (wanda ba ya dogara da RT-PCR kawai).
Haka ma cutar SARS ta faru.
Don haka, haɗuwa da tarihin cutar, bayyanar cututtuka, gwaje-gwajen dakin gwaje-gwaje da binciken radiological suna da mahimmanci kuma suna da mahimmanci don ingantaccen bincike.
A ranar 14 ga Fabrairun 2020, ƙungiyar Feng Zhang ta bayyana wata yarjejeniya ta amfani da fasahar CRISPR-based SHERLOCK don gano SARS-CoV-2, wanda ke gano zaren SARS-CoV-2 na roba a cikin awa ɗaya ba tare da buƙatar kayan aiki masu yawa ba daga 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (kwafin 10-100 a kowace microliter na shigarwar).
Da fatan idan aka tabbatar da shi a cikin samfurin magani, sabuwar fasahar na iya haɓaka ƙwarewa da sauƙi sosai.
Saboda rashin gogewa game da sabon CoV, likitoci na iya ba da kulawa ta taimako kawai ga marasa lafiya na COVID-19 kuma suna iya gwada hanyoyin magance cututtuka daban-daban da aka yi amfani da su a baya ko aka ba da shawarar a kan wasu CoVs kamar SARS-CoV da MERS-CoV da sauran cututtukan ƙwayoyin cuta (Table 2).
Wadannan hanyoyin maganin sun hada da maganin riga-kafi, magungunan rigakafi, steroids, jini, magungunan kasar Sin da kuma hanyoyin da za a iya amfani da su, ciki har da maganin rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magungunan rigakafi, magunguna, magungunan ruwa, magungunan ruwa, magunguna, magungunan ruwa, magunguna, magunguna, magunguna, magungunan ruwa, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, magunguna, mag
Ba wai kawai hakan ba, an kuma ba da shawarar yin amfani da ƙwayoyin da aka samu daga marasa lafiya da suka warke don yin maganin.
Kamfanonin harhada magunguna suna aiki tukuru don samar da rigakafi da alluran rigakafi don cutar.
SARS-CoV-2 da farko yana kai hari ga huhu kuma yana iya kai hari ga wasu gabobin da ke bayyana ACE2 kamar tsarin hanji da koda.
Saboda haka, rashin aiki da lalacewar tsarin numfashi yana haifar da babban haɗari ga marasa lafiya kuma shine babban dalilin mutuwa.
Don haka, don rage alamun cututtuka da ceton rayuka, tsarin numfashi yana buƙatar tallafi, gami da maganin oxygen na yau da kullun, oxygen mai gudana, iska mai guba da iska mai guba dangane da tsananin cutar.
Marasa lafiya da ke fama da mummunan cututtukan numfashi ya kamata su goyi bayan maganin oxygenation na membrane (ECMO), ingantaccen fasahar karamin zuciya da ake amfani da ita don cutar zuciya ko rashin lafiya na numfashi.
Bugu da kari, kiyaye daidaiton electrolyte, hana kamuwa da cuta ta biyu da harin septic da kuma kula da lafiyar jiki, da kare ayyukan gabobin jiki masu mahimmanci suna da mahimmanci ga marasa lafiya tare da SARS-CoV-2.
An gano cewa ƙarin halayen tsarin garkuwar jiki a cikin marasa lafiya na SARS da MERS suna haifar da guguwar cytokine.
Cytokine Storm wani nau'i ne na tsarin kumburi wanda ke nunawa ta hanyar sakin jerin cytokines wanda ya hada da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Wadannan cytokines suna motsa kwayoyin jikin mutum don sakin kwayoyin halitta masu yawa, wanda shine babban dalilin ARDS da kuma lalacewar gabobin jiki.
Maganin rigakafi yana da mahimmanci wajen magance guguwar cytokine, musamman ga marasa lafiya masu tsanani.
Ana amfani da maganin IL6 monoclonal antibody don magance cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Sauran maganin rigakafin cutar ta cytokine sun hada da maganin rigakafin kwayar T-cell, hana IFN-Y, IL-1 da TNF, hana JAK, Blenetumomab, mai hana siginar cytokine 4, da masu hana HDAC.
Ana amfani da kwayoyin steroid a matsayin masu hana rigakafi a cikin maganin SARS don rage tsananin lalacewar kumburi.
Koyaya, manyan allurai na steroids ba su da amfani ga mummunan raunin huhu a cikin marasa lafiya SARS da COVID-19.
Maimakon haka, suna iya haifar da mummunan sakamako masu illa, musamman: osteoarthritis na ƙwayoyin cuta, wanda zai iya shafar ganewar asali.
Koyaya, ana ba da shawarar yin amfani da ƙananan magungunan corticosteroids a cikin ƙananan allurai a cikin marasa lafiya masu cutar COVID-19 masu tsanani.
A lokacin da na rubuta wannan, babu wani magani mai tasiri da aka tabbatar da cutar.
Amma, an gano cewa remdesivir yana da tasiri lokacin da aka ba da shi cikin jijiya ga wani mai cutar COVID-19 a Amurka.
Remdesivir magani ne mai ban mamaki wanda aka fara samarwa da kamfanin GILID don magance cututtukan da ke haifar da cutar Ebola da Marlburg.
Daga baya, remdesivir ya nuna yiwuwar hana wasu ƙwayoyin cuta na RNA guda ɗaya, gami da ƙwayoyin cuta na MERS da SARS.
Da fatan, Gilead ta samar da waɗannan abubuwan ga China don gwaji akan marasa lafiya da ke fama da SARS-CoV-2, kuma sakamakon yana da matukar alƙawarin.
Bugu da ƙari, baricTNB, interferon-α, lopinavir/ritonavir, da ribavirin an ba da shawarar su zama yiwuwar magani ga marasa lafiya da ke fama da mummunan cututtukan numfashi.
Magungunan haɗin gwiwa na Lopinavir/Ritonavir na iya haifar da zazzabi, tashin zuciya, amai, lalacewar hanta da sauran halayen da ba su dace ba.
Ya kamata a lura da tasirin wadannan magunguna akan sauran magungunan da ake amfani dasu a cikin marasa lafiya.
Ana yin jini da kuma ƙwayoyin rigakafi daga marasa lafiya da suka warke.
Akwai tarihi mai tsawo na tattara jinin marasa lafiya da suka warke daga cututtuka masu yaduwa don magance cututtukan da ke kama da su ko kuma don hana mutane lafiya daga kamuwa da cuta.
Gaskiya ne cewa marasa lafiya da suka warke suna da ƙwayoyin rigakafi da yawa a cikin jinin su fiye da waɗanda suke da cutar.
Kwayoyin rigakafi don yaƙi da cututtuka da sauran abubuwan waje sune immunoglobulin (IG) waɗanda ƙwayoyin B ke samarwa waɗanda ke gano takamaiman kwayoyin halitta a cikin cututtukan kuma suna lalata su kai tsaye.
Bisa ga wannan, an tattara ƙwayoyin daga jinin rukunin marasa lafiya da suka warke daga COVID-19 kuma an saka su cikin marasa lafiya 10 masu fama da rashin lafiya.
Alamun cututtukan sun inganta cikin awanni 24, tare da rage kumburi da matsin lamba na kwayar cutar da kuma ingantaccen yaduwar oxygen a cikin jini.
Duk da haka, har sai an samar da takamaiman hanyoyin magani, ana buƙatar tabbatarwa da bayani don amfani da yawa.
A lokaci guda, wasu rashin amfani da ke tattare da kwayoyin halitta dole ne a yi la'akari da su sosai don samun sakamako mai kyau.
Misali, kwayoyin cutar na iya haifar da mummunan amsawar rigakafi da haifar da cutar sakin cytokine, wanda zai iya zama mai guba.
Yawan adadin kwayoyin cutar a cikin jini yawanci ba shi da yawa kuma ana buƙatar ƙwayoyin don kula da marasa lafiya masu tsanani.
Yana da wahala a samar da takamaiman kwayoyin cutar da sauri don yaƙar cutar ta duniya.
Saboda haka, yana da mahimmanci kuma mai amfani don ware ƙwayoyin B daga marasa lafiya da suka warke kuma gano lambobin kwayoyin da ke ɓoye ƙwayoyin cuta masu tasiri ko gwada ƙwayoyin cuta masu tasiri akan sunadarai masu mahimmanci na kwayar cutar.
Ta wannan hanyar, za mu iya ƙara yawan samar da ƙwayoyin cuta.
An yi amfani da TCM don magance cututtuka daban-daban a China tsawon dubban shekaru.
Koyaya, tasirinsa ya dogara da yawancin abubuwan haɗin da ke cikin tsarin da aka tsara don gane cutar bisa ga ka'idar TCM.
Yawancin abubuwan da ke tasiri ba a sani ba ko kuma ba a sani ba saboda yana da wuya a cire da kuma tabbatar da irin waɗannan abubuwa ko kuma haɗuwa da su.
A halin yanzu, saboda rashin ingantaccen magani na musamman don COVID-19, TCM ya zama zaɓi na magani ga marasa lafiya masu saurin nuna alamun cutar ko waɗanda suka warke daga mawuyacin yanayi.
Misali, an gano cewa capsules na Shu Feng Ji Do da Lian Hua King Wen capsules suna da tasiri ga marasa lafiya COVID-19.
A lardunan kasar Sin da ke amfani da TCM don magance COVID-19 kashi 87% na marasa lafiya sun sami mafi girman adadin warkewa, gami da Gansu (63.7%), Ningxia (50%) da Hunan (50%), yayin da lardin Hubei, inda aka yi amfani da TCM a cikin kashi 30% na marasa lafiyar COVID-19, ya sami mafi ƙarancin adadin warkewa (13%).
Amma wannan kwatancen ya yi kadan ne saboda wasu abubuwan tasiri kamar yawan marasa lafiya da kuma tsananin cutar ya kamata a hada su cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Bui Zhang da abokan aiki sun buga wani bincike da ke kwatanta magungunan Yammacin Turai (WM) da haɗin magungunan WM da TCM.
Sun gano cewa lokacin dawo da zafin jiki, bayyanar cututtuka da kwantar da asibiti sun kasance ƙasa da ƙasa a cikin rukunin WM + TCM fiye da rukunin WM kawai.
Mafi mahimmanci, yawan haɓakar alamun (mai laushi zuwa mai tsanani) ya kasance ƙasa da ƙasa a cikin WM+TCM fiye da rukunin WM kawai (7.4% vs 46.2%) da kuma ƙananan mutuwar a cikin rukunin WM+TCM fiye da rukunin WM kawai (8.8% vs 39%).
Koyaya, don tabbatar da inganci da amincin TCM, ana buƙatar yin gwaji mai kyau a cikin cibiyoyi da yawa.
Yana da wuya a bayyana yadda ake aiki da kuma bayyana abubuwan da ke cikin maganin TCM ko kuma haɗuwa da su idan zai yiwu.
Yawancin marasa lafiya da ke da cutar COVID-19 da aka tabbatar ko ake zargi da cutar suna fama da cututtuka masu saurin yaduwa ko cututtuka masu saurin mutuwa, kuma mutanen da ke keɓewa suna fuskantar rashin jin daɗi, kaɗaici da fushi.
Hakanan, alamun kamuwa da cuta kamar zazzabi, hypoxia da tari da kuma illolin magani kamar rashin bacci da ke haifar da corticosteroids na iya haifar da damuwa da baƙin ciki.
A farkon lokacin barkewar cutar SARS, an samu ciwon zuciya kamar ci gaba da damuwa, damuwa, firgita, tashin hankali, alamun cutar ta Durman, rikice-rikice da tunanin kashe kansa.
Binciken tuntuɓar da ke tattare da keɓewa a matsayin ɓangare na amsar lafiyar jama'a ga ɓarkewar COVID-19 na iya sa mutane su ƙara damuwa game da kamuwa da cuta, keɓewa, da laifi tsakanin dangi da abokai.
Don haka, ya zama dole a samar da kulawar lafiyar kwakwalwa ga marasa lafiya, wadanda ake zargi da cutar COVID-19, da mutanen da suka yi hulɗa da su, da kuma sauran mutanen da ke cikin bukata.
Tallafin tunani ya hada da kafa rukunin kiwon lafiya na tunani da yawa, tattaunawa ta yau da kullun game da labarai na yau da kullun da kuma shirye-shiryen magani game da barkewar SARS-CoV-2, amfani da kayan aikin lantarki na kasuwanci da kuma amfani da aikace-aikacen don guje wa kusanci da wasu.
Ana buƙatar allurar rigakafi mai tasiri don karya sarkar watsawa daga ajiyar kwayar cutar a cikin dabbobi da kuma daga mai cutar ɗan adam zuwa mai karɓar cutar, kuma ana iya amfani da allurar rigakafi don maganin rigakafi don sarrafa cutar da ke haifar da ƙwayoyin cuta masu tasowa.
Ana ƙoƙarin haɓaka allurar rigakafin S-protein don samar da rigakafi mai ɗorewa da tasiri da/ko rigakafin kariya ga SARS-CoV.
An kimanta alluran rigakafin SARS masu rai-mai rauni akan samfuran dabbobi.
Koyaya, har yanzu ba a gano abubuwan da ke karewa daga cututtukan da ke yaduwa da dabbobi ba a cikin tsofaffi da suka sami damar yin aiki da kuma ƙalubalen rayuwa a cikin waɗanda aka ba da allurar rigakafin kafin fara binciken asibiti.
Wannan na iya zama saboda SARS ya ƙare shekaru 17 da suka gabata kuma babu wani sabon shari'ar da aka ruwaito tun daga wannan lokacin.
Akasin haka, wasu ƙananan cututtukan da wasu manyan abubuwan da suka faru na MERS sun samo asali ne a cikin ƙasashen Gabas ta Tsakiya kuma suna ci gaba da yaduwa zuwa wasu yankuna, wanda ke nuna cewa akwai tushen dabbobin da ke cikin yankin.
An tsara dabarun rigakafin MERS ta amfani da ƙwayoyin cuta marasa tasiri, plasmids na DNA, masu ɗaukar hoto, ƙwayoyin cuta, ƙwayoyin cuta kamar ƙwayoyin cuta da ƙwayoyin cuta masu sake haɗawa, kuma an kimanta wasu daga cikin su akan samfuran dabbobi.
Samar da ingantaccen allurar rigakafi ga SARS-CoV-2 ga marasa lafiya shine aiki mai gaggawa da mahimmanci don annobar da ke faruwa.
Duk da haka, shawo kan wannan ƙalubalen yana da ƙalubale saboda ana buƙatar lokaci mai tsawo (a matsakaita watanni 18) don haɓaka allurar rigakafi da haɓaka bambancin CoV.
A matsayin sabon cuta, COVID-19 yanzu ya fara nuna cikakkiyar hanyar warkewa a cikin dubban marasa lafiya.
A mafi yawan lokuta, mai haƙuri zai iya murmurewa a hankali ba tare da sakewa ba.
Koyaya, kamar SARS da MERS, COVID-19 yana da alaƙa da ƙimar rashin lafiya da mutuwa a cikin mawuyacin hali.
Don haka, akwai buƙatar kafa samfurin bincike don cibiyoyin kiwon lafiya su fifita ayyukansu, musamman a yankunan da ba su da albarkatu.
Dangane da nazarin asibiti da aka ruwaito zuwa yanzu, abubuwan da ke gaba suna iya kasancewa suna da alaƙa ko tasiri ga ganewar asali na marasa lafiya na COVID-19 (Table 33):
Shekaru: Shekaru sune babban mahimmin abu don gano cutar SARS, kamar yadda yake ga COVID-19.
A cikin nazarin shari'o'i 8,866, kamar yadda aka bayyana a sama, kashi 47.7 cikin ɗari na marasa lafiya da suka kamu da COVID-19 waɗanda shekarunsu suka haura 50 sun kasance tsakanin 30-65.
Marasa lafiya da ke buƙatar kulawa mai tsanani sun fi saurin samun cututtuka da rikitarwa kuma sun tsufa sosai fiye da waɗanda ba su da su (a matsakaicin shekaru 51 da 66), wanda ke nuna cewa shekaru shine babban abin da ke haifar da cutar ga marasa lafiya na COVID-19.
Jima'i: Kamar yadda aka bayyana a sama, SARS-CoV-2 yana kamuwa da maza fiye da mata (0.31/1,00,000 vs. 0.27/1,00,000).
Coma da rikitarwa: Marasa lafiya na COVID-19 waɗanda ke buƙatar kulawa mai tsanani suna iya fuskantar matsaloli kamar cututtukan zuciya da rashin ƙarfi.
Cutar zuciya ita ma babbar hanyar mutuwa a cikin marasa lafiyar SARS.
An kuma ba da rahoton cewa SARS-CoV-2 yana ɗaure da colangiocytes masu ACE-2 mai kyau, wanda zai iya haifar da lalacewar hanta a cikin marasa lafiya COVID-19.
Yana da mahimmanci a lura cewa alaƙar shekaru da cututtukan da ake ciki suna da mahimmanci kuma suna iya shafar juna.
Binciken dakin gwaje-gwaje na yau da kullun: Matsayin jini na C-reactive protein (CRP) yana nuna tsananin kumburi ko raunin nama kuma yana iya kasancewa mai saurin kamuwa da cuta, amsawa ga magani da kuma dawowa na ƙarshe.
Hakanan an nuna alaƙar matakan CRP tare da tsananin cutar COVID-19 da kuma ganewar asali.
Bugu da ƙari, ƙaruwa a cikin lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Ana bayyana wadannan kwayoyin a cikin gabobin jiki, musamman a zuciya da hanta, kuma ana sakin su a cikin jijiyoyin jiki.
Saboda haka, su ne alamun da aka saba amfani da su wajen gano ciwon zuciya ko na hanta.
Manyan alamun kiwon lafiya: Radiography na kirji da haɓaka na lokaci-lokaci na alamun kiwon lafiya dole ne a yi la'akari da su tare da sauran matsalolin don tantance sakamakon da kuma tsinkayar cutar COVID-19.
Amfani da steroids: Kamar yadda aka bayyana a sama, steroids sune masu hana rigakafi waɗanda ake amfani dasu azaman magungunan taimako don cututtukan cututtuka don rage tsananin lalacewar kumburi.
Saboda yaduwar amfani da maganin corticosteroids mai yawa a cikin marasa lafiya masu fama da cutar SARS, yawancin waɗanda suka tsira sun kamu da cututtukan da ba a iya jurewa ba, gami da nakasa da rage tsawon rai.
Don haka, ya kamata a yi amfani da steroids a cikin ƙananan allurai da gajeren lokaci a cikin marasa lafiya na COVID-19 idan an buƙata.
Matsin lamba: Kamar yadda aka bayyana a sama, yawancin marasa lafiya suna fama da ƙarin damuwa yayin barkewar COVID-19 saboda sun kasance cikin keɓewa na dogon lokaci da yanayin rashin tabbas da kuma shaida mutuwar danginsu da ƙaunatattun su.
Bayar da shawarwari na tunani da tallafi na dogon lokaci yana da mahimmanci don su warke daga damuwa da komawa rayuwar yau da kullun.
A cewar nazarin alƙaluma da aka yi har zuwa yanzu, cutar COVID-19 ta bambanta da SARS.
SARS-CoV-2 na iya sakewa cikin ƙarancin iska fiye da na sama kuma yana iya zama mai sauƙi ko ba tare da alamun bayyanar cututtuka ba a farkon lokacin kamuwa da cuta, kamar sauran CoVs waɗanda ke haifar da sanyi.
Don haka, marasa lafiya da ke cikin farkon matakin ko kuma lokacin riƙewa na iya samar da ƙwayoyin cuta da yawa yayin ayyukan yau da kullun, wanda zai iya zama da wahala a sarrafa cutar.
Koyaya, ana tsammanin kamuwa da SARS-CoV yana yaduwa lokacin da marasa lafiya ke cikin mawuyacin hali, yayin da yawancin kamuwa da cuta ba sa faruwa a farkon matakan.
Saboda haka, cutar COVID-19 ta yanzu ta fi ta SARS tsanani kuma tana da wahalar sarrafawa.
A halin yanzu, ana yin ƙoƙari sosai a China, gami da kulle Wuhan da biranen da ke kewaye da shi da kuma keɓe kusan dukkanin jama'a a cikin keɓewa na dindindin, don dakatar da yaduwar SARS-CoV-2.
Duk da cewa wadannan ayyukan suna haifar da mummunan sakamako ga tattalin arziki da sauran sassan kasar, yawan sabbin masu cutar na raguwa kuma hakan yana nuna cewa cutar ta ragu.
Hasashen mafi kyawun shine cewa barkewar cutar za ta ƙare a watan Maris kuma za a ci gaba da raguwa har tsawon watanni 3-4.
Amma wasu masana ba su da tabbaci.
Paul Hunter, masanin kimiyyar halittu, ya yi hasashen cewa COVID-19, wanda ya fi SARS kamuwa da cuta, ba zai ƙare a shekarar 2020 ba.
Ira Langini ya kafa wata hanyar da za ta iya hango sakamakon cutar kuma ya nuna cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan mutanen duniya.
Wata kungiyar Kanada ta ba da rahoton cewa an gano SARS-CoV-2 a cikin mid-turbinate da kuma swabs na makogwaro na wani mai haƙuri wanda aka sallama daga asibiti makonni 2 da suka gabata bayan warkewa daga cutar, wanda ke nuna cewa sabon kwayar cutar da aka gano na iya kasancewa cikin jerin cututtukan mura.
Duk da haka, akwai alamun fatan daga China dangane da raguwar sabbin cututtukan, wanda ke nuna tasirin manufofin da ake bi yanzu.
Da farko an yi hasashen cewa cutar Ebola za ta kai mutum miliyan daya da mutuwar mutane miliyan biyar.
Amma, saboda tsananin killacewa, cutar ta ƙarshe ta kasance ƙarƙashin iko.
Zai yiwu cewa SARS-CoV-2 kamar SARS-CoV zai yi rauni har ya zama mara tasiri kuma a ƙarshe ya ɓace ko ya zama ƙarancin ƙwayar cuta mai cutarwa tare da ɗan adam.
Kwatanta cutar ta COVID-19 da cutar ta SARS da MERS an nuna su a kasa (Figure 55).
SARS-CoV-2 yana da saurin yaduwa ta hanyar tari ko hancinsa kuma ana iya kamuwa da shi ta hanyar hulɗa kai tsaye da kayan da cutar ta gurɓata.
An kuma gano kwayar cutar a cikin shara, wanda hakan ya haifar da sabon yiwuwar kamuwa da cutar ta hanyar bakin ciki.
Wani sabon bincike da aka yi kan mutane 138 ya nuna cewa kashi 41 cikin dari na masu cutar na iya kasancewa daga kamuwa da cuta a asibiti, tare da 17 da ke da wasu cututtuka da suka gabata da kuma 40 daga cikin masu ba da kiwon lafiya.
Saboda haka, akwai bukatar a kula sosai don kare mutane, musamman ma masu kula da lafiya, ma'aikatan zamantakewa, dangi, abokan aiki da kuma wasu da ke cikin haɗuwa da marasa lafiya ko masu kamuwa da cutar.
Mataki na farko na kariya don rage haɗarin kamuwa da cuta shine sanya abin rufe fuska; abin rufe fuska na tiyata da abin rufe fuska na N95 (jerin #1860s) duka suna taimakawa hana yaduwar kwayar cutar.
Masks na tiyata suna hana ruwa daga cikin iska daga mutane masu yuwuwar kamuwa da cutar zuwa saman kayan, don haka ba za su iya cutar da wasu ba.
Koyaya, kawai N95 (jerin # 1860) masks na iya dakatar da numfashi na ƙwayoyin cuta daga 10 zuwa 80 nm, wanda kawai kashi 5% na ƙwayoyin cuta zasu iya shiga gaba ɗaya; SARS-CoV-2 yayi kama da SARS-CoV a cikin girman kuma duka suna da kusan 85 nm.
Tun da yake ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin
Baya ga abin rufe fuska, masu ba da kiwon lafiya suna buƙatar sanya rigunan keɓewa masu dacewa don hana hulɗa da kwayar cutar.
Kwayar cutar tana iya kamuwa da mutane ta hanyar idanu.
A ranar 20 ga Janairun 2020, likitan ya kamu da SARS-CoV-2 duk da saka abin rufe fuska na N95; mai yiwuwa kwayar cutar ta shiga jikinsa ta hanyar idanunsa masu ƙonewa.
Don haka, masu ba da kiwon lafiya suna buƙatar sanya abin rufe fuska ko tabarau yayin aiki tare da marasa lafiya.
Ana ba da shawara ga jama'a a yankunan da ke fama da cutar ko kuma waɗanda za su iya kamuwa da cutar cewa kowa ya wanke hannayensu da sabulu mai kashe ƙwayoyin cuta sau da yawa fiye da yadda ya saba, ya kasance a cikin gida don keɓe kansa, kuma ya iyakance hulɗa da mutanen da za su iya kamuwa da cutar.
An yi amfani da nisan kafa uku don nisantar mutane daga marasa lafiya.
Wadannan ayyukan an dauke su ingantattun hanyoyi ne na rage hadarin kamuwa da cutar da kuma hana yaduwar kwayar cutar.
Kodayake SARS-CoV-2 ya zo ga ɗan adam a matsayin sabon kwayar cuta, tun da yake yana da alaƙa da SARS-CoV kamar yadda aka ruwaito a ranar 7 ga Janairu 2020, abubuwan da suka faru a lokacin barkewar cutar SARS a 2003 ya kamata su zama ƙararrawa mai ƙarfi a China.
Amma a ranar 19 ga Janairu, 2020, darektan Cibiyar Kula da Cututtuka ta Wuhan ya gaya wa mutane cewa sabon kwayar cutar ba ta da saurin kamuwa da cuta kuma ba ta da sauƙin haifuwa daga mutum zuwa mutum kuma ba ta da wahalar hanawa da sarrafa cutar.
Wannan sakon ya rage yawan fargabar jama'a musamman a lokacin da kasar ke shirin bikin bazara kuma Wuhan ta rasa wani muhimmin lokaci don kiyaye cutar a matakin da ya dace.
Hukumar Kula da Cututtuka ta kasar Sin na iya koyon darasi daga wannan mummunan darasi kuma ta yi canje-canje masu mahimmanci a nan gaba.
Misali, wadannan kungiyoyi suna bukatar su dauki wadannan matakan kariya: (1) su kara taka tsantsan wajen yin sanarwa ga jama'a saboda duk wata kalma da aka fada wa 'yan kasa tana da mahimmanci kuma tana iya canza halinsu da yanke shawara; (2) su kara nuna kulawa da kuma amsawa ga bayanan da ba a saba gani ba a asibitoci ba tare da jiran rahotannin likita ko ma'aikacin jinya ba; (3) sanya karin takunkumi don hana yiwuwar barkewar cutar a farkon matakan maimakon kwantar da hankalin jama'a; da kuma (4) bayar da atisaye masu tasiri da tasiri a lokaci-lokaci don wayar da kan jama'a game da cutar da kuma gwadawa da inganta tsarin amsawar al'umma.
Cutar COVID-19 ta samo asali ne daga sabon kwayar cutar SARS-CoV-2, wanda ya fara a ƙarshen Disamba 2019.
A cikin watanni biyu na rubuta wannan labarin, ya bazu ko'ina cikin kasar Sin da kuma kasashe 50 a duniya.
Tun da yake kwayar cutar ta yi kama da SARS-CoV kuma alamun cutar sun yi kama da na COVID-19 da SARS, barkewar COVID-19 ta haifar da jin cewa SARS ya dawo.
Koyaya, akwai wasu bambance-bambance masu mahimmanci tsakanin COVID-19 da SARS, waɗanda ke da mahimmanci don sarrafa cutar da kuma kula da marasa lafiya.
COVID-19 yana shafar tsofaffi fiye da matasa da maza fiye da mata, kuma yana da mafi girman mawuyacin hali da mutuwar tsofaffi fiye da matasa.
Yawan mutuwar SARS ya fi na COVID-19 girma (10.91% vs. 1.44%).
Marasa lafiya na COVID-19 suna kamuwa da kwayar cutar ba tare da alamomi ba, yayin da marasa lafiya na SARS ke kamuwa da cutar bayan sun kamu da rashin lafiya, wanda ya sa hana yaduwar COVID-19 ya fi SARS wahala.
Wannan ya bayyana wani ɓangare na dalilin da yasa SARS-CoV-2 ke yaduwa da sauri kuma ya fi SARS-CoV yawa.
A wasu marasa lafiya na COVID-19, gwajin RNA na yau da kullun na SARS-CoV-2 na iya zama mara kyau.
A gefe guda kuma, marasa lafiya da suka warke suna iya sake yin kwayar cutar.
Wadannan binciken sun kara yawan hadarin yaduwar kwayar cutar.
Wannan ci gaba mai sauri a cikin binciken COVID-19 bai warware wasu mahimman batutuwa ba, kamar:
Daga ina ne SARS-CoV-2 ya fito?
Ko da yake an gano daidaiton kwayoyin halitta na 96% tsakanin SARS-CoV-2 da SARS-like CoVs biyu, ba za mu iya yanke shawarar cewa SARS-CoV-2 ya fito ne daga jemage ba.
Wane dabba ne ya zama nau'in matsakaici don watsa kwayar cutar daga asalin mai masaukin, jemage ko mutane?
Ba tare da sanin amsoshin # 1 da 2 ba, ba za mu iya dakatar da kamuwa da cuta yadda ya kamata ba, kuma barkewar cutar na iya dawowa a kowane lokaci.
Ko da yake samfurin kwayoyin halitta da kimantawa na biochemical sun nuna cewa SARS-CoV-2 yana ɗaure ACE2, ta yaya kwayar cutar ke shiga cikin ƙwayoyin iska kuma ta canza yanayin cutar?
Shin kwayar cutar tana ɗaure ƙwayoyin bayyanawa na ACE-2 a wasu gabobin jiki?
Idan ba mu da amsoshi masu kyau ga waɗannan tambayoyin ba za mu iya samun saurin ganewar asali da kuma magani mai inganci ba.
Har yaushe cutar za ta ci gaba?
Ta yaya kwayar cutar ke bunkasa ta hanyar kwayoyin halitta yayin kamuwa da cutar a cikin mutane?
Shin zai zama annoba ta duniya, ko kuma ya mutu kamar SARS, ko kuma ya ci gaba da zuwa kamar mura?
Waɗannan da sauran tambayoyin suna da amsoshi da yawa da za a bincika, amma hakan na iya ɗaukar lokaci.
Amma duk da haka, ba mu da wani zaɓi sai dai mu kawo ƙarshen cutar da wuri-wuri kuma mu dawo da rayuwarmu ta yau da kullun.
An gano cewa cutar coronavirus ta mutum ta samo asali ne daga dabbobi.
Tun shekaru dubbai, juyin halitta da daidaitawa sun haifar da juyin halitta na coronaviruses (CoVs) da kwayoyin halittar su, gami da mutane.
Kafin 2003, an san cewa wasu cututtukan mutum guda biyu da ake kira HCoVs suna haifar da rashin lafiya kamar sanyi.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
An sake gano cutar coronavirus tare da bayyanar SARS-CoV-2 a tsakiyar China a ƙarshen 2019, kuma mun yi mamakin yadda ta kasance mai saurin yaduwa amma ba ta da cutarwa kamar ta SARS-CoV.
HCoV shine cutar da ke tattare da dabbobi, saboda haka yana da kyau mu fahimci asalin cutar HCoV.
Yawancin HCoVs sun samo asali ne daga jemage, inda ba su da cutar.
Wasu daga cikin kwayoyin HCoVs masu tsaka-tsakin kwayoyin halitta sun san su.
Gano abubuwan gina jiki na dabbobi na iya haifar da tasiri kai tsaye don hana cututtukan ɗan adam.
Binciken hulɗar COVID-Paramid a cikin dabbobi na iya ba da haske game da mahimman bayanai game da cutar COVID a cikin mutane.
A cikin wannan bita, muna ba da bita game da bayanan da muke da su game da HCoVs bakwai, tare da mai da hankali kan tarihin binciken su da kuma asalin su da kuma kamuwa da cututtukan da ke cikin dabbobi.
Abu mai mahimmanci, muna kwatanta HCoVs daban-daban daga yanayin haɓakar kwayar cuta da sake fasalin kwayoyin halitta.
An tattauna game da cutar COVID-19 a halin yanzu.
Bugu da kari, an kuma jaddada bukatar samun nasarar sauya abinci mai gina jiki da kuma tasirin juyin halittar kwayar cutar akan cutar.
Coronavirus (COV) na cikin dangin Coronaviridae, wanda ya ƙunshi rukuni na ƙwayoyin cuta masu ɗauke da ƙwayoyin cuta masu ɗauke da ƙwayoyin cuta guda ɗaya.
Waɗannan ƙwayoyin cuta na RNA waɗanda ke da mafi girman ƙwayoyin halitta na kilobases 26-32 ana kiransu "COV" saboda suna kama da rawanin a cikin microscope na lantarki.
A tsarin, COVs suna da kwayoyin halittar da ba a rarraba su ba waɗanda ke da tsari iri ɗaya.
Kimanin kashi biyu bisa uku na kwayoyin halitta suna da manyan manyan maɓallan buɗewa (ORF1a da ORF1b), waɗanda aka canza zuwa pp1a da pp1ab polyproteins.
Ana sarrafa polyproteins don samar da sunadarai 16 marasa tsari, waɗanda aka sanya su a cikin jerin NSP1-16.
Sauran ɓangaren kwayoyin halitta sun ƙunshi ORFs don gina furotin, wanda ya haɗa da spike (S), envelope (E), membrane (M) da nucleoprotein (N).
Hakanan ana amfani da ƙwayoyin cuta masu taimako da yawa na musamman don tsara kwayoyin cuta daban-daban na COVID.
An rarraba COVs zuwa ƙarni huɗu bisa ga jerin sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen
Shaidar phylogenetic ta nuna cewa jemage da beraye suna aiki a matsayin tushen kwayoyin halitta don yawancin alpha-CoVs da beta-CoVs yayin da tsuntsaye sune manyan masu ciyarwa don gamma-CoVs da delta-CoVs.
A cikin dubunnan shekaru, COVIDs sun ci gaba da ƙetare shingen jinsuna kuma sun fito a matsayin manyan cututtukan ɗan adam.
A yau, an san mutane bakwai da ke dauke da cutar ACOV.
Daga cikin su, HCoV-229E da HCoV-NL63 sune Alpha-CoV.
Sauran beta-CoVs guda biyar sun hada da HCoV-OC43, HCoV-HKU1, Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan SARS-Covirus.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 yawanci suna haifar da alamun rashin lafiya kamar sanyi da / ko zawo.
Sabanin haka, SARS-CoV, MERS-CoV da sabon SARS-CoV-2 wanda aka gano suna da cutarwa sosai, suna haifar da cututtukan cututtukan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
A cikin shekarun 1960 ne aka gano kwayar HCoV-229E ta farko, B814 daga ɓoyayyen hanci na marasa lafiyar sanyi.
Tun daga wannan lokacin, an sami ƙarin ilimi ta hanyar nazarin HCoV-229E da HCoV-OC43, waɗanda ke haifar da alamun cutar.
A gaskiya, har zuwa barkewar SARS, an yi imani cewa kamuwa da cutar HCoV ba ta da lahani.
Cutar SARS ta 2003 ta kasance ɗaya daga cikin ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓar ɓarnar ɓar.
Shekaru goma bayan haka, barkewar cutar murar MERS ta Gabas ta Tsakiya ta haifar da barkewar cutar a cikin yankin Larabawa wanda ya bazu cikin sauri zuwa sauran duniya.
Sabuwar HCoV-2019 (2019-NCoV), wanda daga baya aka sake masa suna SARS-CoV-2, ita ce hanyar da ta haifar da annobar cutar coronavirus ta 2019 (COVID-19), wacce ta yi sanadiyar mutuwar sama da 3,120 da kuma kamuwa da mutane sama da 91,000 har zuwa 3 ga Maris, 2020.
Ƙararrawar barazana tana ci gaba da ƙarawa kuma dole ne duniya ta shirya don yaduwar SARS-CoV-2.
Dukkanin cututtukan da ke cikin ACOV guda bakwai suna da asali a cikin bat, bera ko dabbobi.
Shaidu daban-daban suna ba da ƙarfi ga ka'idar cewa sun samo asali ne daga jemage, inda ƙwayoyin cuta suka ɗauki matsayin kuma ba su da cutar amma suna nuna bambancin kwayoyin halitta.
Cutar COVID-19 ta kawo kalubale na kiwon lafiya, kimiyya, zamantakewa da ɗabi'a ga Sin da duniya.
Binciken asalin cutar da ke tattare da ACOV ya nuna tarihin halitta, abubuwan motsawa da kuma abubuwan da ke hana sauye-sauye a cikin jinsuna.
Hakanan zai jagoranci ko sauƙaƙe gano wuraren zama, masu ba da izini da masu haɓaka kwayoyin cuta (V) na SARS-CoV-2, wanda zai taimaka wajen yin mahimman ayyuka don hana yaduwar sa a nan gaba.
A cikin wannan bita, mun ba da bita game da asalin cututtukan dabbobin dabbobi, kamuwa da cuta tsakanin jinsuna da kuma cutar HCoV.
Musamman: Mun jaddada batutuwan da ke gaba kuma mun tattauna cewa kwayar cutar HCoV ba ta da cutar a cikin kwayoyin halittar ta halitta amma ta zama mai cutarwa yayin kamuwa da cutar ta hanyar sabbin kwayoyin halitta.
Mun kuma bincika yadda HCoVs ke juyin halitta, wanda idan ya karu, zai rage yawan kamuwa da cuta.
An kuma tattauna game da tasirin barkewar cutar SARS-CoV-2 da ke gudana.
An san game da cutar COVID a cikin dabbobi tun daga ƙarshen 1930s.
Kafin a fara gano HCoV-229E mai cutar B814 daga ɓarkewar hanci na mai cutar sanyi, an gano wasu nau'ikan COVID-19 daban-daban daga dabbobi daban-daban da ke dauke da cutar, wadanda suka hada da turkey, beraye, shanu, aladu, kuliyoyi da karnuka.
An gano HCOV guda bakwai a cikin shekarun da suka gabata.
A taƙaice, taƙaitaccen taƙaitaccen binciken HCoV a cikin jerin lokuta (Table 1) zai zama mai ba da bayani da kuma bayani.
An fara gano HCoV-229E daga marasa lafiya da ke fama da cutar sama a shekara ta 1966 kuma daga nan ne aka samu kwayoyin halittar WI-38 na huhu.
Marasa lafiya da ke dauke da HCoV-229E sun nuna alamun sanyi kamar ciwon kai, atishawa, ƙumburi da ciwon makogwaro, da zazzabi da tari a cikin kashi 10-20% na masu cutar.
Daga baya, a shekara ta 1967, an ware HCoV-OC43 daga ƙananan kwayoyin halitta na ƙananan beraye, sannan daga ƙwaƙwalwar ƙwaƙwalwa.
Alamar asibiti ta kamuwa da cutar HCoV-OC43 ta bayyana kamar cutar HCoV-229E, wacce ba za a iya rarrabe alamun bayyanar cututtuka daga sauran cututtukan cututtukan numfashi kamar su cutar mura A da rhinoviruses ba.
HCoV-229E da HCoV-OC43 duka suna yaduwa a duniya kuma ana kamuwa da su ne a lokacin hunturu a yanayin zafi.
A yadda aka saba, lokacin warkewa na kamuwa da waɗannan ƙwayoyin cuta biyu bai kai mako ɗaya ba sannan kusan makonni biyu na rashin lafiya.
A cikin nazarin da aka yi a kan masu sa kai, an gano cewa mutane masu lafiya da ke dauke da HCoV-229E sun kamu da sanyi mai sauƙi.
Wasu marasa lafiya da ke da rashin lafiya suna fama da cututtukan ƙananan iska.
SARS wanda ake kira "Atypical Pneumonia" shine farkon HCoV mai yaduwa a cikin tarihin ɗan adam kuma mai haifar da cutar SARS-CoV shine HCoV na uku da aka gano.
An gano cutar SARS ta farko a lardin Guangdong na kasar Sin a karshen shekara ta 2002.
Cutar ta SARS ta haifar da mutane 8,096 da suka kamu da cutar, tare da mutuwar 774, wanda ya bazu zuwa ƙasashe da nahiyoyi da yawa.
Ba tare da masu yaduwa ba, an kiyasta cewa kowane shari'ar na iya haifar da kusan cututtukan cututtukan biyu, tare da lokacin tafasa na kwanaki 4 zuwa 7 kuma ƙarancin tasirin kwayar cutar na iya bayyana a rana ta goma bayan kamuwa da cuta.
Marasa lafiya da ke dauke da SARS-CoV na iya fara fama da ciwon tsoka, ciwon kai, zazzabi, ƙwanƙwasawa da sanyi, sannan numfashi, tari da wahalar numfashi.
Rashin ƙwayar lymphocytes, rashin aikin hanta da kuma karuwar creatinine kinase sune abubuwan da aka saba gani a cikin dakin gwaje-gwaje na SARS.
Hakanan an gano lalacewar alveolar difuse, haɓakar ƙwayoyin cuta da haɓaka macrophages a cikin marasa lafiyar SARS.
Kimanin kashi 20-30 na marasa lafiya suna buƙatar kulawa mai tsanani da iska mai aiki bayan haka.
A cikin ƙananan hanyoyin numfashi, hanta, hanta da koda suna iya kamuwa da wannan mummunan cuta, sau da yawa yakan haifar da guguwar cytokine, wanda zai iya zama mai haɗari musamman ga marasa lafiya masu rauni.
An fara ware kwayar cutar ne daga buɗewar huhu daga wani dangi na wani mai haƙuri wanda ya zo Hong Kong daga Guangzhou.
Tun daga wannan lokacin, an yi ƙoƙari sosai don bincika HCoV.
An gano HCoV-NL63 daga jariri mai wata bakwai a Netherlands a ƙarshen shekara ta 2004.
Da farko an gano shi a cikin yara, tsofaffi da marasa lafiya da ke fama da cutar numfashi mai rauni.
Cutar da HCoV-NL63 ke haifarwa yawanci tana haifar da sanyi, zazzabi, zazzabi da kuma cututtukan huhu.
Wani bincike na daban ya nuna cewa an ware kwayar cutar daga hancin jariri mai wata takwas da ke fama da cutar huhu a Netherlands.
Ko da yake an samo shi ne a Netherlands, amma ya yadu a duniya.
An kiyasta cewa HCoV-NL63 yana da alhakin kashi 4.7% na cututtukan numfashi na yau da kullun, kuma ana samun mafi yawan ɓarkewar cutar a lokacin bazara, bazara da farkon hunturu.
HCoV-NL63 yana da alaƙa da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
A wannan shekarar, an gano HCoV-HKU1 daga wani mutum mai shekaru 71 da aka kwantar da shi a asibiti don ciwon huhu da kuma ciwon huhu a Hong Kong.
HCoV-HKU1 yana da alaƙa da cututtukan asma mai tsanani, gami da cutar nimoniya da cutar huhu da aka samu a cikin al'umma.
HCoV-HKU1, kamar HCoV-NL63, HCoV-229E da HCoV-OC43, ana samun su a duk duniya wanda ke haifar da cututtukan numfashi masu saurin gaske.
Dukkanin HCoVs huɗu da aka samu a cikin al'umma suna da kyau a cikin mutane kuma ba su da wata cuta mai tsanani, amma har yanzu ba a san dalilin da ya sa ba za a iya samun hatsari ba kamar yadda ya faru da wasu ƙwayoyin cuta na HCoV-NL63 da aka ruwaito kwanan nan a China wanda ke haifar da mummunan cututtukan ƙananan numfashi.
A yadda aka saba, idan waɗannan HCoVs sun sami damar kamuwa da cutar sosai kuma suna ci gaba da kasancewa cikin mutane, su ma suna da ƙarancin cutar ko cutar.
A shekarar 2012, an fara gano MERS-CoV a cikin wani mutum mai shekaru 60 a Saudiyya wanda ke fama da ciwon huhu da kuma ciwon koda.
Kodayake yawancin cututtukan da aka tabbatar sun samo asali ne daga Gabas ta Tsakiya, an sami wasu lokuta a cikin ƙasashen Turai da Tunisia da aka shigo da cututtukan na biyu saboda kusanci.
A shekara ta 2015, an samu barkewar cutar a Koriya ta Kudu inda aka samu mutum 186.
Alamun cututtukan MERS sun yi kama da na SARS, wanda ke nuna ci gaba da ciwon huhu mai tsanani.
Ba kamar SARS ba, yawancin marasa lafiya da ke fama da cutar MERS suna fama da mummunan ciwon koda, wanda ba a saba gani ba a cikin cututtukan da ke haifar da HCoV.
Yawan marasa lafiya da ke fama da cututtukan narkewa kamar zawo da amai ya kai kashi 30 cikin dari.
A ranar 14 ga Fabrairun 2020, an sami karin mutane 2,500 da suka kamu da cutar tare da mutuwar kashi 34.4 cikin dari, wanda ya sanya MERS-CoV ya zama daya daga cikin cututtukan da suka fi cutarwa da mutane suka sani.
A tsakiyar zuwa ƙarshen Disamba 2019, an fara samun tarin masu cutar nimoniya a Wuhan, lardin Hubei na ƙasar Sin, waɗanda ke da alaƙa da sanannen kamuwa da cutar SARS-CoV-2.
Hukumar Lafiya ta Duniya ta ayyana barkewar cutar sankarar numfashi ta SARS-CoV-2 a matsayin gagarumar matsalar lafiyar jama'a ta duniya kuma ta sanya wa cutar suna COVID-19.
A ranar 3 ga Maris, 2020, an tabbatar da mutane 90,053 a duk duniya, tare da mutuwar mutum 3.4 cikin dari.
Abin lura, yawan mace-macen da ke faruwa a Hubei na kasar Sin ya kai kashi 4.2 cikin dari, yayin da a waje ya kai kashi 1.2 cikin dari.
SARS-CoV-2 yana haifar da cututtukan numfashi mai tsanani kamar SARS-CoV da MERS-CoV wanda ke nuna zazzabi, tari da kumburi.
Wasu marasa lafiya ma sun kamu da cutar kumburi.
Ciwon huhu yana daya daga cikin manyan alamun cutar kuma yana iya saurin karawa zuwa ciwon numfashi mai tsanani.
Kodayake SARS-CoV da SARS-CoV-2 suna da kamanceceniya sosai saboda daidaiton tsari na nucleotide, suna cikin rassa daban-daban a cikin tsarin phylogenetic.
A bayyane yake cewa SARS-CoV-2 ba shi da cutar amma yana da saurin kamuwa da cuta fiye da SARS-CoV da MERS-CoV.
An samu rahotannin marasa lafiya marasa alamun da ke dauke da SARS-CoV-2 kuma suna iya taimakawa wajen saurin yaduwar cutar a duniya.
Idan aka kwatanta SARS-CoV-2 da sauran HCoVs shida, akwai kamanceceniya da bambance-bambance da yawa.
Na farko, tsawon lokacin kumburi da cutar HCoV sun yi kama sosai.
A wannan yanayin, SARS-CoV-2 yana bin al'adun al'ada na sauran HCoVs shida.
Na biyu, cutar COVID-19 ta fi muni tsakanin SARS-CoV da HCoVs guda huɗu (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da SARS-CoV-2 yana nuna halaye da ake samu a lokacin kamuwa da cutar HCoV na yau da kullun, gami da rashin takamaiman, mai laushi ko rashin alamun cutar.
A gefe guda, ko da yake ƙananan ƙwayoyin cuta, akwai ƙananan ƙananan ƙananan cututtukan COVID-19 a cikin SARS-CoV.
Na uku, kamuwa da SARS-CoV-2 yana nuna halaye masu ban sha'awa na HCoV da SARS-CoV da ke kamuwa da al'umma.
A gefe guda, SARS-CoV-2 yana da sauƙin yaduwa kamar HCoVs na al'umma.
A gefe guda, kamar yadda cutar SARS-CoV da MERS-CoV ke rage saurin kamuwa da cuta yayin da aka yada su ga mutane, har yanzu ba a tabbatar da ko cutar SARS-CoV-2 ta rage ba.
A ƙarshe, kamar sauran HCoVs, SARS-CoV-2 na iya bayyana a cikin samfuran stool.
Nazarin da za a yi a nan gaba zai nuna ko yaduwar SARS-CoV-2 ta baki-da-baki na taka muhimmiyar rawa kamar SARS-CoV a wasu yanayi.
Zai zama abin sha'awa a ga ko SARS-CoV-2 yana nuna yanayi kamar yadda yake a cikin al'ummomin da ke fama da cutar HCoV.
Koyaya, bayan yaduwar mutum, halaye na SARS-CoV-2, gami da halaye na kamuwa da cuta, cututtuka da ci gaba da yaduwa tsakanin mutane, zasu kasance masu tasiri ga makomar ƙarshen barkewar cutar COVID-19.
HCoVs daga dukkanin al'ummomi huɗu da ke haifar da alamun rashin lafiya sun daidaita sosai ga mutane.
A wani bangare kuma, zai iya zama gaskiya cewa mutane sun saba da waɗannan HCoVs guda huɗu.
Watau, duka biyu sun tsira daga cutar HCoV.
Ya kamata a kawar da HCoVs masu haifar da cututtuka masu tsanani a cikin mutane da kuma cututtukan HCoVs masu haifar da cututtuka masu tsanani.
Don wannan ya faru, HCoVs dole ne su sake yin kwafi a cikin mutane har sai sun sami damar yin amfani da maye gurbi mai kyau wanda zai iya hana abubuwan hana abinci.
A wannan ma'anar, yayin da barkewar SARS-CoV-2 ta daɗe kuma ta kamu da mutane da yawa, zai iya zama cikakke ga ɗan adam.
Idan ya dace, zai yi wuya a dakatar da yaduwar cutar tsakanin mutane ta hanyar keɓewa ko wasu matakan kula da kamuwa da cuta.
CIVs guda huɗu da aka samu a cikin al'umma sun kasance suna yaduwa ga mutane tsawon shekaru, suna haifar da sanyi ga mutanen da ke da rauni.
Waɗannan ƙwayoyin cuta ba sa bukatar mafaka ta dabbobi.
Akasin haka, SARS-CoV da MERS-CoV masu cutarwa ba su daidaita da kyau ga mutane ba kuma ba za su iya zama masu kamuwa da cutar ba.
Dole ne a kiyaye su a cikin mazauninsu na dabbobi kuma a ba su damar yaduwa ta hanyar matsakaici ɗaya ko fiye da masu haɓaka abinci mai gina jiki zuwa ga maƙasudin ɗan adam mai hankali.
Abubuwan da ke tattare da SARS-CoV-2 sun yi kama da SARS-CoV/MERS-CoV da kuma HCoVs huɗu na al'umma.
Aƙalla a yanzu, yana da saurin yaduwa kamar HCoVs na cikin al'umma.
Koyaya, ya fi cutar HCoVs na al'umma cutarwa kuma ba shi da cutarwa kamar SARS-CoV ko MERS-CoV.
Za su iya zama cikakke ga mutane ba tare da mafaka ko matsakaiciyar dabba mai gina jiki ba kuma za a ga idan za su iya yadawa ga mutane.
Kafin tattauna asalin dabbobi na HCoV, zai dace mu tattauna ma'anar da halaye na juyin halitta, na halitta, na gida, na matsakaici da kuma haɓaka HCoV.
Dabbobi na iya zama masu kula da juyin halitta na HCoV idan sun kasance suna da magabata masu dangantaka da suka raba babban kama a matakin jerin kwayoyin halitta.
A cikin wannan yanayin, kwayar cutar ta asali tana iya zama mai dacewa kuma ba ta haifar da cututtuka.
Hakazalika, kwayoyin suna ciyar da HCoVs a cikin dogon lokaci.
A lokuta biyu, mai cutar yana da kamuwa da cuta ta hanyar halitta kuma yana da kwayar cutar HCoV ko kuma mahaifinta.
Akasin haka, idan HCoV ya shiga cikin mai watsa shiri kafin ko lokacin da aka gabatar da shi ga mutane, ba zai dace da sabon kwayoyin ba kuma zai iya zama mai cutarwa.
Wadannan kwayoyin halitta na iya zama masu samar da kwayoyin halitta na mutum kuma suna iya zama masu samar da kwayoyin halitta ta hanyar samar da kwayar cutar ta hanyar yin kwafi na ɗan lokaci sannan kuma suyi amfani da su don cutar da mutum.
HCoVs na iya zama cikakke idan ba su iya ci gaba da kamuwa da cutar a cikin matsakaiciyar hanyar rayuwa ba.
A gefe guda, HCoVs na iya ɗaukar matsakaiciyar abinci mai gina jiki kuma ba wai kawai ba amma suna iya kafa rashin lafiya na dogon lokaci.
A wannan yanayin, matsakaiciyar mai gina jiki ta zama mai gina jiki na halitta.
Bayanai na annoba sun nuna cewa farkon yanayin SARS ya kasance tarihin haɗuwa da dabbobi masu farauta.
Binciken da aka yi a baya ya nuna cewa an sami karuwar cutar SARS-CoV-IGG a cikin masu cinikin dabbobi fiye da sauran mutane.
An fara gano dabbobi masu shayarwa a kasuwar dabbobi masu rai da kuma karnukan raccoon da ke dauke da kwayar cutar SARS-CoV wanda yayi kama da SARS-CoV.
Wannan ya samo asali ne daga gaskiyar cewa ba a sake samun rahoton SARS ba bayan an kashe dukkan 'yan kasuwa a kasuwa.
Koyaya, an kuma lura cewa mafi yawan masks na dabbobi masu shayarwa daga gandun daji ko gonaki waɗanda ba su haɗu da kasuwar dabbobi masu rai ba sun kasance marasa kyau ga SARS-CoV, wanda ke ba da shawarar cewa masks na dabbobi masu shayarwa na iya zama matsakaiciyar tushen haɓaka amma ba asalin SARS-CoV ba.
Abin lura, 80% na dabbobi daban-daban a kasuwar Guangzhou suna da ƙwayoyin anti-SARS-CoV, don haka ba za a iya musanta yiwuwar cewa ƙananan nau'ikan dabbobi masu shayarwa daban-daban suna aiki a matsayin matsakaiciyar abinci mai gina jiki don SARS-CoV ba.
Duk waɗannan suna nuna alamun ƙarshe na SARS-CoV.
Binciken da aka yi na abinci na dabbobi na SARS-CoV ya gano wata cutar COVID mai alaƙa da ita, wanda aka kira SARS-related Rhinolipus batCoV HKU3 (SARS R-RH-BATCoV-HKU3), wanda ke cikin ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙ
Waɗannan kwari suna da kyau ga ƙwayoyin anti-SARS-CoV da kuma tsarin kwayoyin halittar SARS-RH-BATCoV-HKU3.
Wannan da sauran batuna suna da kamanceceniya tsakanin kashi 88-92% na jerin nucleotide tare da SARS-CoV.
Waɗannan binciken sun kafa tushen sabon ra'ayi cewa jemage suna ciyar da ƙwayoyin cuta na ɗan adam da ke tasowa.
An gano wasu SARS-like COVIDs (SL-CoVs) daga jemage, amma babu wanda aka iya warewa a matsayin kwayar cuta mai rai sai WIV1.
An san cewa enzyme mai canzawa na Angiotensin na mutum 2 (ACE2) shine mai karɓar SARS-CoV.
An samo WIV1 daga samfurin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo
Abin sha'awa, jini na mai cutar SARS da ya warke daga cutar ya iya hana WIV1.
Don haka, WIV1 yana wakiltar mafi kusa da ke da alaƙa da kakanin SARS-CoV a cikin jemage wanda ke da kusan kashi 95% na daidaiton tsarin nucleotide.
Kodayake akwai babban kamannin tsakanin ƙwayoyin cuta biyu, amma an yarda cewa WIV1 ba shine matsakaiciyar ƙwayar cuta ta SARS-CoV ba kuma bats ba masu kula da kwayar cutar SARS-CoV ba ne.
Binciken tarihin kwayoyin halitta ya hada MERS-CoV a cikin rukuni daya kamar yadda yake tare da COVID-HKU4 da BAT COVID-HKU5.
Kwayoyin cuta na COVID-HKU4 da MERS-CoV suna amfani da peptidyl peptidase 4 (DPP4) don shiga cikin kwayar.
Tsarin RNA-dogara RNA polymers na MERS-CoV yana da alaƙa da tarihin kwayoyin halitta ga nau'ikan da aka samo a cikin bat beta-CoVs a Turai da Afirka.
Har zuwa yanzu, ba a gano wani MERS-CoV mai rai a cikin kuraje na daji ba.
An gano cewa kawai kashi 87 cikin ɗari na jerin nucleotide sun kasance daidai tsakanin MERS-CoV da bat COVID-HKU25, wanda ke da alaƙa da shi.
Saboda haka, ƙila ba za a iya cewa waɗannan jemage ba masu kula da MERS-CoV ba.
A gefe guda kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuman Dromedary suna da ƙwayar cuta ga ƙwayoyin cuta na MERS-CoV, kamar raƙuman Gabas ta Tsakiya da aka samu a ƙasashen Afirka da yawa.
Rayayyen MERS-CoV yayi kama da kwayar cutar da aka gano a cikin mutane wanda aka ware daga swabs na hanci na raƙumi mai haɗari, yana nuna cewa raƙumi suna aiki a matsayin masu cin abinci masu amfani da MERS-CoV.
Ya kamata a lura cewa an gano cewa yawancin kwayoyin cutar MERS-CoV da ke da alamun rashin lafiya sun shiga cikin raƙuman da ke dauke da cutar.
Ya kamata a lura cewa raƙuma masu cutar ba kawai suna watsa ƙwayoyin cuta ta hanyar numfashi ba amma har ma ta hanyar bayan gida, wanda shine babban hanyar da ƙwayoyin cuta daga kwari ke shiga.
Koyaya, tambayar ta kasance cewa yawancin shari'o'in da aka tabbatar da MERS ba su da tarihin hulɗa da raƙumi kafin bayyanar cututtuka, hanyar kamuwa da cutar ɗan adam zuwa ɗan adam, ko hanyar kamuwa da cuta da ba a san nau'in dabba da ba a san su ba wanda ke ba da MERS-CoV mafaka.
SARS-CoV-2 yana da kusan kashi 96.2% na nucleotide homology tare da bat COVID RATG13 wanda aka ware daga bat bat da ke da alaƙa da rhinolophus.
Kamar yadda yake a cikin shari'ar SARS-CoV da MERS-CoV, bambancin tsari tsakanin SARS-CoV-2 da RATG13 yana da kyau wajen tantance alaƙar iyaye.
Wannan yana nufin cewa ba za a iya ɗaukar bat a matsayin mai ba da abinci mai guba na SARS-CoV-2 ba, sai dai idan an gano irin wannan cutar ta bat a nan gaba.
Yawancin lokaci, mai ɗaukar hoto na SARS-CoV-2 ya kasance daga nau'in namun daji wanda aka sayar kuma aka kashe a kasuwar sayar da kayan abincin teku ta Hunan, wanda ya haɗa da yawancin shari'o'in farko da suka shafi COVID-19, waɗanda ke nuna yiwuwar yiwuwar yaduwar kwayar cutar ta dabba zuwa mutum.
Yawancin binciken da aka yi kwanan nan, wanda ya danganci jerin abubuwan metagenomic, ya nuna cewa rukunin ƙananan dabbobi masu shayarwa masu haɗari da aka sani da pangolins (manis javanensis - cat eaten) na iya zama tushen asalin beta-CVO da ke da alaƙa da SARS-CoV-2.
Waɗannan sabbin kwayoyin halittar Cov na Pangolins suna da kashi 85-92% na jerin nucleotide tare da SARS-CoV-2.
Duk da haka, suna da alaƙa da RATG13 a kusan kusan 90% daidai a matakin jerin nucleotide.
Sun rarraba ƙwayoyin cuta kamar SARS-CoV-2 zuwa rassa biyu a cikin bishiyar asalin, ɗayan ɗayan yana da alaƙa da sararin samaniya kamar SARS-CoV-2 wanda ke da alaƙa da yankin haɗin gwiwa (RBD), wanda ke da alamun amino acid 97.4%.
A cikin rikice-rikice na gaskiya, RBD na SARS-CoV-2 da RATG13 sun bambanta, duk da haka, mafi girman adadin kwayoyin halitta suna da babban adadin daidaito.
Binciken da aka yi kwanan nan kan marasa lafiya na pangolins ya kuma ba da rahoton gano wani kwayar cutar a cikin samfurin huhu, wanda aka gano yana da alaƙa da SARS-CoV-2.
Wannan binciken ya ɗauki hanyar haɗuwa ta daban da kuma maganin jiki don samar da jerin kwayoyin halittar ɗan adam kusan kashi 86.3% na cikakken kwayar cutar.
Ba za mu iya watsi da yiwuwar cewa ɗayan abincin da ke cikin SARS-CoV-2 shine pangolin ba.
Koyaya, babu wata hujja a halin yanzu don tallafawa asalin SARS-CoV-2 kai tsaye daga Pangolins saboda bambancin tsari tsakanin SARS-CoV-2 da Pangolins SARS-CoV-2 masu alaƙa da beta-CoVs.
Bugu da kari, tazara tsakanin SARS-CoV-2 da RATG13 ma ta fi tazara tsakanin SARS-CoV-2 da kuma beta-CoVs masu alaƙa da SARS-CoV-2 da ke tattare da pangolins.
Har yanzu ba a tabbatar da hanyar juyin halitta na SARS-CoV-2 a cikin jemage, pangolins da sauran dabbobi masu shayarwa ba.
A cikin RBD, SARS-CoV-2 da pangolins sun sami daidaito mafi girma, tare da SARS-CoV-2 da ke da alaƙa da beta-CoV, SARS-CoV-2 da RATG13 suna da daidaito mafi girma a cikin tsarin kwayoyin halitta.
Akwai babban hasashe cewa akwai babban kamanceceniya tsakanin RBD na SARS-CoV-2 wanda ke dauke da cutar ta SARS-CoV-2 da kuma SARS-CoV-2 wanda ke dauke da cutar ta SARS-CoV-2 wanda ke dauke da cutar ta SARS-CoV-2.
Akwai wata shawara ta madadin a cikin fa'idar sake haɗuwa tsakanin beta-CoVs masu alaƙa da SARS-CoV-2 da kuma RATG13 a cikin nau'in dabbobi na uku.
A matsayin mai motsa juyin halitta, sake haɗuwa ya zama ruwan dare gama gari a cikin beta-CoV.
Har yanzu, juri'a na ci gaba da bincike kan asalin dabbobi na SARS-CoV-2.
Duk da yawan cutar HCoV, an kuma yi nazarin asalin dabbobi na HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar ilimin halittar jini ta nuna cewa HCoV-NL63 da HCoV-229E duka sun samo asali ne daga COVID na kifi, yayin da HCoV-OC43 da HCoV-HKU1 suka samo asali ne daga ƙwari.
An bayar da rahoton cewa cutar COVID a cikin jemage ta ARCOV.2 (Appalachian Ridge COVID) da aka gano a cikin jemage na Arewacin Amurka, yana nuna alaƙa da HCOV-NL63.
A gefe guda, HCoV-229E yana da alaƙa da kwayar halitta a cikin wani kwayar cutar COVID ta bat, wanda aka kira Hipposiderosis/Ghanaquam/19/2008, wanda aka gano a Ghana, a lokacin da aka yi zargin raƙuma a matsayin masu kula da su.
Don ƙarin haske, an ba da taƙaitaccen ilimin yanzu game da asalin dabbobi na HCoV da aka sani a cikin Figure 1 da Table 2.
A tarihi, an gabatar da hujjojin yaduwar HCoV tsakanin jinsuna ta hanyar nazarin tarihin.
Lokacin da HCoV-OC43 ya wuce jinsuna daga dabbobin gida zuwa mutane a cikin shekarun 1890, an rubuta annoba ta kamuwa da cututtukan numfashi.
Tarihin yaduwar HCoV-229E tsakanin jinsuna ba shi da kyau.
An gano cutar ta Bat Alpha-CoV, wacce ke da alaƙa da HCoV-229E.
Ɗaya daga cikinsu yana ɗauke da cutar alpha-CoV.
Akwai shaidu da yawa da ke tallafawa watsa kwayar cutar kai tsaye daga jemage zuwa mutum.
Na farko, yana yiwuwa cewa alpacas ba mutane ba ne suka haɗu da waɗannan dabbobi a cikin yanayin da suke ciki.
Maimakon haka, mutane suna da dangantaka ta kusa da alpacas.
Na biyu, cutar HCoV-229E ta Alpha-CoV ta banbanta da kuma rashin cutarwa a cikin bat, yayin da cutar Alpacus Alpha-CoV ta haifar da cutar numfashi a cikin dabbobi masu cutar.
A ƙarshe, ba a taɓa samun cutar alpacus alpha-CoV a cikin namun daji ba.
Don haka, ba za a iya kawar da yiwuwar cewa alpacas sun sami HCoV-229E-related alpha-CoV daga mutane ba.
A zahiri, jemage sune tushen kai tsaye na ƙwayoyin cuta na ɗan adam, gami da cutar tafin kafa, cutar Ebola, cutar Nipah da cutar Hendra.
Saboda haka, ba abin mamaki ba ne cewa waɗannan jemage suna iya yaɗa HCoV-229E kai tsaye ga mutane.
A madadin haka, bat alpha-CoV shine asalin HCoV-229E, alpacas da dromedary raƙuma na iya zama matsakaici don watsa kwayar cutar ga mutane, kamar yadda ya faru da MERS-CoV.
MERS-CoV ya zama mafi kyawun misali na yaduwar jinsuna daga gizo-gizo zuwa raƙuman dromedary da kuma daga raƙuman dromedary zuwa mutane.
Asalin juyin halitta na MERS-CoV daga kuraje sananne ne saboda asalinsa kuma an ƙarfafa shi ta binciken da aka yi a baya.
A bayyane yake cewa waɗannan jemage suna samar da wadataccen adadi na ƙwayoyin cuta don musayar ƙwayoyin cuta da kuma musayar ƙwayoyin cuta tsakanin jinsuna.
Rayuwa mai tsawo, yankuna masu yawa, hulɗar zamantakewar jama'a da kuma iyawar tashi, duk waɗannan sun sa malam buɗe ido ya zama 'mai watsa kwayar cutar'.
A gefe guda kuma, MERS-CoV ya shiga cikin raƙuman Dromedary shekaru da yawa.
Waɗannan raƙuman sun karɓe su sosai wanda ya sa suka zama masu daidaitaccen abinci mai gina jiki na halitta.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana da ƙananan ƙananan canjin canji a cikin waɗannan dabbobin.
Cutar ta zama haɗari ga ƙananan mutane, kuma mutane suna cikin ƙarshen lokacin MERS-CoV saboda kamuwa da cutar ba ta da ƙarfi.
Matsayin raƙumi a cikin watsa MERS-CoV ya bambanta da na pangolins, idan akwai, a cikin yaduwar SARS-CoV-2.
Musamman, PanGolins beta-CoV yana da yawan kamuwa da cuta a cikin PanGolins.
Suna iya zama masu karewa na ƙarshe ga SARS-CoV-2 da ke da alaƙa da beta-CoVs, kamar yadda yake a cikin yanayin SARS-CoV.
A cikin binciken da za a yi a nan gaba, za a yi la'akari ko a musanta yiwuwar yaduwar SARS-CoV-2 daga dabba zuwa mutum.
Da farko dai, jemage na iya zama masu daukar kwayar cutar SARS-CoV-2, wanda yayi kama da SARS-CoV-2.
Mutane za su iya raba wannan yanayin tare da jemage ta hanyar yanka ko kuma ta hanyar hakar ma'adinai.
Na biyu, pangolins, na iya zama ɗaya daga cikin masu haɓaka abinci mai gina jiki waɗanda aka gano kwanan nan don cutar SARS-CoV-2.
Ana samun kwayar cutar ta hanyar cin kifi da aka kashe a wurin yanka.
Yana yiwuwa cewa dabbobi masu shayarwa da yawa, gami da dabbobin gida, suna da saukin kamuwa da SARS-CoV-2.
Dole ne a gudanar da binciken dabbobi da na daji don gano kwayoyin cutar.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da karɓar SARS-CoV-2 ana iya samun su a cikin nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau
Har yanzu ana ci gaba da bincike kan asalin SARS-CoV-2.
Baya ga nau'ikan nau'ikan dabbobi daban-daban, akwai manyan abubuwa guda uku da ke da mahimmanci ga COVID don sauƙaƙe ƙetare shingen nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Na farko, suna da yawan canji a cikin kwafin RNA.
Idan aka kwatanta da sauran ƙwayoyin cuta na RNA guda ɗaya, ƙididdigar canjin canji na COVID ya dogara da matakin karɓar COVID ta hanyar sabon kwayar halitta, kuma matsakaicin canjin canji na iya zama "mai laushi" zuwa "mai girma" yayin da akwai sauyawa -10-4 a kowace shekara a kowane rukunin yanar gizo 2.
Cov yana da kwayar halitta mai dauke da kwayar halitta mai dauke da kwayar halitta, wanda cire shi ke haifar da tsayayya da canji mai yawa da kuma lalacewa ko ma rayuwa.
Abin mamaki, analogue na nucleotide remdesivir an san shi don rage hanawa na wannan exoribonuclease da RNA-dogara RNA polymers don sake yin kwafin COVID.
Daya daga cikin mafi kyawun wakilai masu yaki da SARS-CoV-2 da ake gwadawa a gwajin asibiti shine remdesivir.
Duk da haka, yawan canjin kwayoyin cutar COVID ya ninka na rayuwa sau miliyan.
Bugu da ƙari, lokacin da kwayoyin cuta ba su da kyau a cikin COVIDs, yawan canjin yana da yawa.
Idan aka kwatanta da SARS-CoV wanda ke da yawan canjin yanayi, yawan canjin yanayi na SARS-CoV-2 ya yi ƙasa da ƙasa, yana nuna babban matakin yarda ga ɗan adam.
Wataƙila wasu ƙwayoyin cuta da ke kusa da mutum sun riga sun karɓe shi.
Kamar yadda yake a cikin SARS-CoV-2, wannan ya shafi MERS-CoV, wanda raƙuman ruwa suka karɓa sosai.
A ka'ida, ba zai yiwu ba cewa maye gurbin kwayoyin halitta zai iya haifar da tasirin SARS-CoV-2 a cikin rigakafi da kuma yanayin da ke haifar da cutar.
Na biyu, manyan kwayoyin RNA a cikin COVs suna jan ƙarin sassauci a cikin gyaran kwayoyin halitta don maye gurbi da sake haɗawa, yana haɓaka damar haɓaka tsakanin jinsuna, wanda zai iya zama da amfani ga fitowar sabon COVID lokacin da yanayi ya dace.
Wannan yana da goyon baya ta hanyar wasu furanni masu buɗewa da kuma aikin sunadarai da aka tsara a ƙarshen 3 'na kwayoyin halitta.
Na uku, COVs suna canza samfuran tsakanin kwafin RNA ta hanyar "zaɓar kwafi" ta hanyar bazuwar da kuma sau da yawa.
A cikin nutrition suna aiki a matsayin tukunyar hadawa, sauyawa na iri yana faruwa sau da yawa yayin kwafin COVID RNA.
Ana iya sake haɗa babban adadin homologous full-length da sub-genomic RNA don samar da sabon COVID.
An gano shaidar tarihin halitta na sake haɗuwa a cikin HCoV-HKU1 da HCoV-OC43 da kuma COV na dabba kamar bat SL-CoV da bat COV-HKU9.
Hadin gwiwar kwayar cuta da mai ɗaukar hoto dangane da kamuwa da cuta
Baya ga abubuwa uku na kwayar cutar da aka ambata a sama, hulɗar kwayar cuta tare da mai karɓar abinci mai gina jiki wani muhimmin abu ne wanda ke da tasiri a cikin kamuwa da cuta tsakanin jinsuna.
A nan, an ɗauki sake haɗuwa da SARS-CoV a matsayin misali mai kyau, wanda kuma ya nuna shaidar zabin tabbatacce tsakanin abubuwan da ke faruwa na kamuwa da cututtuka.
Bisa ga kwatancen bincike tsakanin mutane da kuma SARS-CoV na Civet, SARS-CoV ya bayyana da sauri a cikin kwayoyin halitta daban-daban, musamman tare da maye gurbi a RBD na S-protein.
A cikin RBD na S-protein, COV yana hulɗa da mai karɓar ƙwayoyin cuta kuma yana da zaɓi mai kyau ta hanyar amsawar ƙwayoyin cuta.
A cikin SARS-CoV, RBDs suna cikin S1 yanki a cikin amino acid na 318 zuwa 510, wanda ke ɗaure masu karɓar su da ƙwayar cuta don shiga cikin mutum ACE2 daidai.
RBD na SARS-CoV yana ba da damar yaduwar kwayar cutar ta hanyar gano masu karɓar ACE2 na dabbobi daban-daban, gami da kifi, kifi, beraye da karnuka masu raccoon.
A zahiri, an gano ragowar amino acid guda 6 ne kawai a cikin RBD tsakanin ɗan adam da mai ɗaukar hoto na mutum, kuma 4 daga cikinsu suna cikin tsarin mai karɓar mai karɓar mai karɓar ACE2 don hulɗa.
A cikin SARS-CoV, masu canjin K489N da S487T suna cikin RBDs, wanda zai iya ƙarfafa sha'awar haɓakar furotin tare da masu karɓar ACE2 na ɗan adam.
A wasu kalmomi, maye gurbin waɗannan amino acid biyu na iya zama mahimmanci a cikin yarda da kwayar cutar ga mutane.
Yana da mahimmanci a lura cewa SARS-CoV-2 yana da masu karɓar ƙwayar cuta iri ɗaya da SARS-CoV.
Bambanci tsakanin SARS-CoV-2 da SARS-CoV-2 a cikin S1 na S2 sun nuna cewa sun canza sha'awar ɗaure S-protein ɗin su tare da ACE2 na ɗan adam.
Tabbas, binciken EM-Cryomeshine ya nuna cewa wannan haɗin yana da ƙarfi sau 10 zuwa 20 fiye da haɗin da ke tsakanin ACE2 na ɗan adam da furotin SARS-CoVS.
Hakanan zai zama mai ban sha'awa don tabbatar da ko akwai wasu masu karɓar masu karɓar SARS-CoV-2.
HCoV-NL63 kuma yana iya zama yana ɗaure da ACE2, amma tare da wani ɓangare na S.
Akwai wasu masu karɓar HCoV da yawa, kamar amino peptides N don HCoV-229E, da 9-O-acetylated sialic acid don HCoV-OC43.
Hakanan suna iya zama masu alhakin nasarar karɓar waɗannan COVIDs a cikin mutane bayan kamuwa da cuta ta cikin jinsuna daga masu ba da abinci.
A matsayin ƙari a cikin ƙwayoyin ƙwayoyin cuta, tasirin kamuwa da kwayar cutar HCoV a cikin kwayoyin halitta yana sarrafawa ta hanyar dogaro da sauran abubuwan gina jiki da kuma abubuwan hanawa.
Rashin rarrabuwa na wannan furotin mai gina jiki tsakanin mutane da kuma masu tattara abubuwan gina jiki na HCoVs kamar su bat, dromedary camel da rodents na iya hana yaduwar jinsuna.
Don samun nasarar yaduwar HCoVs tsakanin jinsuna, dole ne a ƙarfafa abubuwan dogaro da abinci mai gina jiki kuma a kawar da abubuwan hana abinci mai gina jiki.
A wannan yanayin, har yanzu ba a gano da kuma bayyana abubuwan ƙayyade kwayoyin halitta a cikin wannan muhimmin yanki na hulɗar kwayar cutar da ƙwayar cuta ba.
Don SARS-CoV-2, ba tare da nuna bambanci ba, bincike na ƙwayoyin cuta da abubuwan hanawa na ƙwayoyin cuta ta amfani da fasahar CRISPR.
Sabuwar HCoV ta fito: Komawa zuwa sifili
Bambancin COVID na bat yana ba da dama mai yawa don fitowar sabon HCoV.
A wannan hanyar, COVID na kwari yana aiki a matsayin tushen kwayoyin HCoV.
Bugu da kari, sauye-sauye da sauye-sauyen kwayoyin halitta suna haifar da juyin HCoV kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan tsari.
Alal misali, saye ko lalata sabbin kwayoyin halittar gina jiki na iya sauya yanayin kwayar cutar.
Daga cikin furotin masu taimakawa SARS-CoV, ORF8 an dauke shi mai mahimmanci don karɓa a cikin mutane, saboda an gano ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo
An gano cewa SARS-CoV yana da siffar kawar da 29-nucleotide a cikin jinsunan da aka ware a farkon cutar a cikin ɗan adam.
Bayan an cire wannan, ORF8 ya rabu zuwa ORF8a da ORAP8B kuma an dauke shi mai karɓa mutation, wanda ke ƙarfafa ƙaurawar sunadarai.
Bugu da ƙari, SARS-CoV yana da tarihin yiwuwar sake haɗuwa tare da asalin alpha- da gamma-CoV, wanda ke nuna yawancin ƙananan sassan da aka sake haɗuwa a cikin RNA.
An kuma gano wuraren sake haɗuwa a cikin NSP 9, mafi yawa a cikin NSP 10, da kuma wasu sassan NSP 14.
Hakanan, an nuna cewa cutar MERS-CoV ta sami lokuta na sake haɗuwa a cikin al'ummomi daban-daban, waɗanda aka gano a cikin raƙuman dromedary a Saudi Arabiya.
Baya ga SARS-CoV da MERS-CoV, an kuma lura da sake haɗuwa a cikin sauran HCoVs, inda HCoVs ke sake haɗuwa da wasu dabbobi COVs a cikin kwayoyin halittar su.
Zaɓin na wucin gadi na iya taimakawa wajen canza kwayar cutar ba tare da so ba, wanda sau da yawa yakan haifar da cutar ta hanyar zaɓin zaɓin da tsarin garkuwar jiki ke amfani da shi.
Misali na wannan sakamako shine lalacewar cikakken tsawon ORF4 wanda ya haifar da cirewa na nucleotide biyu a cikin samfurin HCoV-229E.
An gano ORF4 a cikin ƙwayoyin cuta na bat da raƙumi da ke da alaƙa da HCOC-229E, alpaca alpha-CoV yana nuna haɓakar nucleotide guda ɗaya, wanda ke haifar da sauyawa.
A ƙarshe amma ba mafi ƙaranci ba, juyin halitta na sabon HCoVs yana yiwuwa ta hanyar zaɓin matsin lamba a cikin abincin su na kwari.
Alamomin bayyanar cututtuka ko kuma kawai alamu masu laushi ne da aka gano lokacin da COVID ya kamu da waɗannan jemage, wanda ke nuna yarda tsakanin COVID da jemage.
Ya bayyana cewa waɗannan tsuntsayen sun yi aiki da kyau wajen kamuwa da cutar COVID-19 ta hanyar motsa jiki da kuma gani.
Misali, rashin aiki a cikin kunnawar amsawar pre-inflammatory a cikin bat yana rage tasirin maganin cutar da COV ke aiwatarwa.
Bugu da kari, ana hana ayyukan kwayoyin halitta na halitta a cikin bat ta hanyar yin amfani da kwayoyin halitta na halitta na NKG2 / CD94 da kuma ƙananan maganganun manyan kwayoyin halitta na Class I.
Bugu da kari, yawan adadin oxygen mai amsawa (ROS) wanda ya samo asali daga aikin metabolism mai yawa na bats duka biyu yana hana aikin kwafin COVID kuma yana haifar da tabbatarwa ta hanyar exoribonucleases, don haka lokacin da aka shiga sabon abinci, asalin asalin kwayar cutar yana samar da matsin lamba don zama mai cutarwa sosai.
Hakanan kwayoyin cutar COVID masu cutarwa suna canzawa zuwa sake haɗuwa, wanda ke haifar da samun sabbin sunadarai ko ƙwayoyin cuta don karɓar abubuwan gina jiki.
Ta haka ne, waɗannan sababbin HCoVs uku ba su samo asali ba bisa kuskure ba a cikin shekaru ashirin da suka gabata.
Cov yana haifar da alamun rashin lafiya ko kuma rashin lafiya a cikin masu shayar da su, kamar su bat ko raƙumi.
Waɗannan ƙwayoyin cuta masu ƙarfi suna iya yin kwafi ba tare da hana amsar rigakafi ba.
Wannan shine asirin dalilin da yasa masu dauke da cutar suka bayyana kuma abin da ke haifar da babbar matsala a kamuwa da cutar ɗan adam.
Babban bayyanar cututtuka galibi ana samun su ne ta hanyar haɓakar haɓakar rigakafi da tashin hankali na cytokine, yayin da inda ƙarfin rigakafi ya fi ƙarfi, ana ganin lalacewar huhu a cikin mawuyacin hali.
Akasin haka, a cikin masu ɗaukar hoto, an cire amsawar rigakafi daga kwafin COVID.
Wannan na iya zama dabarar da za ta iya kawo ƙarshen maganin rigakafin SARS-CoV-2.
Musamman a cikin jemage, amsawar interferon tana da ƙarfi.
Don haka, gudanar da aƙalla nau'in-I interferon ya kamata ya kasance da fa'ida a farkon lokacin kamuwa da SARS-CoV-2 a cikin ɗan adam.
Bugu da ƙari, kunnawar mai kunnawa na NLRP3 a cikin bat yana da lahani.
Saboda wannan, haɗin gwiwa na MCC950 na NLRP3 mai kumburi na iya zama mai amfani a cikin maganin COVID-19.
Sakamakon SARS-CoV-2 yana bin tsarin da ya saba, wanda ya haifar da SARS-CoV da MERS-CoV.
A akasin wannan, an gano cewa 95% na nucleotide homogeneity a cikin beta-CoVs na bat sun kasance tare da SARS-CoV, inda 96% na nucleotide homogeneity a cikin bat-CoVs ya kasance tare da SARS-CoV-2.
Amma tun da an gano cewa tsuntsaye da sauran dabbobi a kasuwa suna daukar nauyin kwayar cutar kamar SARS-CoV, ba a gano matsakaitan matsakaici na SARS-CoV-2 ba.
An gano homogeneity na SARS-CoV-2 a cikin pangolins beta-CoVs a cikin abin mamaki, wanda ke nuna cewa pangolins na iya zama ɗaya daga cikin masu ba da abinci na matsakaici ko kuma pangolins beta-CoVs na iya ba da gudummawar rarrabuwa ta kwayoyin halitta a cikin sigar ƙarshe ta SARS-CoV-2.
Amma, tambayar ita ce, babu wata hujja da ta nuna cewa SARS-CoV-2 an yi shi ne da gangan ko kuma ba da gangan ba.
CovJ ya sake shiga cikin sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen san.
Nazarin da aka yi a cikin jemage da sauran dabbobi ya canza fahimtar mahimmancin abinci mai gina jiki na HCoVs na asalin dabba da kuma kamuwa da cutar ɗan adam.
Shaidar yaduwar ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 suna da asalin kifi kuma an watsa su ga mutane ta hanyar matsakaiciyar matsakaiciya.
An fara kamuwa da cutar SARS-CoV ne ta hanyar hulɗa tsakanin mutane da kuma kifi a kasuwa, kuma an kawo ƙarshen cutar ta SARS-CoV ta hanyar rufe kasuwar abincin teku da kashe kifi a can.
Don wannan dalili, saboda binciken da aka yi cewa yawancin kwayoyin halittar beta-CoVs suna da alaƙa da SARS-CoV-2, ya kamata a cire panoglin daga kasuwar abincin teku don hana yaduwar dabbobi.
Koyaya, binciken nan gaba ya rage don bayyana dalilin da yasa kuma yadda SARS-CoV-2 ya kamu da mutane daga pangolins da sauran dabbobi masu shayarwa.
A gefe guda, MERS-CoV ya kasance a cikin raƙuman dromedary na dogon lokaci.
Tun da yake raƙumi yana da mahimmancin hanyar sufuri, ya kasance tushen tushen nama, madara, fata da kayan ulu ga mazauna yankin.
An yadu da su a Gabas ta Tsakiya da Afirka.
Ba zai yiwu a kashe dukkan raƙuman don sarrafa MERS ba, kamar yadda aka yi a kasuwar namun daji ta China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da barkewar cutar ta MERS, ya kamata a ɗauki babban tsari don haɓaka ingantaccen allurar rigakafi a kan MERS-CoV don raƙuma, tare da haɗa kan sauran matakan kula da kamuwa da cuta.
Domin ba za mu iya kawar da waɗannan ƙwayoyin cuta ba, sabon nau'in kwayar halitta zai iya tasowa don haifar da ɓarkewar cutar.
A cikin daji, akwai dabbobi masu yawa da ke yawo.
Musamman, tare da yiwuwar dabbobi, COVIDs na bat suna da bambanci sosai.
Waɗannan CAVs na dabbobi suna da damar da yawa don canzawa da sake haɗuwa, wanda zai haifar da sabon CAV mai saurin yaduwa da / ko kisa ga ɗan adam a nan gaba.
Don rage hulɗar da ba dole ba tsakanin mutane da dabbobi, al'adun cin namun daji a wasu wurare a China ya kamata a daina.
A cikin jerin SARS, MERS da COVID-19, dole ne a sami shiri da shirin amsawa mai kyau.
A gaskiya, akwai ƙwayoyin cuta da yawa da suka daɗe suna wanzuwa a duniya.
Suna zama a cikin mazauninsu har sai sun sami damar yin yawa.
Kodayake akwai halaye da yawa na yada ƙwayoyin cuta a cikin jemage, amma horar da mutane don nisanta kansu da jemage da sauran nau'ikan namun daji na iya rage haɗuwa da mutane.
Don fahimtar rayuwar rayuwar COVID da masu ciyar da su na halitta, ana buƙatar ci gaba da lura da dabbobi masu shayarwa, wanda zai iya zama da amfani don hana kamuwa da cutar daga dabba zuwa mutum da kuma hana barkewar cutar a nan gaba.
A ƙarshe, nisantar da mutane daga yanayin yanayin abinci na halitta na kwayar cutar ta dabbobi shine hanya mafi inganci don hana kwayar cutar ta dabbobi.
Har yanzu akwai wasu abubuwa da yawa da ba a san asalin SARS-CoV-2 ba.
Da farko dai, idan har wata dabbar daji ta kamu da kwayar cutar SARS-CoV-2 zuwa cikin pangolins, zai zama mai ban sha'awa a ga a wane yanayi ne waɗannan dabbar daji da pangolins ke da yanayin muhalli iri ɗaya.
Na biyu, idan har jemage ya taka rawa kai tsaye wajen kamuwa da cutar ga mutane, dole ne mu gano yadda mutane suka kamu da cutar.
Na uku, idan da gaske ne dabbobi masu shayarwa na uku sun kasance masu ba da abinci, ya kamata a bayyana yadda suka yi hulɗa da nau'ikan halittu daban-daban, ciki har da mutane, jemage da pangolins.
A ƙarshe, yawancin dabbobi masu shayarwa, gami da dabbobin gida, suna iya zama masu saurin kamuwa da SARS-CoV-2, wanda ya kamata a lura da shi kuma a yi gwaji.
Ko dai daga harsashi, ko kuma daga wasu dabbobi masu shayarwa, a nan gaba za a iya gano irin wannan SARS-CoV-2 ko kuma asalinsa a cikin abincin su na halitta.
Ci gaba da bincike a wannan fannin zai bayyana mahimman bayanai game da hanyar juyin halittar SARS-CoV-2 a cikin dabbobi, da kuma rigakafin COVID-19 a cikin mutane.
Wannan yana buƙatar sabunta ƙa'idodin bincike na "Laifin da ake zargi" da "Laifin da aka tabbatar" na COVID-19.
A ranar 6 ga Fabrairun 2020, ƙungiyarmu ta buga Jagororin Shawarwari na gaggawa don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututtukuttukutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Koyaya, cutar Coronavirus ta 2019 (COVID-19) sabuwar cuta ce. Saninmu da iliminmu suna ƙaruwa a hankali bisa ga binciken bincike da ke gudana da kuma ƙwarewar aikin likita, saboda haka, ana sabunta dabarun bincike da magani koyaushe.
A cikin wannan wasikar, an nuna wani bayani a kan jagororinmu da kuma sababbin ka'idojin bincike da magani na COVID-19 (Fitowar 7) "Laifin da ake zargi" da "Laifin da aka tabbatar" bisa ga sabuwar hanyar bincike da magani da Kwamitin Kiwon Lafiyar Jama'ar Sin ya bayar.
A watan Disamba na shekarar 2019, an fara barkewar cutar coronavirus ta 2019 (2019-nCoV), wacce aka sanya wa suna Coronavirus Disease 2019 (COVID-19), kuma an sanya wa kwayar cutar sunan Severe Acute Syndrome Coronavirus 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta bayyana COVID-19 a matsayin annoba.
Don magance kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta haɓaka jagororin shawarwari masu sauri kuma an buga su akan layi a cikin binciken likitancin soja a ranar 06 ga Fabrairu, 2020.
Tun bayan wallafa shi, ya sami karbuwa sosai.
Ka lura cewa kodayake COVID-19 sabuwar cuta ce, hankalinmu da iliminmu suna ci gaba da ƙaruwa a hankali bisa ga binciken da ake yi na bincike da kuma aikin likita; don haka hanyoyin bincike da hanyoyin magani suna ci gaba da sabuntawa.
Misali, an buga jimillar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar fitowar
Yanzu, jagororinmu sun sami tsokaci daga Zhou et al., waɗanda suka gabatar da shawarwari masu sauƙi na ƙididdiga bisa ga kwarewarsu ta asibiti.
Ayyukansa sun kara sabbin hujjoji ga ka'idodinmu kuma sun zama mahimmin tunani ga wannan annoba ta duniya.
Muna godiya da kuma yaba masa saboda aikinsa mai ban mamaki.
Koyaya, aikinsa yana buƙatar sabuntawa don dacewa da sabon bincike da jagororin magani na COVID-19 (gwajin na bakwai) da kuma binciken kwanan nan.
A cewar fitowar ta bakwai (3 ga Maris 2020), tabbatar da yanayin da ake zargi yana buƙatar haɗuwa da kowane ɗayan abubuwan da ke cikin tarihin cutar tare da abubuwa biyu na binciken likita, ko kuma idan babu bayyanannen tarihin cutar, ya kamata a kammala abubuwa uku na binciken likita.
Tarihin cutar: (1) Tarihin tafiya ko zama a cikin Wuhan da kewaye, ko a cikin yankin da aka ba da rahoton cutar COVID-19 na kwanaki 14 kafin bayyanar cututtuka; (2) Tarihin hulɗa tare da masu cutar da ke da cutar SARS-CoV-2 (gami da gwajin kwayar nucleic acid mai kyau); (3) Tarihin hulɗa tare da marasa lafiya da ke da alamun zazzabi ko na numfashi daga Wuhan da kewaye, ko wasu al'ummomin da aka ba da rahoton COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) Tarihin hulɗa tare da wuraren da aka tabbatar da cutar, (kamar gida, ofis, makaranta, da sauransu, a cikin ƙananan ɗakunan ajiya, cikin makonni 2 da / ko ƙananan lokuta tare da alamun zazzabin numfashi ≥ 2).
Binciken asibiti: (1) alamun zazzabi da / ko cututtukan numfashi; (2) tare da alamun bayyanar cututtukan COVID-19; (3) nuna ƙarancin ƙwayoyin farin jini a cikin matakin farko, ko ƙarancin ƙwayoyin lymphocytes.
Gano cutar da aka tabbatar ya kamata ya kasance bisa la'akari da shari'ar da ake zargi da cutar ko kuma shaidar cutar kamar yadda aka nuna a baya: (1) gwajin PCR na ainihi don SARS-CoV-2 ya zama tabbatacce; (2) cikakken tsarin kwayoyin cuta na kwayar cutar wanda ke nuna babban kama da sanannen sabon coronavirus; (3) tabbatacce ga takamaiman IgM antibodies da IgG antibodies ga SARS-CoV-2 a cikin gwajin magani; ko sauyawar SARS-CoV-2-takamaiman IgG antibody daga mara kyau zuwa tabbatacce, ko karuwar mai ɗaukar hoto ≥4 sau a lokacin farfadowa a cikin mawuyacin lokaci.
Za mu iya ganin cewa an ƙara gwajin PCR na ainihi don nucleic acid a cikin hanyar numfashi ko samfurin jini a cikin juzu'i na biyu (Janairu 18, 2020) da na uku (Janairu 22, 2020).
An kara gano cututtukan cututtukan jini a cikin na huɗu (27 ga Janairu, 2020) da na biyar (8 ga Fabrairu, 2020); kuma daga baya an ƙara hujja ta ƙwayar cuta a cikin na bakwai.
Waɗannan haɓakawa suna dogara ne akan aikin yau da kullun na masu bincike don bincika gano mafi kyawun acid ɗin nucleic don wannan saurin ganewar asali, gami da haɗa jini daga samfurin numfashi, wanda ya faɗaɗa wadatar samfuran daban-daban, kuma yana da goyan baya don haifar da sakamako mai kyau na takamaiman ƙwayoyin cuta a cikin ƙa'idodin da aka tabbatar.
Bugu da ƙari, akwai ƙarin shaidu da ke tunatar da mu mu yi taka tsantsan da alamun cututtuka da kuma marasa lafiya masu alamun cututtuka.
Don haka, Zhou et al. ya kamata su sabunta jadawalin kwarararsu, saboda suna rarraba mutum ba tare da alamun asibiti ba a matsayin "mai ƙarancin haɗari".
Hakanan akwai buƙatar tabbatar da tsarin maki a cikin ƙarin aikin asibiti da nazarin.
A ƙarshe, muna fatan ƙarin hujjoji na kai tsaye za su zo don masu karatu su yi sharhi.
Don tantancewa na shari'ar da ake zargi da kuma tabbatacciyar shari'ar, ya kamata mu bi da bin sabbin ka'idojin kasarsa.
Don taimakawa, ƙungiyarmu za ta sabunta ƙa'idodinmu a kan kari.
Bangladesh ta ba da rahoton sabbin mutuwar COVID-19 guda biyar, mafi girma a rana ɗaya.
A jiya, Bangladesh ta tabbatar da sabbin mutuwar mutane biyar a rana guda sakamakon COVID-19.
Wannan shine adadin mutane da suka mutu a rana guda sakamakon wannan kwayar cutar.
A jiya, cibiyoyin bincike da kula da cututtuka na Bangladesh (IEDCR) sun ba da rahoton cewa akwai mutane 114 da ke fama da cutar da kuma 33 da suka warke a gida.
An samu mutuwar mutane 17 a cikin wannan hari.
A wani rahoto da aka wallafa a yanar gizo, Daraktan IEDCR, Dakta, Mirzadeh Sabrina Flora, ta ce wadanda suka mutu sun hada da maza hudu da mace daya.
A cewar Dr. Mirzadeh, mutane biyu sun kai shekara 60, biyu kuma suna tsakanin shekaru 51 zuwa 60, daya kuma yana tsakanin shekaru 41 zuwa 50.
Ya kuma ce biyu daga cikin wadanda suka mutu 'yan Dhaka ne.
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba.
Jami'an asibitin sun shaida wa wata kafar yada labarai ta Adolu cewa, daya daga cikin wadanda suka mutu shine Jalal Saifur Rahman, darektan hukumar yaki da cin hanci da rashawa ta Bengal, wanda ake kula da shi a asibitin Kuwait Friendship.
A ranar Asabar, a cikin sanarwar bidiyo ta yanar gizo, Ministan Sufurin Hanya da gadaje na Bangladesh Obaidul Quadar ya ce za a rufe zirga-zirgar jama'a na tsawon lokaci fiye da yadda aka tsara tun farko, har zuwa wannan Asabar mai zuwa.
An shirya wannan rufewar zirga-zirgar jama'a da farko a ranar 26 ga Maris kuma an shirya kawo karshen ranar Asabar, 4 ga Afrilu.
Har yanzu ana ba da izinin jigilar kayayyaki masu mahimmanci - likitoci, mai da abinci.
A ranar 8 ga watan Maris ne aka fara samun mutum biyu da suka dawo daga Italiya da matar daya daga cikinsu a Bangladesh.
A ranar 19 ga watan Maris, duk ukun sun warke.
SARS-CoV-2 ya riga ya wuce kamuwa da cutar miliyan daya a duniya.
A ranar Alhamis, jimlar adadin masu kamuwa da cutar coronavirus SARS-CoV-2 a duniya ya zarce miliyan daya, in ji bayanan Jami'ar Johns Hopkins.
Akalla mutuwar 52,000 an danganta su da cutar COVID-19, cutar da kwayar cutar coronavirus ke haifarwa.
Wannan muhimmin ci gaba ya zo ne a ranar da Malawi ta tabbatar da kamuwa da cutar coronavirus ta farko da kuma Zambia ta tabbatar da mutuwar da ta shafi cutar.
Koriya ta Arewa a ranar Alhamis ta ce tana daya daga cikin kasashe kalilan da ba su kamu da cutar coronavirus ba.
A jiya, Hukumar Lafiya ta Duniya ta tabbatar da mutane 1,051,635 da suka kamu da cutar, ciki har da mutane 79,332 a cikin sa'o'i 24 da suka gabata da karfe 10.00 na safe a tsakiyar Turai (0800 UTC) a ranar 4 ga Afrilu.
A Amurka, an samu sama da mutane 244,000 da suka kamu da cutar coronavirus, kuma an samu mutuwar mutane 5,900.
CBS News, tana ambaton bayanan Jami'ar Johns Hopkins, ta ruwaito cewa cutar coronavirus ta kashe mutane sama da 1,000 a Amurka a ranar Laraba.
A duk faɗin duniya, an sanar da tsauraran matakai don hana yaduwar cutar.
A ranar Alhamis, Sergey Sobyanin, magajin garin Moscow, ya tsawaita dokar kulle har zuwa ranar 1 ga Mayu.
A matakin kasa, Shugaba Vladimir Putin ya sanar da cewa har zuwa 30 ga Afrilu, 'yan Rasha za su ci gaba da samun albashi ba tare da zuwa aiki ba.
Majalisar dokokin Portugal ta tsawaita dokar ta kasa ta kwanaki 15, ta amince da kudirin da kuri'u 215, 10 sun ki halarta, kuma daya ya ki.
Saudiyya ta kafa dokar hana fita a cikin tsattsarkan biranen Makka da Madina: A baya, dokar hana fita ta kasance daga karfe 3 na yamma zuwa 6 na safe.
Thailand ta shirya aiwatar da dokar hana fita daga karfe 10 na dare zuwa 4 na safe.
Gwamnan Ohio, Mike Devine ya tsawaita dokar hana fita zuwa ranar 1 ga watan Mayu.
Shaguna a Ostiraliya sun rage yawan takarda bayan gida da ake amfani da ita a kowane sayarwa.
A ranar Lahadi da Asabar da yamma. Shagon sayar da kayayyaki na Woolworths da Coles na Australiya ya rage takunkumin da aka sanya wa takardar bayan gida zuwa biyu da kuma kunshin daya a kowace ma'amala a kasa.
ALDI ma, a ranar Litinin ta fara iyakance-ta-ɗaya-ta-ɗaya.
An sanya waɗannan iyakokin a matsayin saƙo a wurin biya da kuma shafin Facebook na sarkar.
Idan mutane suna buƙatar keɓe kansu, masu siye suna yin ajiyar kaya saboda tsoron COVID-19.
A ranar Laraba, Woolworths ta kuma iyakance kowane sayayya zuwa fakiti ɗaya a kowane oda don isar da gida.
Wannan canjin ya biyo bayan dokar ta hudu-pack da Woolworths da Coles suka gabatar a ranar 4 da 5 ga Maris, bi da bi.
Coles, a cikin fitowarsu ta 8 ga Maris, za ta ba da rahoton cewa ƙuntatawa na fakitin hudu zai kasance, "shaguna da yawa suna sayarwa a cikin awa ɗaya na isarwa", kuma ya ce buƙata "ba za a iya gaskatawa ba", yayin da ALDI, a cikin rubutun Facebook ɗin su a ranar Talata, ya kira shi "ba zato ba tsammani".
A cewar mai magana da yawun Woolworths, tallace-tallace sun "ƙaru sosai" a makon da ya gabata.
A makon da ya gabata, kantin sayar da kayayyaki na Costco a Canberra ya rage adadin zuwa fakiti biyu.
Don rage karancin, Coles ya ba da umarnin manyan fakiti daga masu samar da kayayyaki kuma ya kara yawan isar da kayayyaki. Woolworths ya ba da umarnin ƙarin kaya, yayin da ALDI ya ba da isar da kayayyaki da wuri don ranar Laraba da aka tsara.
Daraktan kungiyar dillalai ta Australiya, Russell Zimmerman, ya ce dillalai sun yi kokarin kara kaya, amma an yi ta gwagwarmaya saboda takunkumin da majalisar ta yi kan lokacin da ake samar da motoci.
Ya yi tsammanin farashin samarwa zai karu, saboda masu samar da kayayyaki suna buƙatar biyan buƙatu, da ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙaran
A ranar Talata, ADLI ta sanar da cewa saboda jigilar kaya da wuri, wasu shagunan ba za su iya gudanar da na musamman a ranar Laraba ba.
Kamar yadda News.com.au ta ruwaito, Dokta Gary Mortimer, masanin sayar da kayayyaki a Jami'ar Fasaha ta Queensland ya ce shagunan suna cika kaya a kowane dare.
Sun ce takardar bayan gida abu ne mai girma, wanda ke haifar da karancin kaya, kuma, idan aka sayar da shi, yana kawar da sararin samaniya.
Coles da Woolworths sun nuna cewa idan akwai abubuwa da yawa a kan shiryayye, kamar su kayan wanka da kuma tsabtace jiki, kuma suna da yawa a can, za ku rage yiwuwar damuwa, in ji Russell Zimmerman, a cewar ABC News.
Kamfanin da ke kera takarda na bayan gida mai suna Who Gives a Crap ya ce ya ƙare.
Kamar yadda News.com.au ta ruwaito, Kimberly-Clark, wanda ke kera Kleenex Toilet Tissue, da Solaris Paper wanda ke kera Sorbent, sun jaddada cewa suna aiki 24/7 don kiyaye wadatar.
Domain.com, wani shafin yanar gizon gidaje, ya ruwaito cewa wasu masu sayar da gidaje a Melbourne suna ba da takarda na gidan wanka kyauta ga mai neman farko a gwanjon sa, yayin da aka yi gwanjon kaɗan saboda masu siye suna da lokaci a babban karshen mako na ranar aiki.
A cikin jaridar NT News ta ranar Alhamis, wanda ake buga shi a kullum a Darwin, an saka takarda mai ruwa guda takwas don a yanke su kuma a yi amfani da su a matsayin takarda na bayan gida.
A cewar rahoton ABC Australia na ranar 3 ga Maris, shagon ya kasance yana adawa da dokar hana sayayya, yana mai cewa ba shi da wani shiri na sanya takunkumi kan sayayya.
Russell Zimmerman ya ce akwai bukatar wasu kayayyaki da suka hada da masks, sanitizers, kayan bushewa, wanke hannu da gari.
Hakazalika, a wajen Ostiraliya, a ranar Lahadi da yamma, babban kanti na Burtaniya na kan layi Ocado ya iyakance sayan takardar bayan gida ta Andres zuwa fakiti biyu na 12-rubuce.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba ta duniya.
A ranar Laraba ne Hukumar Lafiya ta Duniya (WHO) ta ayyana barkewar cutar COVID-19 a matsayin cutar da ke haifar da cutar coronavirus SARS-CoV-2.
Ko da yake kalmar "annoba" tana nufin yaduwar cutar ne kawai maimakon yadda ta fi muni, WHO ta ce akwai bukatar gwamnatoci su dauki mataki.
Dukkan kasashen duniya na iya canza kudaden da suke amfani da su a wannan annoba.
Darakta Janar na WHO, Tedros Adhanom Ghebreyesus ya ce idan al'ummomi suka gane hakan, za su fara gwaji, magani, keɓewa, ganowa da kuma haɗa kan al'ummarmu a wannan yaƙi.
Muna matukar damuwa da yadda cutar ke yaduwa da kuma yadda take da tsanani da kuma yadda ake nuna rashin aiki.
Dokta Tom Freeden, tsohon shugaban cibiyar kula da cututtuka da rigakafi ta Amurka, ya ce annobar ta duniya "ba ta da misali".
A cikin bayanan da aka buga a CNN a watan Fabrairu, ya ce, "Babu wani kwayar cuta da ke da alaƙa da numfashi da aka gano daga farkonta zuwa yaduwar ta duniya ban da mura".
Gabrayusus ya bayyana wannan ra'ayi, yana cewa, "Ba mu taɓa ganin annobar da ta faru a duniya ba saboda cutar coronavirus".
Ya kara da cewa, "Ba mu taba ganin annobar duniya da za a iya sarrafa ta a lokaci guda ba".
Yanayin annobar a duniya ya biyo bayan shawarar da WHO ta yanke a watan Janairu na ayyana barkewar cutar a matsayin gaggawa ta kiwon lafiyar jama'a na damuwa ta duniya.
"Babu shakka, yanayin zai daɗa muni", in ji Dr. Anthony Fauci, shugaban Cibiyar Kula da Cututtuka da Cututtuka ta Ƙasa ta Amirka.
A ranar Alhamis, Associated Press ta ruwaito cewa akwai aƙalla mutane 126,000 da suka kamu da COVID-19 a duniya, wanda ya haifar da mutuwar sama da 4,600.
Cutar annobar coronavirus ta 2019-20 annobar annobar annobar coronavirus ta 2019 (COVID-19) ce wacce ke haifar da cutar coronavirus 2 (SARS-CoV-2), wacce ke haifar da mummunan cututtukan numfashi.
An gano barkewar cutar a watan Disambar 2019 a Wuhan, China, kuma an ayyana ta a matsayin gaggawa ta kiwon lafiyar jama'a game da damuwa ta duniya a ranar 30 ga Janairu, 2020 kuma an lasafta ta a matsayin annoba ta duniya tun daga ranar 11 ga Maris, 2020.
A ranar 10 ga Afrilu, 2020, an samu kusan mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe da yankuna 210 kuma kusan mutane 97,000 ne suka mutu sakamakon hakan.
Kimanin mutane 3,64,000 ne suka warke.
Kasar Sin tana da kashi 4 cikin dari na mace-macen da ke mutuwa, inda Aljeriya ke da kashi 13.04 cikin dari da kuma New Zealand da kashi 0.08 cikin dari.
Alamomin da aka saba gani sun hada da zazzabi, tari da kuma zazzabi.
A cikin mawuyacin yanayi, ana iya samun alamun cutar nimoniya da wahalar numfashi.
Lokaci daga kamuwa da cutar zuwa bayyanar cututtuka yawanci kusan kwanaki biyar ne, amma zai iya wucewa daga kwana biyu zuwa 14.
Babu wani allurar rigakafi ko takamaiman maganin rigakafi da aka sani.
Maganin farko shine a bi da alamun cututtuka da kuma maganin da ya dace. Matakan kariya da aka ba da shawarar sun haɗa da wanke hannu, rufe fuska lokacin tari, nisantar mutane, saka idanu da kuma ware kai daga mutanen da ake zargi da kamuwa da cutar.
Hukumomi a duk duniya sun amsa ta hanyar hana tafiye-tafiye, keɓewa, dokar hana fita, kula da haɗarin aiki da rufe wuraren aiki.
Wannan annobar ta haifar da rashin zaman lafiya a duniya, wasanni, addinai, siyasa da al'adu sun jinkirta ko an soke su, kuma akwai karancin kayayyaki da ake samu sakamakon sayayya da ake yi cikin tsoro.
Makarantu da jami'o'i a ƙasashe 193 suna rufewa ko dai a matakin ƙasa ko na gida, wanda ke shafar kusan kashi 99.4% na yawan ɗaliban duniya.
Labaran karya game da kwayar cutar sun bazu a yanar gizo kuma akwai wasu lokuta na tsoro ko ƙiyayya da nuna bambanci ga Sinawa, da sauran mutanen Gabas da Kudu maso Gabas da kuma mutanen da suke kama da su kuma suna da manyan cututtukan cutar.
Rage tafiye-tafiye da rufe manyan masana'antu sun rage gurbataccen iska da fitar da iskar carbon.
Jami'an lafiya a Wuhan, China (babban birnin lardin Hubei) sun ba da rahoton cututtukan cutar nimoniya da ba a san dalilin da ya sa ba a ranar 31 ga Disamba, 2019 kuma an fara bincike a farkon Janairu, 2020.
Yawancin masu kamuwa da cutar sun kasance a cikin kasuwar sayar da abincin teku ta Hunan, saboda haka ana tsammanin cutar ta samo asali ne daga dabbobi.
Kwayar cutar da ta haifar da barkewar cutar, wacce aka sani da SARS-CoV-2, sabuwar kwayar cuta ce da aka gano wacce ke da alaƙa da kwayar cutar coronavirus ta bat, kwayar cutar coronavirus da ke tattare da kuliyoyi da SARS-CoV. Mutumin da aka sani da farko da ke nuna alamun cutar daga baya an gano shi mara lafiya a ranar 1 ga Disamba, 2019 kuma mutumin ba shi da alaƙa kai tsaye da rukunin kasuwa na baya.
A cikin rukunin farko na shari'o'in da aka ruwaito a shekarar 2019, kashi biyu bisa uku na shari'o'in da aka gano suna da alaƙa da kasuwa.
Rahoton da aka buga a ranar 13 ga watan Maris na shekarar 2020 a jaridar South China Morning Post ya nuna cewa mutum mai shekaru 55 daga lardin Hubei, wanda aka gano har zuwa ranar 17 ga watan Nuwamba na shekarar 2019, na iya zama mutum na farko da ya kamu da cutar. A ranar 26 ga watan Fabrairun 2020, WHO ta ba da rahoton cewa yayin da sabon adadin da aka samu a kasar Sin ya ragu amma ya karu a cikin Italiya da Koriya ta Kudu, wannan shi ne karo na farko da adadin sabbin masu kamuwa da cutar a wajen kasar Sin ya zarce adadin da ke cikin kasar Sin.
Ana iya samun rahotannin marasa lafiya da yawa, musamman waɗanda ke nuna alamun rashin lafiya.
Har zuwa ranar 26 ga Fabrairu, an samu karancin cututtuka a tsakanin matasa, tare da masu shekaru 19 ko ƙasa da haka da ke da kashi 2.4% na cututtukan duniya.Babban mai ba da shawara kan likitancin Burtaniya, Patrick Vallance ya kiyasta cewa kashi 60% na yawan mutanen Burtaniya za su buƙaci kamuwa da cutar kafin su sami rigakafin cutar.
Lamura na nufin yawan mutanen da aka gwada don COVID-19 da kuma waɗanda aka tabbatar sun gwada tabbatacce bisa ga ƙa'idodin hukuma.
Har zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawanta, kuma yawancin ƙasashe kamar Italiya, Netherlands, Spain da Switzerland suna da manufofin hukuma na rashin gwada waɗanda ke da alamun rashin lafiya.
Wani bincike da aka fitar a ranar 16 ga watan Maris ya nuna cewa kimanin kashi 86 cikin dari na mutanen da ke dauke da COVID-19 a kasar Sin ba a gano su ba har zuwa ranar 23 ga watan Janairu, kuma mutane marasa lafiya da ke dauke da cutar sun kasance tushen kashi 79 cikin dari na wadanda suka kamu da cutar.
Wani bincike na kididdiga da aka fitar a ranar 30 ga Maris ya yi kiyasin cewa adadin masu kamuwa da cutar a Italiya ya fi adadin da aka ruwaito.
Hasashen farko na ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙidid
Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta fitar da wani bincike wanda ya kammala cewa zai iya zama 5.7.
Yawancin mutanen da ke fama da COVID-19 suna murmurewa.
Kuma ga waɗanda ba su da alamun cutar, lokacin da ke tsakanin bayyanar cututtuka da mutuwa ya kai kwanaki 6 zuwa 41 kuma mafi yawan lokuta kwanaki 14 ne.
A ranar 10 ga Afrilu, 2020, kusan mutane 97,000 ne suka mutu sakamakon COVID-19.
A kasar Sin, 80% na mutuwar da aka samu a ranar 5 ga watan Fabrairu sun kasance mutane masu shekaru 60 zuwa sama, kuma kashi 75% na mutuwar sun kasance masu fama da cututtukan zuciya da ciwon sukari tare da wasu matsalolin kiwon lafiya.
Mutuwar da ke faruwa da gaske ta COVID-19 na iya zama mafi girma, saboda ba za a iya haɗa da mutanen da ba a gwada su ba, misali, waɗanda ke mutuwa a gida, asibitocin haihuwa, da sauransu.
Rahotanni kaɗan daga Italiya sun nuna cewa yawan mutuwar a lokacin annobar duniya ya ninka na COVID sau 4-5 na mutuwar hukuma.
"Majalisar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ta yarda cewa", Mun san cewa [yawan mutuwar da aka samu] ƙididdiga ce mai ƙarancin ƙididdiga", wata sanarwa da ke da alaƙa da rahotanni marasa iyaka game da ƙididdigar ƙididdiga a Amurka. Irin wannan ƙididdigar ƙididdiga tana faruwa sau da yawa a cikin annoba, kamar yadda aka gani a cikin cutar ta 2009 H1N1 Swine Flu. An tabbatar da mutuwar farko a Wuhan a ranar 9 ga Janairu, 2020.
Mutuwar farko a waje da babban yankin China ta fara a Philippines a ranar 1 ga Fabrairu, kuma mutuwar farko a waje da Asiya ta fara a Faransa a ranar 14 ga Fabrairu.
A ranar 28 ga watan Fabrairu, fiye da mutane goma sha biyu ne suka mutu a kasashen Iran, Koriya ta Kudu da Italiya.
A duk nahiyoyi banda Antarctica, an samu mutuwar mutane a kasashe da yankuna sama da arba'in har zuwa ranar 13 ga Maris. Ana amfani da hanyoyi da yawa don yin rikodin yawan mutuwar.
Waɗannan ƙididdigar sun bambanta ta yanki da lokaci kuma suna da tasiri akan yawan gwaje-gwajen da aka yi, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tsawon lokacin barkewar cutar da halaye na yawan jama'a; misali, shekaru, jinsi da lafiyar gaba ɗaya.
A cewar Johns Hopkins University, adadin mace-mace da ke fama da cutar a duniya ya kai kashi 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu, 2020.
Wannan adadi ya bambanta daga yanki zuwa yanki.
Yawan mace-mace da suka kamu da cutar a kasar Sin ya ragu daga kashi 17.3% (a cikin 1 zuwa 10 ga Janairu 2020 ga wadanda ke da alamun cutar) zuwa kashi 0.7% (a cikin 1 ga Fabrairu 2020 ga wadanda ke da alamun cutar).
Wannan bayanan ba su da iyaka na lokaci kuma suna bin diddigin yawan jama'a daga kamuwa da cutar har sai an warware matsalar.
Ƙungiyoyin ilimi da yawa sun yi ƙoƙari su ƙididdige waɗannan ƙididdigar ga wasu mutane.
Cibiyar likitanci ta Oxford ta yi hasashen cewa yawan kamuwa da cutar da cutar ta yi a duniya ya kasance tsakanin kashi 0.1 zuwa 0.39 cikin dari.
Hasashen da ke sama a cikin wannan zangon ya dace da gwajin farko na COVID-19 da aka yi a Jamus da kuma nazarin ƙididdiga wanda ke nazarin tasirin gwajin akan CFR.
WHO ta tabbata cewa za a iya kawo annobar cikin iko.
Matsayin mafi girma da kuma tsawon lokacin wannan fashewar ba a sani ba kuma zai iya bambanta daga wuri zuwa wuri.
Masayyan Jami'ar Penn State, Masayye Booney, ya ce, "Idan ba a yi gwajin ba, cutar za ta daina yaduwa zuwa wani matakin da zai rage yayin da ake samun karɓar baƙi kaɗan.
Amma ba zai yiwu a yi hasashen lokacin da hakan zai faru ba".
Zhong Nan Shan, babban mai ba da shawara kan lafiya ga gwamnatin kasar Sin, ya yi jayayya cewa "za a kammala shi a watan Yuni" idan dukkan kasashen suka fara bin shawarar WHO don hana yaduwar kwayar cutar.
A ranar 17 ga Maris, Adam Kucharski na Makarantar Kiwon Lafiyar Jama'a da Magungunan Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Yankin Y Yankin Yankin Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y
Nazarin da Neil Ferguson na Kwalejin Imperial ya jagoranta ya nuna cewa nisantar jiki da sauran matakan "za su zama dole har sai an sami allurar rigakafi (watakila watanni 18 ko fiye)".
William Schaffner na Jami'ar Vanderbilt ya lura cewa "da yake kwayar cutar tana yaduwa cikin sauƙi, ba zai yiwu a kawar da ita gaba ɗaya ba", saboda haka "za ta zama cuta ta yanayi kuma za ta dawo kusan kowace shekara".
Rashin cutarwa ko tsananin dawowa ya dogara da ƙarfin rigakafin jama'a da kuma girman maye gurbin.
Alamomin COVID-19 ba su da bambanci kuma ba za a iya samun alamun cutar ba a cikin mutanen da ke fama da cutar.
Abubuwa biyu da suka fi dacewa sune zazzabi (88%) da bushewar tari (68%).
Wasu daga cikin alamun da ba a yawan gani ba sun haɗa da gajiya, tari, rashin jin ƙamshi, ciwon ƙwari, ciwon tsoka da haɗin gwiwa, ciwon makogwaro, ciwon kai, sanyi, amai, zub da jini, zazzaɓi ko kuma launin shuɗi saboda rashin iskar oxygen. WHO ta ce mutum ɗaya cikin shida yana fama da ciwo mai tsanani kuma yana fama da matsalar numfashi.
Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka (CDC) sun lissafa alamun gaggawa; misali, wahalar numfashi, ciwon kirji ko ciwo mai tsawo, rikicewa kwatsam, wahalar tashi, da launin shuɗi a fuska ko lebe; ana ba da shawarar neman kulawar likita nan da nan idan akwai alamun. Cutar ta ci gaba da ci gaba, wanda zai iya haifar da ciwon huhu mai tsanani, ciwon huhu mai tsanani, ciwon rauni, harin septic, da mutuwa.
Tun da wasu daga cikin mutanen da suka kamu da cutar ba za su iya nuna alamun cutar ba, amma sakamakon gwajin zai tabbatar da kamuwa da cutar, masu binciken sun ba da shawarar cewa duk wanda ya kasance kusa da mutanen da aka tabbatar da kamuwa da cutar ya kamata a lura da shi sosai kuma a bincika shi don kawar da yiwuwar kamuwa da cutar.
Kasar Sin ta kiyasta cewa adadin marasa alamun cutar zai iya kaiwa kashi 44 cikin dari.
Yawanci lokacin bayyanar cutar ta ainihi (lokacin bayyanar cututtuka) daga kwana ɗaya zuwa 14 bayan kamuwa da ƙwayoyin cuta sun shiga jiki, yawanci kwanaki biyar. Misali na rashin tabbas shine cewa yawan mutanen da ke da cutar COVID-19 da suka rasa ma'anar wari ya fara da kashi 30% sannan kuma ya ragu zuwa kashi 15%.
Har yanzu ana ci gaba da binciken wasu bayanai game da yadda cutar ta yadu.
Ana ganin cewa cutar tana yaduwa ne ta hanyar kusanci da ƙananan ɗigon ruwa da ke tattare da tari, hancin kunne ko magana, kusanci da ke tsakanin mita 1 zuwa 2 (ƙafa 3 zuwa 6).
A lokacin binciken, an gano cewa saukad da tari ba tare da rufe baki ba zai iya tafiya daga mita 4.5 (ƙafa 15) zuwa mita 8.2 (ƙafa 27).
Wasu sun ce ana iya samun kwayar cutar ta hanyar ƙananan ɗigon ruwa da ke cikin iska, wanda zai iya zama a cikin iska na dogon lokaci, yayin da ba a samar da kwayar cutar a cikin iska, amma ana iya samar da ɗigon iska a cikin numfashi, yayin magana.
Za a iya shigar da waɗannan ɗigon cikin bakin mutane ko hanci, ko kuma a sha su cikin huhu tare da numfashi.
A wasu lokuta, ana iya yin amfani da hanyoyin likita kamar intubation ko resuscitation na zuciya da na numfashi don fitar da ƙwayoyin cuta a cikin iska.
Idan mutum ya taɓa wani abu da ya kamu da cutar, har da fatar jiki, sai ya taɓa idanunsa, hancinsa ko bakinsa.
Ko da yake akwai damuwa cewa zai iya yaduwa ta hanyar stool, ana ganin cewa ba shi da haɗari.
Gwamnatin kasar Sin ta musanta yiwuwar kamuwa da cutar ta SARS-CoV-2 ta hanyar bargo ko ta baki. Ko da yake ana iya samun kamuwa da cutar a cikin kwanaki uku na farko bayan bayyanar cututtuka, kafin bayyanar cututtuka da kuma a cikin ci gaba da cutar.
Mutane da yawa sun gwada tabbatacce kwanaki uku kafin bayyanar cututtuka, wanda ke nuna cewa ana iya kamuwa da cutar kafin bayyanar cututtuka da yawa.
Akwai rahotanni kaɗan na marasa alamun cutar da aka tabbatar a cikin dakin gwaje-gwaje, amma binciken da aka yi game da hulɗa ya nuna cewa wasu ƙasashe sun kamu da cutar ba tare da alamun cutar ba.
Cibiyar Kula da Cututtuka ta Turai ta ce, ko da yake ba a san yadda cutar ke yaduwa ba, mutum ɗaya yana iya kamuwa da mutane biyu zuwa uku. Kwayar cutar tana rayuwa a farfajiya na awanni zuwa kwanaki.
Musamman, an gano cewa kwayar cutar tana iya kasancewa a kan filastik (polypropylene) da 304 bakin karfe har zuwa kwanaki uku, a kan kwali na kwana daya da kuma jan ƙarfe har zuwa awanni huɗu.
Koyaya, wannan na iya bambanta dangane da zafi da zafin jiki.
Ko da yake hukumomin Burtaniya sun ba da shawarar wanke hannu bayan tuntuɓar wasu wurare da mutane masu cutar suka taɓa, da kuma wanke hannu bayan tuntuɓar dabbobi, babu wata hujja da ta nuna cewa dabbobi na iya watsa kwayar cutar ga mutane.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Dukkanin siffofin sabon SARS-CoV-2 ana samun su a cikin dukkanin coronaviruses masu alaƙa da ke cikin yanayi. A waje da jikin mutum, kwayar cutar tana mutuwa yayin da sabulu na gida ya narkar da murfinta na kariya.
An yi imanin cewa asalinsa dabba ne.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar Corona tana da kwayar halitta guda biyu tare da nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'in nau'ikan nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Yana da daidaito na kashi 96% a matakin kwayoyin halitta tare da wasu nau'ikan kwayar cutar Corona (BatCov RaTG13) da suka shafi sauran jemage.
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai bambanci na amino acid daya kawai a wasu sassan tsarin kwayoyin halittar kwayar cutar da ke dauke da kwayar cutar.
Zuwa yau, an gano kashi 92% na abubuwan da ke cikin kwayar halittar da kwayar cutar SARS-CoV-2 ke rabawa a cikin kwatancen kwayoyin halitta, wanda bai isa ya tabbatar da cewa kwayar cuta ita ce mai watsa shiri na tsakiya ba.
Ana iya tantance kamuwa da kwayar cutar ta hanyar alamomi amma ana tabbatar da shi ta hanyar sake fasalin kwayar cutar ta hanyar sake fasalin kwayar halitta ta hanyar sake fasalin kwayar halitta ta hanyar sake fasalin kwayar halitta ta hanyar sake fasalin kwayar halitta ta hanyar sake fasalin kwayar halitta ta hanyar sake fasalin kwayar halitta ta hanyar sake fasalin kwayar halitta ta hanyar sake fasalin kwayar halitta ta hanyar sake fasalin kwayar halitta ta hanyar sake fasalin kwayar halitta ta hanyar sake fasalin kwayar halitta ta hanyar sake fasalin kwayar halitta ta hanyar sake fasalin kwayar halitta ta hanyar sake fasalin kwayar halitta ta hanyar sake fasalin kwayar halitta ta hanyar CT.
Nazarin kwatancen PCR da CT da aka gudanar a Wuhan ya nuna cewa CT, kodayake ba ta da daidaito sosai, tana da ƙwarewa sosai fiye da PCR kuma yawancin halayen hoto na da alaƙa da sauran cututtukan huhu da tsarin cuta.
A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa kada a yi amfani da CT don gano COVID-19 ko kuma a yi amfani da shi azaman gwaji na farko.
WHO ta fitar da ka'idoji da yawa don gwajin RNA game da SARS-CoV-2, na farko daga cikinsu an fitar da shi a ranar 17 ga Janairu.
Wannan gwajin yana amfani da ainihin lokacin juyawa juyawa polymerase chain reaction (rRT-PCR).
Ana iya yin gwajin ne a kan jini ko kuma na numfashi.
Sakamakon zai iya kasancewa cikin sa'o'i da yawa ko kwanaki.
Yawancin lokaci ana yin gwajin ne da samfurin fitowar daga cikin ƙashin baya na hanci amma ana iya amfani da samfurin fitowar daga cikin makogwaro. Yawancin dakunan gwaje-gwaje da kamfanoni suna haɓaka gwaje-gwaje don gano ƙwayoyin cuta masu alaƙa da jini.
Har zuwa 6 ga Afrilu, 2020, babu ɗayan waɗannan gwaje-gwajen da aka tabbatar da cewa sun dace don yarda da amfani da su sosai.
Wani gwajin jini da aka haɓaka a Amurka ta hanyar CELACS an yarda da shi ne kawai don amfani da gaggawa daga dakunan gwaje-gwaje masu inganci.
Abubuwan da ke cikin hotuna na musamman akan radiography da CT na mutanen da ba su da alamun cutar suna da ƙarancin gilashin gilashin ƙasa da ba a tabbatar da su ba kuma ba su da faduwar ruwa.
Ana tattara bayanan kan layi na duniya na binciken hoto na shari'o'in da aka tabbatar ta hanyar Radiological Society na Italiya.
Yin amfani da hotuna don gano COVID-19 ba tare da tabbatar da PCR ba saboda haɗuwa da cututtukan cututtuka kamar adenoviruses ba daidai bane.
Wani babban bincike a China ya kwatanta sakamakon CT na kirji da PCR kuma ya nuna cewa hotunan hoto, kodayake ba su da cikakkiyar ma'ana don gano kamuwa da cuta, suna da sauri kuma suna da ƙwarewa, kuma sun ba da shawarar yin la'akari da amfani da su azaman kayan aikin bincike a wuraren da cutar ta ɓarke.
An haɓaka hanyoyin sadarwar juyayi tare da radiography da CT waɗanda ke da tushen AI don gano fasalin hoto na kwayar cutar.
Shirye-shiryen hana kamuwa da cutar sun hada da kiyaye lafiyar mutum gaba daya, wanke hannu, kauce wa taɓa idanu, hanci ko baki ba tare da wankewa ba, amfani da nama lokacin tari ko hancinsa da kuma zubar da nama kai tsaye cikin kwandon shara, da sauransu.
An shawarci mutanen da suka riga sun kamu da cutar da su sanya abin rufe fuska a wuraren jama'a.
An kuma bada shawarar kiyaye nesa ta jiki don hana yaduwar cutar. Gwamnatoci da dama sun takaita ko kuma basu da shawarar yin tafiya daga yankunan da cutar ta bulla.
Amma, cutar ta kai ga yaduwar zamantakewa a manyan sassan duniya.
Wannan yana nufin cewa kwayar cutar tana yaduwa a cikin al'umma kuma wasu ɓangarorin al'umma ba su san lokacin da ko inda suka kamu da cutar ba. Ana ba da shawarar masu ba da kiwon lafiya waɗanda ke kula da wanda ya kamu da cutar su kula da ƙa'idodi, kula da hulɗa da idanu. Binciken abokan hulɗa yana da mahimmanci ga jami'an kiwon lafiya don gano asalin kamuwa da cutar da hana kamuwa da cutar gaba.
Gwamnatoci suna amfani da bayanan wurin da aka sanya ta wayar salula don wannan dalili, wanda ya haifar da damuwa game da sirrin mutane, kuma Amnesty International da wasu kungiyoyi 100 sun fitar da wata sanarwa don iyakance irin wannan sa ido.
An aiwatar da aikace-aikacen hannu da yawa ko kuma an ba da shawarar yin amfani da su ta hanyar son rai, kuma a ranar 7 ga Afrilu, 2020, sama da ƙwararrun masana da ke aiki a kan zaɓuɓɓuka kamar amfani da Bluetooth don yin rajistar kusanci da mai amfani da ke son sirri tare da sauran wayoyin salula.
Bayan haka, masu amfani za su sami saƙo idan sun kasance kusa da wanda ya gwada tabbatacce ga COVID-19.
Babu riga-kafi ga COVID-19, kungiyoyi da yawa suna ƙoƙarin samar da allurar rigakafi.
Ana ba da shawarar wanke hannu don hana yaduwar cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu akai-akai da sabulu da ruwa na aƙalla dakika ashirin, musamman bayan sun je bayan gida ko idan hannayensu sun yi datti, kafin cin abinci da bayan shan hanci, tari ko hancin.
Dalilin shi ne, bayan jikin mutum, sabulu na gida yana kashe kwayar cutar saboda sabulun gida yana karya murfinta na kariya.
Idan sabulu da ruwa ba su da wadata, CDC ta ba da shawarar amfani da maganin wanke hannu mai shan giya wanda ya ƙunshi aƙalla kashi 60% na barasa.
WHO ta bada shawarar kada a taba idanu, hanci, ko baki ba tare da wanke hannu ba.
Yawancin magunguna kamar 62-71% ethanol, 50-100% isopropanol, 0.1% sodium hydrochlorite, 0.5% hydrogen peroxide, da 0.2-7.5% povidone-iodine suna iya kawar da gurɓataccen abu a farfajiyar (za a iya kashe ƙwayoyin cuta a cikin ƙarfe mai ƙarancin ƙarfe ta amfani da maganin kashe ƙwayoyin cuta na minti ɗaya kawai).
Sauran magungunan kamar benzalkonium da chryoxydeine ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan akwai zargin ko tabbatar da cutar COVID-19 a wani wuri kamar kantin sayar da abinci ko gidan yara, duk allunan, allon taɓawa, na'urorin sarrafawa ta nesa da na'urorin ATM da marasa lafiya ke amfani da su a cikin wannan yankin su kashe kwayoyin cuta.
Kungiyoyin kiwon lafiya sun ba da shawarar cewa mutane su rufe bakinsu da hancinsu da kayan shafawa ko kuma kayan shafawa yayin da suke tari ko hancin kuma su zubar da kayan da wuri-wuri.
Ana ba da shawarar rufe fuska na tiyata ga waɗanda ke da yiwuwar kamuwa da cutar, saboda sanya abin rufe fuska na iya iyakance yawan da nisa na saukad da numfashi yayin magana, hancinsa ko tari.
WHO ta ba da umarni kan lokacin da kuma yadda za a yi amfani da abin rufe fuska.
A cewar masanin kwayar cutar a Jami'ar Leeds, Stephen Griffin, sanya abin rufe fuska na iya rage yawan mutanen da ke taɓa fuskokinsu, wanda shine babban tushen kamuwa da cuta idan ba a kula da lafiyar hannayensu ba. "An kuma ba da shawarar sanya abin rufe fuska ga masu kula da wanda zai iya kamuwa da cutar.
WHO ta ba da shawarar cewa mutane masu lafiya su sanya abin rufe fuska ne kawai idan suna cikin haɗari, misali waɗanda ke kula da mutanen da ke da cutar COVID-19, kuma sun yarda cewa sanya abin rufe fuska na iya taimaka wa mutane su guji taɓa fuskokinsu.
Kasashe da dama sun fara karfafawa jama'a gwiwa su sanya takunkumin rufe fuska.
CDC ta ba da shawarar amfani da abin rufe fuska na likitanci wanda ba na masana'anta ba a Amurka.China ta ba da shawarar musamman amfani da abin rufe fuska na likita don masu kula da lafiya a cikin jama'a, musamman lokacin da suke kusanci da wasu mutane (mita 1 (ƙafa 3) ko ƙasa da haka).
Hong Kong ta ba da shawarar yin amfani da abin rufe fuska na tiyata yayin amfani da jigilar jama'a ko lokacin da kuke cikin jama'a.
Jami'an kiwon lafiya na Thailand suna ƙarfafa mutane su yi abin rufe fuska a gida kuma su wanke su kowace rana.
Jamhuriyar Czech da Slovakia sun hana fita waje ba tare da rufe baki da hanci ba ko kuma ba tare da sanya abin rufe fuska ba a wuraren jama'a.
A ranar 16 ga Maris, Vietnam ta bukaci kowa da kowa ya sanya abin rufe fuska yayin da yake fita zuwa wuraren jama'a don kare kansa da wasu.
Gwamnatin Austriya ta tilasta sanya abin rufe fuska yayin shiga kantin sayar da kayan masarufi.
Isra'ila ta bukaci duk mazauna da su sanya abin rufe fuska a wuraren jama'a.
Taiwan ta samar da abin rufe fuska miliyan 10 a kowace rana tun daga tsakiyar watan Maris, kuma matafiya za su sanya abin rufe fuska a kan jiragen kasa da bas na tsakanin birane daga 1 ga Afrilu.
Panama ta tilasta sanya abin rufe fuska yayin fita waje kuma ta ba da shawarar waɗanda ba za su iya sayen abin rufe fuska ba su yi abin rufe fuska a gida.
Ana kuma amfani da abin rufe fuska sosai a Japan, Koriya ta Kudu, Malaysia da Singapore.
Nisa ta zamantakewa (wanda kuma ake kira nesa ta jiki) ya ƙunshi ayyukan sarrafa kamuwa da cuta da nufin rage yaduwar cutar ta hanyar rage kusanci tsakanin mutane.
Hanyoyin sun hada da killacewa, takunkumin hana tafiya da rufe makarantu, wuraren aiki, filaye, gidajen wasan kwaikwayo ko cibiyoyin kasuwanci da sauransu.
Mutane na iya aiwatar da wannan hanyar ta hanyar kasancewa a gida, ta hanyar takaita tafiye-tafiye, guje wa wuraren taron jama'a, guje wa taɓa juna yayin gaisuwa da nisantar jiki daga wasu.
Gwamnatoci da yawa sun ba da umarni ko kuma ba da shawarar nisantar da jama'a a wuraren da cutar ta bulla.
Hukumomin gwamnati da ma'aikatun kiwon lafiya na Amurka sun rage yawan taron jama'a daga mutane 250 (idan ba a san yaduwar COVID-19 a yankin ba) zuwa mutane 50 sannan zuwa mutane 10.
A ranar 22 ga Maris, 2020, Jamus ta hana mutane fiye da biyu taruwa a wuraren jama'a. Tsofaffi a wuraren da ke fama da cutar da kuma waɗanda ke da alaƙa da kiwon lafiya, wato cututtuka kamar ciwon sukari, cututtukan zuciya, cututtukan tsarin mulki, hauhawar jini da lalata tsarin garkuwar jiki suna fuskantar haɗarin kamuwa da cututtuka da cututtuka masu tsanani.
Amfani da kalmar "nisanci" ya haifar da mutane sun ware kansu gaba ɗaya ta wasu hanyoyi maimakon ƙarfafa su su kasance tare da juna. Wasu jami'ai sun ba da jagororin kiwon lafiyar jima'i a yayin wannan annobar ta duniya.
Wannan ya hada da shawarwari na yin jima'i da wanda kake zama da shi wanda ba shi da cutar ko kuma wanda ba shi da alamun cutar.
Wadanda aka gano suna dauke da COVID-19 da kuma wadanda ake zargin suna dauke da cutar, an shawarce su da su killace kansu a gida.
Hukumomin kiwon lafiya sun ba da shawarwari masu kyau kan yadda za a killace kai. Gwamnatoci da yawa sun ba da umarni ko kuma ba da shawarar killace dukkan mutanen da ke zaune a wuraren da cutar ta kamu.
An ba da umarnin keɓe kai mafi tsauri ga waɗanda ke cikin manyan ƙungiyoyin haɗari.
Wadanda ake zaton sun kasance tare da wani mai dauke da cutar COVID-19 da kuma wadanda suka yi tafiya zuwa wata kasa ko yanki da ke da cutar a kwanan nan an shawarce su da su killace kansu na kwanaki 14 daga lokacin da suka kasance tare da su.
Rigakafin yaduwar cutar da kuma rage yaduwar cutar sune hanyoyin magance cutar.
Ana yin rigakafin yaduwar cutar a farkon lokacin barkewar cutar kuma ana nufin a bi diddigin waɗanda suka kamu da cutar, a ware su, tare da tsara matakan kula da kamuwa da cuta da kuma yin allurar rigakafi don hana yaduwar cutar ga sauran jama'a.
Idan ba za a iya hana yaduwar cutar ba, ana daukar matakan dakile cutar: ana daukar matakan rage saurin yaduwar cutar da rage tasirin ta ga tsarin kiwon lafiya da al'umma.
Za a iya haɗa duka hanyoyin don hana yaduwar cutar da rage yaduwar cutar.
Don hana yaduwar cutar, dole ne a ɗauki matakan da suka fi ƙarfin gaske, kamar sauya cutar ta duniya ta hanyar rage yawan haifuwa zuwa ƙasa da 1.
Wannan zai rage barazanar matsa lamba ga kiwon lafiya kuma ya ba da lokaci don samar da allurar rigakafi da magunguna.
Abubuwan da ba na likita ba da za su iya magance barkewar cutar sun haɗa da tsabtace hannu, sanya fuska da keɓewa, rufe makarantu, hana taron jama'a, ƙarfafa jama'a su amince da kuma haɗa su, da kuma ɗaukar matakan zamantakewar da ke nufin nisantar jiki da tsabtace wuraren da ke kewaye.
Sauran kasashen ma sun dauki matakai daban-daban don takaita yaduwar kwayar cutar.
Koriya ta Kudu ta fara yin gwaji da keɓewa a cikin gida kuma ta yi gargadin yin taka tsantsan game da motsin mutanen da ke da cutar.
Singapore ta ba da tallafi na kudi ga waɗanda suka ware kansu kuma ta hukunta waɗanda ba su iya ba.
Taiwan ta kara samar da abin rufe fuska da kuma hukunta masu tara kayan aikin likitanci.Bayanin Burtaniya da Majalisar Dinkin Duniya, akwai manyan kalubale wajen dakile yaduwar cutar (rage saurin yaduwar cutar, ba dakatar da ita ba) da kuma hana ta (juya cutar).
Shirye-shiryen da suka dace don rage yaduwar cututtuka na iya rage yawan buƙatun kiwon lafiya da kashi biyu bisa uku kuma rage mutuwar da rabi amma har yanzu yana iya haifar da dubunnan mutuwar da kuma matsin lamba ga tsarin kiwon lafiya.
Hana ko hana yaduwar cutar na iya zama fifiko amma yana buƙatar ci gaba da kasancewa har sai kwayar cutar ta bazu cikin al'ummar ɗan adam (ko har sai an sami allurar rigakafi, idan ta faru da farko), in ba haka ba kamuwa da cuta zai sake yaduwa cikin sauri bayan an sassauta matakan.
Matsaloli na tattalin arziki da zamantakewa suna haifar da tsananin lalacewa idan aka yi aiki na dogon lokaci don hana ko hana yaduwar cutar.
Babu takamaiman maganin rigakafin COVID-19 amma ana ci gaba da kokarin samar da shi wanda ya hada da gwajin magungunan da ake dasu.
Samun maganin sanyi da ake samu a kantin magani, shan ruwa da kuma hutawa zai iya taimaka wajen rage alamun.
Bukatar shan iskar oxygen, jiko, da kuma taimakon numfashi na iya zama da tsanani.
Yin amfani da kwayoyin steroid na iya sa sakamakon ya zama mafi muni.
Ana gudanar da bincike kan magungunan da aka riga aka amince da su don magance wasu cututtukan cututtukan ƙwayar cuta don magance COVID-19.
WHO ta kuma ce "magungunan gargajiya da na gida" na iya sauƙaƙa alamun da SARS-CoV-2 ke haifarwa.
WHO ta ce bunkasa iya aiki da inganta kiwon lafiya ga marasa lafiyar COVID-19 sune manyan hanyoyin magance barkewar cutar.
ECDC da WHO na Turai sun ba da jagororin don ɗaukar albarkatun da ke akwai ga asibitoci da kula da kiwon lafiya na farko zuwa matakai daban-daban waɗanda suka haɗa da mai da hankali kan sabis na dakin gwaje-gwaje don gwajin COVID-19, kawar da hanyoyin maye gurbin idan ya yiwu, ware marasa lafiya da suka gwada tabbatacce ga COVID-19 da haɓaka ƙarfin ICU ta hanyar horar da ma'aikata da haɓaka adadin masu ba da iska da gadaje da ke akwai, da sauransu.
Akwai dabaru da yawa game da inda aka gano farkon yanayin (wanda ake kira mai cutar lambar sifili).
Ana iya gano farkon cutar ta coronavirus a Wuhan, Hubei, China a ranar 1 ga Disamba, 2019.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a Hubei ya karu a hankali.
Yawancin su suna da alaƙa da kasuwar siyar da kayan abincin teku ta Hunan, wanda har da dabbobi masu rai ana siyar da su, kuma wata ka'idar ita ce kwayar cutar ta fito ne daga irin waɗannan dabbobi, ko kuma a wasu kalmomin, asalin dabba. An gano rukunin marasa lafiya da cutar nimoniya da ba a san dalilin da ya sa ba a ranar 26 ga Disamba kuma an kula da su a Asibitin lardin Hubei da likita Zhang Jishian, wanda ya gaya wa Wuhan Jishian CDC a ranar 27 ga Disamba.
A ranar 30 ga Disamba, wasu likitoci a asibitin Wuhan sun gargadi abokan aikin su game da "SARS-Tatsum coronavirus".
Likitoci takwas, ciki har da Li Wenling, sun sami gargadi daga 'yan sanda kan yada jita-jita, kuma wata, Ma'a Fan, ta sami tsauraran matakai daga shugabanninta saboda yin hakan.
Hukumar kula da kula da kananan hukumomin Wuhan ta fitar da wata sanarwa ga jama'a kuma ta sanar da WHO.
An bayar da rahoton yawancin cututtukan cutar nimoniya da ba a sani ba ga jami'an kiwon lafiya a Wuhan wanda ya haifar da bincike a farkon watan Janairu.
Cutar ta yadu zuwa wasu lardunan kasar Sin a farkon da tsakiyar watan Janairun 2020, saboda ƙaura da ake yi saboda Sabuwar Shekarar China da kuma Wuhan a matsayin cibiyar sufuri da kuma babban wurin sauya jirgin ƙasa.
A ranar 20 ga watan Janairu, kasar Sin ta samu kusan mutane 140 da suka kamu da cutar a rana daya, biyu daga birnin Beijing daya kuma daga birnin Shenzhen.
Bayanan hukuma na baya-bayan nan sun nuna cewa a ranar 20 ga Janairun 2020, mutane 6174 sun riga sun fara nuna alamun cutar.Ya zuwa ranar 26 ga Maris, Amurka ta zarce China da Italiya a duniya dangane da mafi yawan adadin wadanda aka tabbatar da su.Ya zuwa ranar 9 ga Afrilu, 2020, an samu rahotanni miliyan 1.61 a duniya; sama da mutane 97,000 sun mutu kuma sama da 364,000 sun warke.
Kimanin kasashe da yankuna 200 sun sami aƙalla ɗaya daga cikin waɗannan cututtukan.
A sakamakon annobar a Turai, kasashe da dama a yankin Schengen sun sanya takunkumi kan 'yancin motsi da kuma sanya iyakoki.
Amsoshin a matakin ƙasa sun haɗa da matakan sarrafa yaduwar cutar (umarnin zama a gida, umarnin zama a inda kake) da kuma dokar hana fita.Kusan mutane miliyan 300 a Amurka, ko kashi 90% na yawan jama'a, suna cikin wasu nau'ikan kullewa kamar na 2 ga Afrilu, sama da mutane miliyan 50 a Philippines, kusan mutane miliyan 59 a Afirka ta Kudu, da mutane biliyan 1.3 a Indiya.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya suna cikin wasu nau'ikan kullewa, wanda ya karu zuwa biliyan 2.6 a cikin kwanaki biyu - wanda ya kai kashi ɗaya bisa uku na yawan mutanen duniya.
An gano farkon yanayin da aka tabbatar da COVID-19 a Wuhan kafin 1 ga Disamba, 2019, tare da wani yanayin da ba a tabbatar da shi ba a ranar 17 ga Nuwamba.
Dr. Zhang Jishian ya gano tarin cututtukan cutar nimoniya da ba a san dalilin da ya sa ba a ranar 26 ga Disamba, bayan asibitin ya sanar da Wuhan Jianghan CDC a ranar 27 ga Disamba.
Gwaje-gwajen farko na kwayoyin halittar samfurin marasa lafiya na 27 ga Disamba sun nuna wanzuwar kwayar cutar coronavirus mai kama da SARS.
A ranar 31 ga Disamba, Hukumar Kiwon Lafiya ta Birnin Wuhan ta fitar da wata sanarwa ga jama'a.
A ranar ne aka sanar da WHO.
A daidai lokacin da wannan sanarwar ta faru, likitoci a Wuhan sun sami gargadi daga 'yan sanda game da yada jita-jita game da barkewar cutar.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara da'awar cewa babu wata hujja mai kyau da ke nuna cewa mutum yana kamuwa da cutar daga mutum zuwa mutum.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani yunkuri na musamman wanda babban sakataren jam'iyyar kwaminis ta kasar Sin, Xi Jinping, ya bayyana a matsayin "yakin mutane" don dakile yaduwar kwayar cutar.
An bayyana "babban keɓewar kai a tarihin ɗan adam" a cikin jerin tsaftacewar da aka sanar a ranar 23 ga Janairu, wanda ya kawo ƙarshen tafiya cikin gida da waje a Wuhan wanda daga baya aka faɗaɗa zuwa birane 15 na Hubei wanda ya shafi mutane miliyan 57.
An haramta amfani da motocin masu zaman kansu a cikin garin.
An soke bukukuwan bikin sabuwar shekara ta kasar Sin (Janairu 25) a wurare da dama.
Jami'ai sun kuma sanar da gina wani asibiti na wucin gadi mai suna Hushenshan Hospital wanda aka kammala a cikin kwanaki 10.
An gina wani asibiti kuma, wato asibitin Laisenshen don kula da ƙarin marasa lafiya.
Baya ga sabbin asibitocin da aka gina, kasar Sin ta sauya wasu wurare a Wuhan kamar cibiyoyin taro da gine-gine kamar filayen wasanni zuwa asibitocin wucin gadi.A ranar 26 ga Janairu, gwamnati ta dauki karin matakai don dakile barkewar COVID-19, wanda ya hada da sanarwar kiwon lafiya ga matafiya da kuma tsawaita hutun bazara.
An rufe jami'o'i da makarantu a kasar.
An dauki matakai da dama musamman ga makarantu da jami'o'i a yankunan Hong Kong da Macao.
An kafa hanyoyin aiki na nesa a sassa da dama na kasar Sin.
An sanya takunkumi kan zirga-zirgar cikin gida da waje na Hubei.
An sauya tsarin sufuri na jama'a kuma an rufe gidajen tarihi na dan lokaci a duk fadin kasar Sin.
An sanya takunkumin hana zirga-zirgar jama'a a birane da yawa kuma an kiyasta cewa kusan mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci takunkumin motsa jiki a waje. Lokacin da barkewar cutar ta kai duniya a watan Maris, jami'an kasar Sin sun dauki tsauraran matakai don hana cutar daga wasu kasashen zuwa kasar Sin.
Alal misali, Beijing ta tilasta wa duk matafiya na kasa da kasa da ke zuwa birnin keɓe kansu na kwanaki 14. A ranar 23 ga Maris, mutum ɗaya ne kawai da aka gano da cutar a cikin ƙasar Sin kwanaki biyar da suka gabata, wanda ya zo daga Istanbul zuwa Guangzhou.
A ranar 24 ga watan Maris, 2020, shugaban kasar Sin Li Keqiang ya ba da rahoton cewa an dakatar da yaduwar cututtukan da aka kamu da su a cikin gida kuma an kawo barkewar cutar a kasar Sin.
A wannan rana, an sassauta takunkumin tafiye-tafiye a Hubei, bayan watanni biyu da fara dokar kulle, ban da Wuhan. A ranar 26 ga Maris, Ma'aikatar Harkokin Wajen China ta sanar da cewa za a dakatar da shiga masu riƙe da takardar izinin shiga ko izinin zama bayan ranar 28 ga Maris, kuma ba ta ba da takamaiman bayani game da lokacin da za a kawo ƙarshen wannan shirin ba.
Waɗanda suke son zuwa China dole ne su nemi izinin ofishin jakadancin kasar Sin ko ofishin jakadancin kasar.
Gwamnatin kasar Sin ta ba da shawarar sake bude kasuwanni da masana'antu da kuma bayar da tallafin kudi ga masana'antu a ranar 30 ga watan Maris. Kwamitin na jihar ya sanar da fara ranar makoki ta minti uku a duk fadin kasar a ranar 4 ga Afrilu da karfe 10 na safe.
An tabbatar da yaduwar COVID-19 daga China zuwa Koriya ta Kudu a ranar 20 ga Janairun 2020.
Hukumar lafiya ta kasar ta ba da rahoton karuwar adadin wadanda aka tabbatar da su a ranar 20 ga watan Fabrairu, wanda aka danganta shi da taron wani sabon addini, Shionji Church of Jesus, a garin Daegu.
An yi zargin cewa masu ibada da Shincheonji da ke ziyarar Wuhan Daegu ne suka haddasa barkewar cutar.
A ranar 22 ga Fabrairu, mutane 1261 daga cikin mabiya 9336 na cocin sun nuna alamun cutar, kusan kashi 13 cikin dari.Koriya ta Kudu ta ba da gargadi mafi girma a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga watan Fabrairu, an samu sama da mutane 2,000 da suka kamu da cutar a Koriya, wanda ya karu zuwa 3,150 a ranar 29 ga watan Fabrairu.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan da aka tabbatar da cewa wasu sojoji uku sun kamu da cutar.
An kuma sauya jadawalin zirga-zirgar jiragen sama saboda tasirin hakan.Koriya ta Kudu ta ƙaddamar da shirin da aka fi sani da mafi girma a duniya don gwada yawan mutanen da ke fama da cutar, ware mutanen da ke fama da cutar, gano su, ware waɗanda suka yi hulɗa da su.
Hanyoyin gwajin sun hada da yin rajistar alamun cutar da kai ta hanyar aikace-aikacen wayar hannu, yin gwajin kwayar cutar ta hanyar tuki, wanda sakamakon sa zai kasance a rana mai zuwa, da kuma kara karfin gwajin da zai iya gwada mutane 20,000 a kowace rana.
An yi amannar cewa shirin Koriya ta Kudu ya yi nasara wajen sarrafa barkewar cutar ba tare da ware dukkan biranen ba. Da farko Shugaba Moon Jae-in ya nuna rashin amincewa da al'ummar Koriya ta Kudu a matsayin martani ga rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman a tuhumi Moon ko kuma su yaba masa saboda yadda gwamnatin ta yi da cutar.
A Koriya ta Kudu, an ba da rahoton cewa mafi ƙarancin adadin masu cutar a rana ɗaya a cikin makonni huɗu ya kasance a ranar 23 ga Maris.
A ranar 29 ga watan Maris, an bayyana cewa daga ranar 1 ga watan Afrilu, duk wanda ya shigo daga kasashen waje za a killace shi na makonni biyu.
Rahotanni a ranar 1 ga Afrilu sun nuna cewa Koriya ta Kudu ta samu buƙatun taimako na gwaji daga ƙasashe 121 daban-daban.
Iran ta ba da rahoton farkon cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Comm, inda ta mutu a ranar, a cewar Ma'aikatar Lafiya da Ilimin Likita.
Matakan da gwamnatin ta fara bayyana sun hada da soke kide kide da sauran al'adu, wasanni da sallar Juma'a, rufe jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta kashe Riyal tiriliyan biyar don yaki da cutar.
Shugaba Hassan Rouhani ya ce a ranar 26 ga Fabrairun 2020, babu wani shiri na ware yankunan da barkewar cutar ta shafa kuma za a ware mutane ne kawai.
An sanar da tsare-tsaren iyakance zirga-zirga tsakanin biranen, amma har yanzu ana ci gaba da zirga-zirgar ababen hawa tsakanin biranen har zuwa bayan Sabuwar Shekarar Farisa.
Har zuwa ranar 16 ga watan Maris na 2020, wuraren bukukuwan Shi'a a Qom sun kasance a buɗe ga mahajjata. A watan Fabrairu, Iran ta zama cibiyar yaduwar cutar bayan China.
A yayin da ake ikirarin rufe yaduwar barkewar cutar a Iran, sama da kasashe goma sun gano cututtukansu zuwa Iran har zuwa ranar 28 ga Fabrairu, suna nuna cewa yaduwar cutar ta fi muni fiye da 388 da gwamnatin Iran ta ruwaito har zuwa wannan ranar.
An rufe majalisar dokokin Iran a ranar 3 ga watan Maris bayan da 'yan majalisa 23 daga cikin 290 suka yi gwajin cutar.
A ranar 12 ga watan Maris, Human Rights Watch ta bukaci jami'an gidan yari na Iran da su saki wadanda suka tsare a matsayin masu nuna adawa da take hakkin dan Adam ba tare da wani sharadi ba, da kuma sakin sauran fursunonin da suka cancanta.
Ya kuma ce cibiyoyin da aka rufe kamar cibiyoyin tsare mutane, inda ba a samun isassun kayayyakin kiwon lafiya, suna da haɗarin yaduwar kwayar cutar.
A ranar 15 ga watan Maris, gwamnatin Iran ta sanar da mutuwar mutane 100 a rana daya, wanda shi ne mafi girma a kasar tun lokacin da cutar ta fara bulla.
A ranar 17 ga watan Maris, akalla 'yan siyasa da jami'an gwamnati 12 na yanzu ko kuma tsoffin 'yan Iran sun mutu.
Har zuwa 23 ga Maris, Iran tana fama da sabbin cututtuka 50 a kowace awa da kuma mutuwa a kowace minti 10 sakamakon cutar.
Wani jami'in WHO ya ce Iran na iya samun adadin masu cutar da ya ninka na da aka samu sau biyar.
An kuma bayar da shawarar cewa takunkumin da Amurka ta sanya wa Iran na iya shafar karfin tattalin arzikin kasar na magance barkewar cutar.
Babban Kwamishinan kare hakkin bil adama na Majalisar Dinkin Duniya ya yi kira da a sassauta takunkumin tattalin arziki da aka sanya wa wasu kasashe, ciki har da Iran, wadanda cutar ta fi shafa.
An tabbatar da yaduwar cutar a Italiya a ranar 31 ga Janairu lokacin da matafiya biyu 'yan China suka gwada SARS-CoV-2 a Roma.
Sakamakon karuwar cututtukan, gwamnatin Italiya ta dakatar da dukkan jiragen da ke zuwa da dawowa daga China kuma ta ayyana dokar ta baci.
A ranar 21 ga Fabrairu, an gano wasu mutane da ba su da alaƙa da COVID-19 a Lombardy bayan an fara da tabbatar da 16 a ranar 22 ga Fabrairu, Majalisar Ministoci ta ba da sanarwar sabon dokar hana fita don shawo kan barkewar cutar, wanda ya haɗa da keɓe mutane sama da 50,000 daga birane daban-daban 11 a arewacin Italiya.
"Ba za a iya shiga ko fita daga yankin da aka yi ambaliyar ba", in ji Firayim Minista Giuseppe Conte.
"A ranar 4 ga Maris, gwamnatocin Italiya sun ba da umarnin rufe dukkan makarantu da jami'o'i gaba ɗaya saboda mutuwar 100 a Italiya".
Duk manyan wasannin da suka hada da wasannin kwallon kafa na Serie A, an shirya su ne a filin wasa har zuwa watan Afrilu, amma an dakatar da dukkan wasannin a ranar 9 ga Maris na akalla wata guda.
A ranar 11 ga watan Maris, Firayim Minista Conte ya ba da umarnin rufe kusan dukkanin ayyukan kasuwanci, ban da manyan kantuna da kantunan magani. A ranar 6 ga Maris, Kwalejin Italiya ta Anesthesiology, Anesthesia, Resuscitation and Intensive Care (SIAARTI) ta fitar da manufofin likita da ke ba da shawarar ɗabi'un da za a iya amfani da su don kula da yara.
A ranar 19 ga watan Maris, Italiya ta zarce China a matsayin kasar da ta fi kowacce kasa a duniya fama da cutar coronavirus, inda ta kai adadin mutane 3,405 da cutar ta kashe.
An bayar da rahoton cewa a ranar 22 ga Maris, Rasha ta aika da jiragen sama tara na soji zuwa Italiya dauke da kayan aikin likita.
A Italiya, an samu mutum 128,948 da suka kamu da cutar a ranar 5 ga watan Afrilu, mutane 15,887 sun mutu, kuma mutane 2,1815 sun warke, kuma yawancin su sun faru ne a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa yawan tsofaffin mutanen Italiya da rashin iya yin gwajin duk mutanen da suka kamu da cutar har zuwa yau na iya haifar da yawan mutuwar.
Amsar da Burtaniya ta bayar ga kwayar cutar ta kasance mafi laushi daga sauran ƙasashe masu kamuwa da cutar, kuma har zuwa 18 ga Maris, 2020, gwamnatocin Burtaniya ba su sanya kowane irin nisantar zamantakewa ko keɓewar jama'a a kan 'yan ƙasa ba.
Sakamakon haka, gwamnati ta fuskanci suka kan rashin gane saurin da kuma tsananin da ake fuskanta na mayar da martani ga matsalolin da mutane ke fuskanta. A ranar 16 ga watan Maris, Firayim Minista Boris Johnson ya ba da sanarwar da ke ba da shawarar kauce wa duk tafiye-tafiye da zamantakewar jama'a, yana ba mutane shawarar yin aiki daga gida idan za su iya kuma su guji wurare kamar mashaya giya, gidajen abinci da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, Gwamnati ta ba da sanarwar cewa za a rufe dukkan wuraren nishaɗi kamar mashaya da wuraren motsa jiki da wuri-wuri kuma ta yi alkawarin biyan ma'aikata kashi 80% na albashin su har zuwa iyakar £ 2,500 a kowane wata don hana rashin aikin yi a cikin rikicin. A ranar 23 ga Maris, Firayim Minista ya ba da sanarwar tsauraran matakan nisantar da jama'a kamar hana mutane fiye da biyu taruwa, tafiya da iyakance aiki a waje kawai kamar yadda ya zama dole.
Wannan ya bambanta da matakan da aka dauka a baya, inda ake iya tilasta 'yan sanda su aiwatar da dokar ta hanyar tara mutane da tarwatsa su.
An ba da umarnin rufe yawancin kasuwancin, ban da kasuwancin da aka ɗauka "mafi mahimmanci" waɗanda suka haɗa da manyan kantuna, shagunan likita, shagunan kayan aiki, tashoshin mai da garages.
An tabbatar da sanannen mutum na farko da ya kamu da cutar COVID-19 a jihar Pacific Northwest ta Washington a ranar 20 ga Janairu a cikin wani mutum da ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rundunar aiki ta White House Coronavirus a ranar 29 ga Janairu.
A ranar 31 ga Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya da kuma hana shiga ga matafiya daga China.
A ranar 28 ga Janairun 2020, Cibiyar Kula da Cututtuka, babbar hukumar kiwon lafiyar jama'a ta gwamnatin Amurka, ta sanar da cewa ta samar da kayan gwajin kanta.
Duk da haka, gaskiyar cutar ba ta bayyana ba a lokacin saboda ƙarancin gwajin da Amurka ke yi.
Gwaje-gwajen sun yi karo da rashin ingancin kayan gwaji da gwamnatin tarayya ta yi a watan Fabrairu, da rashin amincewar gwamnatin tarayya da kayan gwajin da ba na gwamnati ba (wadanda cibiyoyin ilimi, kamfanoni da asibitoci suka yi) har zuwa karshen Fabrairu, da kuma tilastawa mutane su cancanci yin gwaji har zuwa farkon Maris (bayan haka ana buƙatar takardar likita).
A ranar 27 ga Janairu, jaridar Washington Post ta ruwaito cewa an yi gwaji ƙasa da 4,000 a Amurka.
Atlantic ta ba da rahoton cewa an yi gwaje-gwaje ƙasa da 14,000 a ranar 13 ga Maris.
A ranar 22 ga Maris, Associated Press ta ba da rahoton cewa umarnin don gwada mutane da alamomi da yawa da kuma umarnin likitoci suna ɗaukar awanni zuwa kwanaki don yin gwaji. Gwamna Jay Inslee ya ayyana dokar ta baci a jihar bayan an ba da rahoton mutuwar farko a Amurka a Washington a ranar 29 ga Fabrairu, wani mataki da sauran jihohi suka bi.
An soke azuzuwan makarantu a yankin Seattle a ranar 3 ga Maris, kuma an rufe makarantu a duk faɗin ƙasar a tsakiyar watan Maris. A ranar 6 ga Maris, 2020, masana ilimin annoba a Kwalejin Imperial ta Landan sun ba da shawara ga Amurka game da yiwuwar tasirin da sabon coronavirus zai iya yi a ƙasar.
A wannan ranar, Shugaba Trump ya rattaba hannu kan Dokar Shirye-shiryen Cutar Korona da Amsawa ta Ƙarin Bayarwa, wanda ya ba da tallafin gaggawa na dala 8.3 ga hukumomin tarayya don magance barkewar cutar.
Kamfanoni sun hana ma'aikata tafiya, sun soke tarurruka kuma sun ƙarfafa ma'aikata su yi aiki daga gida.
An soke wasannin motsa jiki da kakar wasa. A ranar 11 ga Maris, Trump ya ba da umarnin hana tafiye-tafiye daga Burtaniya zuwa yawancin Turai na kwanaki 30 daga ranar 13 ga Maris.
Washegari, sun ƙara ƙuntatawa zuwa Ƙasar Ingila da Ireland.
A ranar 13 ga watan Maris, ya ayyana dokar ta baci ta kasa, wanda hakan ya samar da kudaden tarayya don magance matsalar.
A farkon ranar 15 ga Maris, kamfanoni da yawa a duk faɗin Amurka sun rufe ko rage lokutan aiki don rage yaduwar kwayar cutar.
A ranar 17 ga Maris, an tabbatar da cutar a cikin dukkan jihohi 50 da gundumar Columbia.A ranar 23 ga Maris, an ba da rahoton cewa New York City tana da shari'o'in 10,700 na coronavirus, wanda ya fi yawan adadin masu cutar a Koriya ta Kudu.
A ranar 25 ga watan Maris, Gwamnan ya ce nisantar da juna tana da alama tana kawo canji, yayin da aka rage kimar ninki biyu daga kwanaki 2.0 zuwa kwanaki 4.7.
A ranar 28 ga watan Maris, New York City ta samu mutum 32,308 da suka kamu da cutar, kuma mutane 672 sun mutu sakamakon cutar. A ranar 26 ga watan Maris, Amurka ta samu adadin mutane da suka kamu da cutar fiye da kowace kasa a duniya, ciki har da China da Italiya. A ranar 8 ga Afrilu, Amurka ta samu mutum 400,335 da suka kamu da cutar, kuma mutane 12,841 sun mutu.
Rahotanni a ranar 30 ga watan Maris sun nuna cewa shugaban Amurka Trump ya tsawaita umarnin nisantar jama'a har zuwa 30 ga watan Afrilu.
A wannan ranar, jirgin ruwan da ke ɗauke da asibiti mai gadaje 1,000 mai suna USS Comfort ya isa birnin New York.
A ranar 3 ga watan Afrilu, Amurka ta samu adadin mutuwar mutum 884 a cikin sa'o'i 24 da suka gabata sakamakon cutar coronavirus.
A ranar 3 ga Afrilu, adadin masu kamuwa da cutar a jihar New York ya zarce 100,000.Fadar White House ta fuskanci suka saboda rashin nuna tsananin barazanar da kuma daidaitawa da ofishin mataimakin shugaban kasa Mike Pence game da maganganun jama'a da kuma sanarwa game da cutar ta hanyar sarrafa sakonnin kai tsaye daga jami'an kiwon lafiya da masana kimiyya.
A cikin duka, gwamnatin Trump ta kasance mai nuna bambanci da nuna son kai game da rikicin.
Wasu jami'an Amurka da masu sharhi sun soki Amurka saboda dogaro da shigo da abubuwa masu mahimmanci daga China, gami da kayayyakin kiwon lafiya masu mahimmanci.
An yi amfani da nazarin samfuran tafiye-tafiyen jirgin sama don gano yanayin yaduwar cutar da kuma tantance girman yaduwar cutar, kuma an buga wannan binciken a cikin Journal of Travel Medicine a tsakiyar watan Janairu.
A shekarar 2018, kungiyar sufurin jiragen sama ta kasa da kasa ta bayyana cewa, fasinjoji da suka fi yawa daga Wuhan zuwa Bangkok, Hong Kong, Tokyo da Taipei.
An kuma ba da rahoton cewa Dubai, Sydney da Melbourne sun kasance sanannun wuraren da mutane ke zuwa Wuhan.
Daga cikin wurare 20 da aka fi so, Bali an ce ita ce mafi ƙarancin ƙarfin kamuwa da cutar, yayin da biranen Austriya suka kasance mafi ƙarfin gaske.
Ya ce akwai sauran bincike da yawa game da COVID-19 kuma Ostiraliya za ta mai da hankali kan kula da iyakoki don sanar da amsar da ta bayar game da wannan annobar ta duniya.
An ayyana dokar ta baci ta lafiyar dan adam a Ostiraliya a ranar 21 ga Maris.
Sakamakon kebewar hanyoyin sufuri na jama'a a Wuhan da Hubei, kasashe da dama suna shirin kwashe 'yan kasarsu da ma'aikatan kasashen waje daga yankin, galibi ta hanyar jirgin sama da aka yi haya da kasar da kuma amincewar jami'an kasar Sin.
Kasashen Canada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, da Thailand sun kasance na farko da suka fara shirin kwashe 'yan kasarsu.
Pakistan ta ce ba za ta kwashe wani daga cikin 'yan kasarta daga China ba.
A ranar 7 ga watan Fabrairu, Brazil ta kwashe 'yan kasar Brazil 34 ko danginsu, ciki har da' yan Poland 4, dan kasar Sin daya da kuma dan kasar Indiya daya.
'Yan kasar Poland, China da Indiya sun sauka a Poland inda jirgin na Brazil ya tsaya kafin ya koma Brazil.
An killace wasu 'yan kasar Brazil da suka zo Wuhan a sansanin soja kusa da Brasilia.
A wannan ranar, an kwashe 'yan Kanada 215 (jirgin farko 176 da jirgin gwamnati na Amurka 39) daga Wuhan zuwa CFB Trenton don keɓewa na makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama mai dauke da 'yan kasar Kanada 185 daga Wuhan ya sauka a CFB Trenton.
Hukumomin Ostiraliya sun tura mutane 277 zuwa cibiyar tsare mutane ta tsibirin Kirsimeti a ranar 3 da 4 ga watan Fabrairu, wanda aka sake gina shi a matsayin wurin warewa, inda suka zauna na kwanaki 14.
Lokacin da jirgin sama mai kwashe mutanen New Zealand ya isa Auckland a ranar 5 ga Fabrairu, an killace fasinjojinsa (ciki har da wasu 'yan Australia da na Pacific) a sansanin sojan ruwa a Wangaparoa, Arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kwashe 'yan kasar Amurka daga jirgin ruwan Diamond Express.
Jirgin da ke dauke da fasinjojin Kanada 129 da aka kwashe daga Diamond Princess ya sauka a Trenton, Ontario a ranar 21 ga Fabrairu.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasar ta daga Iran. A ranar 14 ga Maris, jirgin saman South African Airways wanda gwamnatin Afirka ta Kudu ta ba da izini ya dawo da' yan Afirka ta Kudu 112.
An gudanar da gwajin likita kafin tashi kuma an tsare 'yan Afirka ta Kudu hudu da ke nuna alamun cutar coronavirus don kauce wa haɗari.
Sai dai 'yan Afirka ta Kudu da suka yi gwajin ba su da lafiya ne kawai aka mayar da su.
Sakamakon gwajin ya saki dukkan 'yan Afirka ta Kudu da suka hada da ma'aikatan jirgin sama, ma'aikatan otal,' yan sanda da sojoji da ke cikin wannan aikin jin kai kuma suka kasance a The Ranch Resort a karkashin kulawa da keɓewa na kwanaki 14 a matsayin matakin kariya.
A ranar 20 ga watan Maris, saboda annobar, Amurka ta fara janye dakarunta daga Iraki.
A ranar 5 ga watan Fabrairu, ministan harkokin wajen kasar Sin ya bayyana cewa kasashe 21 (da suka hada da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da taimakon likita zuwa kasar Sin.
Wasu daliban kasar Sin daga jami'o'in Amurka sun hada kai da wata kungiya a Greater Chicago don aika da agaji zuwa yankin da cutar ta addabi kasar Sin, kungiyar da ake zargin ta gudanar da aikawa da masks N 95 50,000 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun ba da gudummawar dala miliyan 100 ga WHO don tallafawa binciken allurar rigakafi da ƙoƙarin warkewa, gami da kare mutane masu haɗari a Afirka da Afirka ta Kudu.
Interaksiyon ta ruwaito cewa a ranar 6 ga watan Fabrairu, gwamnatin kasar Sin ta ba da gudummawar masks 200,000 ga Philippines bayan da Sanata Richard Gordon ya aika da masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kamfanin Red Crown na Singapore ya sanar da cewa zai tura tallafin da ya kai dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da gudummawar abin rufe fuska miliyan daya ga Wuhan, Turkiyya ta ba da kayan aikin likita, Rasha ta ba da gudummawar sama da tan 13 na kayayyakin kiwon lafiya ga Wuhan, Malaysia ta ba da gudummawar safar hannu miliyan 18 ga China, Jamus ta ba da gudummawar kayayyakin kiwon lafiya iri daban-daban guda 10,000, gami da tufafin kariya daga haɗari, Amurka ta ba da gudummawar tan 17.8 na kayayyakin kiwon lafiya ga China, tare da ba da tabbacin cewa za a ba da ƙarin tan miliyan 100 na tallafin tattalin arziki ga ƙasashen da cutar ta shafa.
A watan Maris, China, Cuba da Rasha sun aika da kayayyakin kiwon lafiya da masana zuwa Italiya don magance barkewar cutar coronavirus.
Wani dan kasuwa mai suna Jack Ma ya aika da kayan gwaji miliyan 1.1 zuwa Addis Ababa Habasha, da abin rufe fuska miliyan 6 da kuma tufafin kariya 60,000 don kungiyar tarayyar Afirka ta rarraba.
Daga baya suka aika da kayan gwaji 5,000 zuwa Panama, abin rufe fuska 100,000 da na'urorin numfashi 5.
Ma kuma ta ba da gudummawar kayayyakin kiwon lafiya ga Kanada, yayin da Netherlands, Spain, Turkey, Georgia da Jamhuriyar Czech suka nuna damuwa game da kayan kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalliyar kwalli
Alal misali, Spain ta cire kayan gwajin kwayar cutar Corona mai karya ta kasar Sin 58,000 da ke da daidaito na kashi 30 cikin dari, yayin da Netherlands ta dawo da abin rufe fuska na kasar Sin 600,000 da ke da lahani.
Belgium ta dawo da abin rufe fuska da ba za a iya amfani da su ba 100,000 da aka ɗauka sun fito ne daga China amma a zahiri sun fito ne daga Colombia.
A wani bangare kuma, tallafin da kasar Sin ta bayar ya samu karbuwa sosai a sassan Latin Amurka da Afirka. A ranar 2 ga watan Afrilu, Bankin Duniya ya fara ba da tallafin gaggawa ga kasashe masu tasowa.
Hukumar Lafiya ta Duniya ta yaba wa jami'an kasar Sin kan kokarin da suke yi na kula da cutar da kuma hana ta.
WHO ta yi bayanin bambancin da ke tsakanin barkewar cutar SARS tsakanin 2002-2004 lokacin da aka zargi jami'an kasar Sin da yin sirri wanda ya haifar da matsaloli a kokarin dakile cutar ta hanyar hana cutar da kuma rikicin da ake ciki yanzu inda gwamnatin tarayya ta samar da bayanai akai-akai don kauce wa fargaba a gaban sabuwar shekara ta hasken rana.
A wata sanarwa da ta yi a ranar 23 ga watan Janairu, wakilin WHO, Goden Gyi, ya ce shawarar WHO ba ta da inganci kuma tana nuna cewa an yi niyyar kawo karshen cutar a inda cutar ta fi yaduwa, inda ya kira ta "wani lamari da ba a taba gani ba a tarihin kiwon lafiya". Bayan tabbatar da kamuwa da cutar daga mutum zuwa mutum a China a ranar 30 ga Janairu da kuma karuwar adadin masu kamuwa da cutar a wasu kasashe, WHO ta ayyana barkewar cutar a matsayin Alamar Kiwon Lafiyar Jama'a ta Duniya (PHEIC), wanda shine karo na farko da WHO ta aiwatar da matakan PHEIC shida a lokacin annobar cutar ta 2009 ta duniya.
Darakta Janar na WHO Tedros Adhanom ya ce PHEC yana haifar da barazanar yaduwar duniya musamman a cikin ƙasashe masu ƙarancin kuɗi da matsakaitan kuɗi inda tsarin kiwon lafiya ba shi da ƙarfi.
Da yake mayar da martani game da takunkumin tafiye-tafiye, Tedros ya ce "babu bukatar daukar matakan da ba dole ba da ke tsoma baki tare da tafiye-tafiye da cinikayya na duniya" kuma "WHO ba ta ba da shawarar sanya takunkumi kan kasuwanci da motsi ba".
A ranar 5 ga watan Fabrairu, WHO ta yi kira ga al'ummomin duniya da su samar da dala miliyan 675 don samar da kudaden shirya shirye-shirye a kasashe masu karamin karfi, inda ta ga bukatar gaggawa don taimakawa kasashen da ba su da tsarin gano mutanen da ke dauke da kwayar cutar, koda kuwa sun fara kamuwa da cutar.
Tedros ya ci gaba da cewa "muna da ƙarfi kamar yadda mafi rauni a cikin sarkarmu yake" kuma ya bukaci al'ummar duniya da su "sa hannun jari a yau ko su biya ƙarin gobe".
A wannan rana, Tedros ya ce Sakatare Janar na Majalisar Dinkin Duniya, Antonio Guterres, ya amince da ba da ikon dukkanin tsarin Majalisar Dinkin Duniya don amsawa.
Sakamakon haka an kunna kungiyar kula da rikicin Majalisar Dinkin Duniya kuma an ba ta damar daidaita martani na Majalisar Dinkin Duniya gaba daya, wanda WHO ta ce zai basu damar mai da hankali kan martani na kiwon lafiya da kuma amfani da kwarewarsu ga sauran hukumomin don magance tasirin zamantakewa, tattalin arziki da ci gaba.
A ranar 14 ga watan Fabrairu, an fara aiki da wata kungiya ta hadin gwiwa tare da kasar Sin, wadda WHO ta jagoranci, don samar da kwararrun masana duniya da na WHO don taimakawa gudanar da ayyukan gida a kasar Sin, tare da gudanar da bita da nazarin cutar da kuma taron kara kuzari da kuma ganawa da manyan cibiyoyi a matakin kasa, da kuma ziyartar yankuna na birane da na karkara a lardin da na kasa don tantance tasirin ayyukan mayar da martani. A ranar 25 ga Fabrairu, WHO ta sanar da cewa "akwai sauran aiki da za a yi don magance cutar ta coronavirus a duniya".
A sakamakon barkewar cutar a Iran, WHO ta tura wani hadin gwiwa don tantance lamarin. A ranar 28 ga Fabrairu, jami'an WHO sun ce za a kara girman kimantawa na duniya game da barazanar cutar coronavirus daga "mafi girma" zuwa "mafi girma" wanda ke nufin matakin gargadi da kimantawa mafi girma.
Mike Ryan, darektan zartarwa na shirin gaggawa na lafiya na WHO, ya yi gargadin a cikin wata sanarwa cewa lokaci ya yi da kowace gwamnati a duniya za ta yi nazarin gaskiyar.
Ya kuma yi kira ga mutane da su kasance a shirye idan cutar ta zo, kuma ya yi kira ga mutane da su kasance a shirye don yadda za su magance matsalar.
Ryan ya ci gaba da cewa bayanan da ake da su yanzu ba su ba da shawarar cewa jami'an kiwon lafiya su ayyana cutar a matsayin annoba ba, kuma ya ce yin hakan zai nuna cewa mun yarda cewa kowane mutum a duniya zai kamu da cutar.
A ranar 11 ga watan Maris, WHO ta ayyana barkewar cutar coronavirus a matsayin annoba ta duniya.
Manajan Darakta ya ce WHO tana da "babbar damuwa game da karuwar yaduwar cutar da kuma mummunan yanayin rashin aiki da rashin aiki". WHO na fuskantar suka sosai saboda nuna rashin kula da cutar ta duniya wanda ya hada da jinkirin ayyana dokar ta baci ta kiwon lafiya da kuma rarraba kwayar cutar a matsayin annoba ta duniya.
Sakamakon rashin jin daɗi ya haɗa da takarda mai neman murabus daga Darakta Manajan WHO, Tedros Adhanom, wanda mutane 733,000 suka sanya hannu a ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, wasu masana kan kare hakkin dan adam da dama sun yi kira ga girmama hakkin kowa a lokacin annobar COVID-19.
Masana sun ce kowa na da hakkin ya sami taimakon da zai ceci rayukan mutane kuma wannan hakki ne na gwamnati.
Kungiyar ta jaddada cewa rashin kayan aiki ko rashin inshorar lafiya bai kamata a yi amfani da shi don bayyana nuna bambanci ga wani rukuni ba.
Masana sun jaddada cewa kowane mutum yana da hakkin kiwon lafiya wanda ya hada da nakasassu, wadanda suka fito daga kananan kungiyoyi, wadanda ba a bayyana ba, wadanda suka tsere daga gidajensu, marasa gida, wadanda ke rayuwa cikin matsanancin talauci, wadanda aka tsare da kuma wadanda suka tsere da sauran wadanda ke bukatar taimakon gwamnati.
Hukumomin kasa da kasa suna magance tasirin tattalin arziki da zamantakewar COVID-19 rikicin.
Kungiyar hadin gwiwa ta tattalin arziki da ci gaba ta kafa wani dandamali wanda ke samar da cikakken bayani da kuma ra'ayoyi da shawarwari kan shirye-shiryen mayar da martani a duk duniya.
Daga tsare-tsaren karfafa tsarin kiwon lafiya da tattalin arzikin duniya zuwa magance tasirin kulle-kulle da takunkumin tafiye-tafiye, cibiyar dijital ta ƙunshi bin diddigin tsare-tsaren ƙasa, kuma an yi niyyar taimaka wa ƙasashe su koya daga juna da sauƙaƙe daidaitaccen martani na duniya ga ƙalubalen coronavirus.
Ministan Amurka, ofishin majalisar ministocin Burtaniya Michael Glowe da dan Shugaba Jair Bolsonaro na Brazil Eduardo Bolsonaro sun soki gwamnatin kasar Sin kan yadda ta kula da annobar da ta barke a lardin Hubei na kasar Sin.
An kori wasu shugabannin jam'iyyar kwaminis ta kasar Sin (CPC) a lardin saboda yadda suka bi da kokarin warewa a tsakiyar kasar Sin, wanda ke nuna rashin jin dadin da jam'iyyar siyasa ta kafa ta yi game da barkewar cutar a yankin.
Wasu masu sukar sun yi imanin cewa an yi wannan yunkurin ne domin hana babban sakataren jam'iyyar kwaminis ta kasar Sin, Xi Jinping, fushin jama'a game da barkewar cutar coronavirus.
Wasu jami'an kasar Sin kamar Zhao Lijian sun goyi bayan ka'idar da ke nuna cewa COVID-19 ta samo asali ne daga Amurka ko Italiya, suna musanta cewa cutar ta fara bulla ne daga Wuhan.
Gwamnatin Amurka ta Donald Trump ta kira kwayar cutar coronavirus "kwayar cutar ta China" ko "kwayar cutar Wuhan" kuma ta ce "sirrin China ya sanya kwayar cutar ta zama mai tasiri sosai har ta zama annoba ta duniya" wanda wasu masu sukar suka soki a matsayin wariyar launin fata da "rashin nasarar gudanar da mulkinta wajen shawo kan cutar".
Jaridar Daily Beast ta samu wata wayar tarho daga gwamnatin Amurka da ke dauke da sakon da ke nuna makircin yaudarar abokan gaba wanda ya samo asali ne daga Majalisar Tsaro ta Kasa, inda ta ce shirin "duk game da China ne".
An gaya mana mu yi kokarin yada wannan sakon ta kowane hali, kamar taron manema labarai da kuma nunawa a talabijin. Kafofin yada labarai kamar su Politico, Foreign Policy da Bloomberg sun yi ikirarin cewa kokarin tura tallafi zuwa yankunan da cutar ta addabi China wani yunkuri ne na yada mulkin duniya.
Shugaban EU na harkokin waje, Josep Borel, ya yi gargadin cewa "siyasa ta sassaucin ra'ayi" ta ƙunshi wani ɓangare na geopolitical wanda ya ƙunshi gwagwarmayar rinjaye.
Borel ya kuma ce China tana aika sako ne da karfi cewa ita ta fi Amurka zama mai dogaro da dogaro da juna.
China ta bukaci Amurka ta dage takunkumin da ta kakaba wa Syria, Venezuela da Iran, kuma an ce ta aika da tallafi ga Venezuela da Iran.
An dakatar da taimakon Jack Ma na abin rufe fuska 100,000 zuwa Cuba a ranar 3 ga Afrilu saboda takunkumin Amurka.
Ana kuma zargin jami'an Amurka da karkatar da tallafin da suke baiwa wasu kasashe zuwa kasashensu.
An kuma bayar da rahoton rikice-rikice game da abin rufe fuska a wasu ƙasashe, kamar Jamus, Austria da Switzerland; da Jamhuriyar Czech da Italiya.
A wani bangare kuma, Turkiyya ta kwace daruruwan kayan aiki na numfashi da ta ke da su domin Spain.
A farkon watan Maris, gwamnatin Italiya ta zargi Tarayyar Turai da rashin nuna haɗin kai ga Italiya, inda cutar ta bulla.
"Sai dai China ce ta mayar da martani ta bangarorin biyu", in ji jakadan Italiya ga EU Maurizio Massari.
Wannan ba alama ce mai kyau ba ce ta hadin kan Turai".
A ranar 22 ga watan Maris, bayan tattaunawa ta wayar tarho da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya sojojin Rasha su aika da kayayyakin magani na soja, motocin kashe kwayoyin cuta na musamman da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta yi ikirarin cewa kashi 80 cikin dari na kayan agajin da Rasha ta aika ba su da amfani ko kuma ba su da amfani ga Italiya, ta hanyar dogara ga wani "babban tushen siyasa".
Majiyar ta zargi Rasha da gudanar da wani mummunan aiki na "ƙaddamar da siyasa da diflomasiyya".
Shugaban Lombardy Attilio Fontana da Ministan Harkokin Wajen Italiya Luigi de Mayo sun yi watsi da rahotannin kafofin watsa labarai kuma sun nuna godiyarsu.
Rasha ta kuma aika da jiragen sama masu jigilar kayayyakin kiwon lafiya zuwa Amurka.
"A lokacin da yake ba da taimako ga abokan aikinsa na Amurka, [Putin] ya yi la'akari da cewa idan masana'antun kayayyakin kiwon lafiya na Amurka suka yi sauri, za su biya idan sun bukaci hakan", in ji kakakin Kremlin Dmitry Piskov.
A cikin shirin NATO na Defender 2020, za a yi wani karamin shiri na sojoji a Jamus, Poland, da Baltic, wanda shine mafi girman shirin NATO tun bayan ƙarshen Cold War.
Sakatariyar Kamfen don Yaki da Makaman Nukiliya Kate Hudson ta soki shirin Defender 2020: "A cikin rikicin kiwon lafiyar jama'a na yanzu, wannan shirin ba kawai yana barazanar sojojin Amurka da sauran kasashen Turai ba, har ma da mazauna kasashen da suke aiki". Gwamnatin Iran ta yi fama da cutar sosai, kuma kusan 'yan majalisa biyu sun kamu da cutar, haka kuma wasu' yan siyasa 15 na yanzu ko kuma da suka gabata.
Shugaban Iran Hassan Rouhani ya rubuta wata wasika ta jama'a ga shugabannin duniya don neman taimako a ranar 14 ga Maris, 2020, yana mai cewa kasarsa na fama da fama da barkewar cutar saboda rashin samun damar shiga kasuwannin duniya saboda takunkumin da Amurka ta sanya musu. Wannan barkewar cutar ta sa Amurka ta karɓi shirye-shiryen zamantakewar da suka zama ruwan dare a wasu ƙasashe masu arziki ciki har da kula da lafiya na duniya, kula da yara na duniya, hutun dangi masu biyan kuɗi da ƙarin kuɗi don lafiyar jama'a.
Masu nazarin siyasa sun yi hasashen cewa hakan zai yi mummunan tasiri ga sake zaben shugaban kasa na Donald Trump a shekarar 2020.
Koriya ta Kudu ta soki "kokarin da Japan ke yi na warewa da kuma rashin aiki" lokacin da Japan ta sanar da cewa duk wanda ya zo daga Koriya ta Kudu za a killace shi na makonni biyu a wuraren da gwamnati ta tsara.
A farkon lokacin, al'ummar Koriya ta Kudu sun kasance masu tsaka tsaki ko kuma masu zaman kansu game da yadda Shugaba Moon Jae-in ya amsa rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman a tuhumi Moon ko kuma su yaba wa Moon saboda yadda gwamnatin ta bi da annobar Ch'u Ji.
Wasu masu sukar sun nuna damuwa cewa hakan na iya ba gwamnatoci damar da za su iya riƙe ikon su.
A Hungary, majalisarsu ta kada kuri'ar ba Firayim Minista Viktor Orban damar yin mulki har abada ta hanyar ba da umarni, don rusa majalisa da zabuka da kuma hukunta waɗanda ake zargi da yada labaran karya game da kwayar cutar da kuma magance rikicin gwamnati.
An zargi barkewar cutar coronavirus da wasu abubuwa da dama da suka hada da karancin kayayyaki da ke tattare da karuwar amfani da kayan aikin yaki da barkewar cutar a duniya, sayayya cikin firgici da katsewar masana'antu da zirga-zirga.
Hukumar Abinci da Magunguna ta Amurka ta yi gargadin cewa akwai karancin magunguna da kayayyakin kiwon lafiya saboda karuwar bukatar masu amfani da kuma katsewar masu samar da kayayyaki.
A yankuna da dama, an ga mutane suna cin kasuwa cikin tsoro, sakamakon haka, kayan masarufi kamar abinci, takarda na bayan gida, da ruwan kwalba sun ɓace daga kayan shagon, wanda hakan ya haifar da karancin kayayyaki.
An gargadi masana'antun fasaha musamman game da jinkirin jigilar kayayyaki na lantarki.
A cewar Darakta Darakta na WHO, Tedros Adhanom, bukatar kayan kariya na mutum ya karu sau 100.
Sakamakon wannan karuwar bukatar, farashin ya karu da ninki ashirin kuma samar da kayayyakin kiwon lafiya ya yi jinkiri na makonni hudu zuwa shida.
Wannan ya haifar da karancin kayan kariya na mutum a duk duniya, kuma WHO ta yi gargadin cewa hakan na iya sanya ma'aikatan lafiya cikin hadari.
A Ostiraliya, annobar ta ba da damar sake sayarwa ga masu siyar da kayayyaki na Australiya zuwa China.
Wannan ya haifar da karancin abinci a wasu manyan kantunan abinci, kuma daga baya gwamnatin Australiya ta dakatar da shi. Duk da yawan masu cutar COVID-19 a arewacin Italiya da kuma Wuhan, dukansu sun tsira daga karancin abinci.
Matakan da China da Italiya suka dauka na hana cinikin kayayyaki da kayayyakin masarufi sun yi nasara, kuma hakan ya kawar da karancin abinci da ake tsammani a Turai da Arewacin Amurka.
Ba a sami raguwa sosai ba saboda yawan aikin gona a arewacin Italiya, amma wakilan masana'antu sun ce farashin na iya tashi.
A lokacin da aka bude kantunan sayar da abinci a Wuhan, jami'an kasar Sin sun bude kantunan naman alade don ciyar da yawan jama'a.
A ƙasar Italiya, ana bin irin wannan dokar, kuma ana bukatar masu sayar da abinci su adana abinci don gaggawa.
An fara jin rauni ga tattalin arzikin duniya a kasar Sin, a cewar wani rahoto na kafofin watsa labarai na ranar 16 ga Maris, tattalin arzikin kasar Sin ya sha wahala sosai saboda matakan da gwamnatin kasar Sin ta dauka don dakile yaduwar kwayar cutar a farkon watanni biyu na shekarar 2020, kuma tallace-tallace sun ragu da kashi 20.5%.
Kasar Sin, babbar tattalin arziki da cibiyar samar da kayayyaki, ana ganin barkewar cutar a matsayin babbar barazana ga tattalin arzikin duniya.
Agatha Demarais na Economist Intelligence Unit ta yi hasashen cewa kasuwanni za su ci gaba da yin tashin hankali har sai an san sakamakon da za a iya samu.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa koma baya a tattalin arzikin duniya saboda cutar zai koma baya daga lokacin barkewar SARS na 2002-2004.
Wani kwararre a Jami'ar Washington da ke St. Louis ya kiyasta cewa tasirin da sarkar samar da kayayyaki ta duniya za ta yi na dala biliyan 300+ kuma zai iya wucewa na tsawon shekaru biyu.
Kungiyar Kasashen Fetur Masu Fitar da Man Fetur (OPEC) ta ce farashin mai ya fara faduwa sakamakon raguwar bukatar da kasar Sin ke yi.
Kasuwancin hannayen jari na duniya sun fadi a ranar 24 ga Fabrairu, sakamakon karuwar adadin masu kamuwa da cutar COVID-19 a wajen kasar Sin.
A ranar 27 ga Fabrairu, saboda damuwa game da barkewar cutar coronavirus, alamun hannun jari na Amurka da suka hada da NASDAQ-100, S&P 500 da Dow Jones Industrial Average sun nuna faɗuwar da ta fi muni tun 2008, tare da faɗuwar Dow da maki 1191, wanda shine mafi girma a cikin rana ɗaya tun bayan rikicin tattalin arziki na 2007-08.
Dukkanin alamun sun rufe a ƙasa da kashi 10 cikin ɗari a wannan makon.
A ranar 28 ga watan Fabrairu, kamfanin Scope Ratings GmbH ya amince da darajar darajar kasar Sin amma ya ci gaba da nuna rashin amincewa.
Hannun jari sun sake faduwa saboda tsoron cutar coronavirus, mafi yawan ragowar a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa za a sami koma bayan tattalin arziki.
Masanin tattalin arziki Mohammed Al Ariyan ya yaba da matakan gaggawa da Babban Bankin da jihohi suka dauka a kan lokaci.
Babban bankunan suna amsawa da sauri fiye da yadda suka amsa a lokacin matsalar tattalin arziki ta 2008.
Yawon shakatawa shine sashin da ya fi fama da matsalar saboda dokar hana tafiye-tafiye da rufe wuraren taruwa da wuraren jan hankali da gwamnatoci suka ba da shawarar kada a yi tafiya ko'ina a duniya.
Sakamakon haka, kamfanonin jiragen sama da yawa sun soke zirga-zirgar su saboda karancin buƙatu, gami da British Airways, China Eastern Airlines da Qantas, yayin da kamfanin jirgin sama na yankin Burtaniya FlyBee ya rufe.
Tasirin da ke kan masana'antar jirgin ruwa ya kai matakin da ba a taɓa gani ba.
An rufe tashoshin jirgin kasa da yawa da kuma jiragen ruwa masu jigilar fasinjoji.
Cutar ta zo ne a daidai lokacin babban lokacin tafiye-tafiye na hutun Sabuwar Shekarar China, Chunyang.
Gwamnatocin kasa da na gida sun soke manyan abubuwan da suka shafi jama'a da suka hada da bikin sabuwar shekara, yayin da kamfanoni masu zaman kansu suka rufe shagunan su da wuraren shakatawa kamar Hong Kong Disneyland da Shanghai Disneyland.
An rufe wasu abubuwan bikin sabuwar shekara da kuma wuraren shakatawa don hana taron jama'a, ciki har da birnin da aka haramta da kuma bikin bikin alloli na gargajiya a Beijing.
Jami'ai a larduna 24, gundumomi da yankuna 31 na kasar Sin sun tsawaita hutun sabuwar shekara zuwa ranar 10 ga watan Fabrairu, kuma sun umarci yawancin wuraren aiki da kada su bude har zuwa wannan ranar.
Wadannan sassan suna wakiltar kashi 80% na GDP na kasar da kashi 90% na fitarwa.
Hong Kong ta kara girman matakanta na amsawa ga cutar ta hanyar bayyana dokar ta baci, rufe makarantu har zuwa watan Maris da soke bikin Sabuwar Shekara.
A Turai da Latin Amurka, yawan masu cin kasuwa ya ragu da kashi 40 cikin ɗari.
A Arewacin Amurka da Gabas ta Tsakiya, an samu raguwar kashi 50 zuwa 60 cikin dari.
Sakamakon haka, yawan masu siyayya a cibiyoyin cinikin Pahi Hindut ya ragu da kashi 33-43 cikin dari a watan Fabrairu idan aka kwatanta da watan Maris.
Masu gudanar da manyan kantunan kasuwanci a duk duniya sun ba da ƙarin umarni game da tsaftacewa, sanya na'urorin daukar hotuna don ganin yanayin zafin jiki na abokan ciniki, da soke abubuwan da suka faru. Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka ta ce koma bayan da annobar ta haifar zai jefa mutane miliyan 14 zuwa 22 a Latin Amurka cikin talauci fiye da yadda suke a yanzu.
A lokacin da cutar ta yi tsanani a Wuhan, kusan mutane miliyan biyar sun rasa ayyukansu a China a watan Janairu da Fabrairu.
Kusan ma'aikata 'yan gudun hijira miliyan 300 na kasar Sin sun makale a gidajen su a lardunan cikin gida ko kuma a lardin Hubei. A watan Maris na shekarar 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Babban bankin Tarayya na St. Louis ya kiyasta cewa barkewar cutar coronavirus na iya rasa ayyuka miliyan 47 a Amurka kuma yawan rashin aikin yi zai iya kaiwa kashi 32%. A Indiya, an yi watsi da ma'aikatan baƙi na Indiya da yawa (waɗanda ke samun albashi na yau da kullun) saboda kulle-kulle.
A cikin rabin watan Maris, ma'aikata Faransa miliyan 4 sun nemi alawus na rashin aikin yi na wucin gadi, kuma ma'aikata Biritaniya miliyan 1 sun nemi tsarin bashi na duniya. Kusan kamfanoni miliyan biyar a Jamus sun tura ma'aikatansu aiki a kan tsarin aiki na gajeren lokaci da ake kira Kurzarbeits, wanda gwamnati ke tallafawa.
Faransa da Burtaniya sun amince da tsarin biyan bashin gajeren lokaci na Jamus.
Wannan annoba ta duniya ta yi tasiri sosai ga fannonin zane-zane da al'adun gargajiya, da kuma tasirin hukumomi da mutane - masu aiki da marasa aiki - a duniya.
Kungiyoyin da ke cikin al'adu da al'adu sun ci gaba da kokarin ci gaba da kamfen din su (mafi yawa na kudaden jama'a) wanda ya hada da baiwa al'umma damar fuskantar al'adun gargajiya, tabbatar da lafiyar ma'aikatansu a wuraren jama'a da kuma tallafawa masu fasaha a duk lokacin da zai yiwu.
Har zuwa watan Maris na shekarar 2020, gidajen tarihi, dakunan karatu, wuraren baje kolin kayayyaki da sauran cibiyoyin al'adu a duk duniya sun rufe har abada kuma an soke ko kuma an dage baje kolin kayayyakin su, abubuwan da suke yi da kuma gabatarwarsu.
A halin yanzu, wani nau'in rufewa da cutar ta haifar shine soke ayyukan addini, manyan abubuwan wasanni da sauran abubuwan kiɗa da kuma abubuwan zamantakewa kamar kide kide, taro na fasaha da nunin kayan kwalliya.
Har ila yau, masana'antar fim ma ta sami matsala. Vatican ta sanar da cewa ta soke bikin mako na addini a Rome, wanda ya zo a makon ƙarshe na lokacin tuba na Kirista na Lent.
Yawancin yankuna da ke ƙarƙashin ikon bishop sun umarci manyan Kiristoci su zauna a gida maimakon zuwa addu'ar Lahadi, wasu majami'u suna ba da sabis na coci ta hanyar rediyo, watsa shirye-shiryen kan layi ko talabijin, yayin da wasu ke ba da zaɓi na yin amfani da coci a cikin ibada.
Sa'ad da yankin da ke ƙarƙashin ikon Roman Katolika na Roma ke rufe majami'unsu da ɗakunan sujada, kuma St. Peter's Square ya zama ba tare da masu bautar ba, sauran ƙungiyoyin addinai ma sun dakatar da ayyuka kuma sun iyakance taron jama'a a majami'u, masallatai, majami'u, temples da gurudwara.
Ma'aikatar Lafiya ta Iran ta soke sallar Juma'a a yankin da cutar ta bulla kuma ta rufe bayan azumin alhamis, yayin da Saudiyya ta hana baƙi masu ibada da mazauna yankin shiga wuraren ibada na Makka da Madina.
Wannan annoba ta haifar da babbar matsala ga jadawalin wasanni a duk duniya tun bayan yakin duniya na biyu.
An soke ko kuma an dage wasu manyan wasannin wasanni da suka hada da gasar zakarun Turai ta 2019-20, gasar Premier ta 2019-20, gasar cin kofin Turai ta UEFA Euro 2020, kakar wasan NBA ta 2019-20 da kuma kakar wasan NHL ta 2019-20.
Barkewar ta katse shirye-shiryen wasannin Olympics na bazara na 2020, wanda da farko za a fara a ƙarshen Yuli; Kwamitin Olympics na Duniya ya ba da sanarwar a ranar 24 ga Maris cewa "za a sake tsara abubuwan da za a yi bayan 2020, amma zai kasance kafin bazara na 2021".
Wannan ya haifar da yawan caca ta yanar gizo, wanda ya haifar da ƙaruwa mai yawa a cikin sabbin masu shiga yanar gizo da yawa. Yawancin ƙungiyoyin kiɗa sun jinkirta ko soke rangadin kide kide, wanda hakan ya shafi masana'antar nishaɗi.
Wasu manyan gidajen wasan kwaikwayo kamar Broadway sun jinkirta yin gwaji.
Wasu masu fasaha sun nemi hanyoyin ci gaba da ƙirƙirar da raba fasaha akan Intanet a matsayin madadin ga wasan kwaikwayo na gargajiya, kamar su wasan kwaikwayo na raye-raye ko ƙirƙirar "bikin" na yanar gizo don masu fasaha don gabatarwa, rarrabawa da kuma bayyana ayyukansu.
Akwai wasu abubuwan da ke faruwa a yanar gizo game da cutar coronavirus, da yawa daga cikinsu suna da ban dariya da kuma jan hankali a cikin wannan yanayi na rashin tabbas.
Tun bayan barkewar cutar COVID-19, an samu tashin hankali da nuna kyamar baki da wariyar launin fata a tsakanin Sinawa da mutanen yankin gabashin Asiya da kuma wuraren da ake fama da cutar a Turai, Amurka da sauran ƙasashe.
Musamman a kasashen Turai, Gabashin Asiya, Arewacin Amurka da yankin Asiya da Pacific, an samu rahotanni da ke nuna tsoro, shakku da kuma adawa.
Rahotanni a watan Fabrairu (lokacin da yawancin lokuta har yanzu ke iyakance ga China) sun nuna cewa mutane na kasar Sin sun cancanci cutar ko kuma suna fuskantar sakamako mai kyau a cikin kungiyoyi daban-daban a duniya.
Wasu kasashen Afirka ma sun ga karuwar adawa da kasar Sin.
Yawancin 'yan kasar Wuhan da Hubei sun ce an nuna musu wariya bisa asalin yankin.
Akwai tallafi ga jama'ar kasar Sin da kuma mutanen da ke yankunan da cutar ta shafa, a kan layi da wajen layi.
Mutane a Italiya, kasar farko a Turai da ta fara fuskantar mummunar barkewar cutar COVID-19 bayan barkewar cutar zuwa sabbin kasashe masu zafi, na iya zama abin shakku da jin tsoron baki. Mutane daga wasu kasashe, da suka hada da Malaysia, New Zealand, Singapore da Koriya ta Kudu, da farko sun hada kai don sanya hannu kan takardun neman haramta wa Sinawa shiga kasarsu a kokarin dakile yaduwar cutar.
A Japan, #ChineseDontKnowJapan ya zama babban batun a shafin Twitter.
Kasashen China da sauran kasashen Asiya a Ingila da Amurka sun ba da rahoton karuwar hare-haren wariyar launin fata da kuma hare-hare.
Shugaban Amurka Donald Trump ya fuskanci suka saboda ambaton coronavirus a matsayin "Covid-19 na kasar Sin", wanda masu sukar suka yi la'akari da cewa wariyar launin fata ne da kuma adawa da kasar Sin.
Masu zanga-zangar Ukraine sun kai hari kan bas din da ke dauke da 'yan kasar Ukraine da kuma 'yan gudun hijirar kasashen waje daga Wuhan zuwa Novi Sad.
Dalibai daga Arewa maso Gabashin Indiya, waɗanda ke zuwa daga yankunan da ke kan iyakar China da ke karatu a manyan biranen Indiya, an ba da rahoton cewa sun fuskanci zalunci dangane da barkewar cutar coronavirus.
Shugaban jam'iyyar BJP a jihar West Bengal, Dilip Ghosh ya bayyana cewa, Sinawa sun lalata yanayi kuma "Allah ya rama musu".
Daga baya, ofishin jakadancin kasar Sin a Kolkata ya yi tir da wannan ikirarin, yana mai cewa "yana da laifi". An kara samun tashin hankali da wariyar launin fata a kasar Sin a lokacin annobar, inda ake kwatanta baƙi a matsayin "sharar waje" kuma ana nufin "sake su".
A halin yanzu, wasiƙun da ke da bangon waya sun cire wasu ko duk bangon waya don taƙaitawar su game da cutar coronavirus.
Yawancin masu wallafa kimiyya sun samar da bincike na kimiyya game da fashewa kuma suna ba da kyauta.
Wasu masana kimiyya sun zaɓi hanyar da za su iya raba sakamakon su da sauri a kan sabobin bugawa kamar bioRxiv.
Cutar cututtuka mai tasowa - cututtukan cututtuka na cututtuka masu tasowa, sau da yawa suna da yanayin fashewa ko hanyar watsawa.
Duniya da Cututtuka - Binciken Duniya da Cututtuka
Jerin cututtuka da annoba - yawan mutuwar cututtuka masu yaduwa
Cinikin namun daji da cututtukan dabbobin daji - Hadarin Lafiya da ke tattare da cinikin namun daji na musamman
Gwaje-gwaje a dakin gwaje-gwaje don cutar coronavirus ta numfashi ta 2019 (COVID-19) da kuma SARS-CoV-2 da ke tattare da ita sun haɗa da hanyoyin gano cutar da kuma gano maganin rigakafi da aka samar a cikin maganin kamuwa da cuta.
Ana tabbatar da kasancewar kwayar cutar a cikin gwajin ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwajin na musamman ne kuma an tsara shi ne don gano RNA na SARS-CoV-2 kawai.
Ana amfani da shi don tabbatar da cutar da ta faru kwanan nan ko kuma ta ci gaba.
Ana iya amfani da gwajin maganin rigakafi don tantancewa da kuma lura da yawan jama'a.
Gwaje-gwajen maganin rigakafi suna nuna yawan mutanen da ke fama da cutar, har da waɗanda ba su da alamun cutar ko kuma waɗanda ba su da alamun cutar.
Sakamakon gwajin zai iya ba da cikakken bayani game da yawan mutuwar cutar da kuma matakin rigakafin cutar a cikin al'umma.
Saboda karancin gwaji, babu wata kasa da ta samu tabbataccen bayani game da yaduwar cutar a cikin al'ummarsu har zuwa watan Maris na 2020.
Har zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawanta, kuma akwai bambance-bambance da yawa tsakanin ƙasashe.
Wannan bambancin yana iya yin tasiri sosai ga yawan mutuwar da aka ruwaito, wanda a wasu ƙasashe ba zai yiwu ba.
Ana iya gwada ainihin lokacin juyawa ta hanyar amfani da polymerase chain reaction (RRT-PCR) akan samfurori na numfashi da aka samo ta hanyoyi daban-daban, gami da swabs na nasopharyngeal ko samfurin sauro.
Sakamakon yawanci yakan zo cikin sa'o'i da yawa zuwa kwanaki biyu.
Gwajin RT-PCR na tari yana da inganci a farkon makon cutar.
Daga nan kwayar cutar za ta iya fita daga makogwaro kuma ta ci gaba da ƙaruwa cikin sauri a cikin huhu.
A lokacin gwajin mutane masu kamuwa da cutar a mako na biyu, za a iya ɗaukar samfurin daga zurfin iska ta hanyar bututun injin shan ruwa ko amfani da kayan tari.
An haɓaka ɗayan gwajin PCR na farko a Charity a Berlin a cikin Janairu 2020 wanda ke amfani da ainihin lokacin juyawa jujjuyawar polymer chain reaction (RRT-PCR) kuma ya kasance tushen kayan aikin gwaji 250,000 da Hukumar Lafiya ta Duniya (WHO) ta samar don rarrabawa.
A ranar 28 ga Janairun 2020, kamfanin Koriya ta Kudu na Cogenebiotech ya haɓaka kayan aikin gano SARS-CoV-2 na asibiti, tushen PCR (Powercheck coronavirus).
Wannan gwajin ya gano kwayar halitta "E" da dukkanin beta-coronavirus ke rabawa da kuma kwayar halitta ta RdRp wacce ta dace da SARS-CoV-2. Kungiyar BGI ta kasance daya daga cikin kamfanoni na farko da suka sami izinin amfani da gaggawa daga Hukumar Kula da Kayayyakin Kiwon Lafiya ta kasar Sin don kayan aikin gano SARS-CoV-2 na PCR a kasar Sin. A Amurka, Cibiyoyin Kula da Cututtuka da Cututtuka (CDC) suna rarraba kwamitin bincike na 2019-Novel Coronavirus (2019-NCoV) na ainihi ta hanyar Cibiyar Kula da Cututtuka ta Duniya (Regient Resources).
Daya daga cikin nau'ikan gwaje-gwaje guda uku a cikin tsofaffin nau'ikan gwajin ya haifar da sakamako mara kyau kuma ya kawo cikas ga gwaji a CDC a Atlanta; sakamakon haka, an sami nasarar sarrafa samfura ƙasa da 100 kowace rana a cikin Fabrairu 2020.
Har zuwa 28 ga Fabrairun 2020, ba a amince da gwajin da aka yi amfani da abubuwa biyu ba, kuma har zuwa lokacin ba a ba da izinin fara gwajin a dakunan gwaje-gwaje na jihar da na gida ba.
Hukumar Abinci da Magunguna ta amince da gwajin a karkashin izinin Amfani da Gaggawa. Dakunan gwaje-gwaje na kasuwanci a Amurka sun fara gwaji a farkon Maris 2020.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da wadatar gwajin COVID-19 na RT-PCR a duk faɗin ƙasar.
Hakazalika, a ranar 9 ga Maris, 2020, Quest Diagnostics ta samar da gwajin COVID-19 a duk faɗin ƙasar.
Babu iyakancewar yawa; Samfurin tattarawa da sarrafawa dole ne a yi su daidai da bukatun CDC.
Cibiyar Nazarin Jihar Virology da Biotechnology a Rasha ta samar da gwajin COVID-19.
A ranar 11 ga Fabrairun 2020, Hukumar Kula da Kiwon Lafiya ta Tarayya ta yi rajistar gwajin. A ranar 12 ga Maris, 2020, Mayo Clinic ta ba da rahoton cewa ta haɓaka gwajin don gano kamuwa da cutar COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewa daga FDA don gwajin da za a iya yi a cikin awanni 3.5, don haka an ba da izinin injin guda ɗaya don yin gwaje-gwaje kusan 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa (EUA) ga Abbott Laboratories don yin gwaji akan tsarin M2000 na Abbott; FDA ta ba da irin wannan izinin ga Hologic, LabCorp da ThermoFisher Scientific.
A ranar 21 ga Maris, 2020, Safeid ya sami EUA daga FDA don gwaji na kimanin minti 45.
Hukumar FDA ta amince da gwajin da ke amfani da fasahar karawar isothermal nucleic acid maimakon PCR.
Ba tare da buƙatar jerin zafin jiki na zafin jiki ba, wannan hanyar tana ba da tabbataccen sakamako a cikin minti 5 da sakamako mara kyau a cikin minti 13.
A halin yanzu akwai kimanin 18,000 irin waɗannan na'urori a Amurka kuma Abbott yana fatan haɓaka samarwa har zuwa gwaje-gwaje 50,000 a rana. Ana ci gaba da gwajin da ke amfani da maganin rigakafi na monoclonal wanda ke ɗaure ƙwayoyin nucleocapsid (N) na kwayar cutar coronavirus musamman a Taiwan, ana tsammanin zai ba da sakamako mai sauri kamar gwajin mura a cikin mintuna 15 zuwa 20.
Binciken bayanan a watan Maris na 2020 ya kammala cewa "X-ray na kirji ba shi da amfani sosai don ganewar asali a farkon matakin, yayin da sakamakon CT [ƙididdigar tomography] na iya kasancewa kafin bayyanar cututtuka".
Abubuwan da ke tattare da CT sun haɗa da rarraba gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen gefen ge
A yayin da cutar ke ci gaba, akwai ci gaba da rinjaye, hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan
Nazarin kwatancen PCR da CT a Wuhan, asalin cutar ta yanzu, ya nuna cewa CT ya fi PCR hankali sosai duk da cewa ba shi da ƙwarewa saboda yana ɗaukar wasu cututtukan huhu da sauran hanyoyin cutar tare da yawancin fasalin hotonta.
A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa "kada a yi amfani da CT a matsayin farkon abin da za a yi a cikin bincike ko ganewar asali na COVID-19".
Ana samar da kwayoyin cuta da suka hada da IgM da IgG a matsayin wani bangare na maganin rigakafi ga kamuwa da cuta.
Ana iya amfani da waɗannan gwaje-gwajen don gano kamuwa da cuta, ƙayyade rigakafi da kuma lura da yawan jama'a, a cikin kwanaki 7 bayan bayyanar cututtuka ko kuma a wani lokaci bayan haka. Ana iya yin gwaje-gwaje ta hanyar Cibiyar Nazarin Cibiyar (CLT) ko Point of Care Testing (POCT).
Yawancin dakunan gwaje-gwaje na asibiti za su iya yin wannan gwajin ta hanyar tsarin sarrafa kansa mai yawa wanda aka tsara ta hanyar wasu matakai a cikin wani lokaci, amma samun su zai dogara da farashin samarwa ga kowane tsarin.
Ko da yake ana iya amfani da samfurori da yawa don bin diddigin amsar rigakafi, ana amfani da samfurin jini guda ɗaya don CLT.
Don POCT, ana yawan samun samfurin jini guda ɗaya ta hanyar fatar jiki.
Ba kamar hanyoyin PCR ba, ba a buƙatar cirewa kafin gwaji.A ranar 26 ga Maris, 2020, FDA ta bayyana sunayen abubuwa 29 waɗanda suka ba da umarni ga hukumar kamar yadda ake buƙata kuma saboda haka suna iya ba da gwajin maganin rigakafin su.
FDA ta amince da gwaji guda ɗaya kawai a ƙarƙashin izinin amfani da gaggawa har zuwa 7 ga Afrilu, 2020. A ƙarshen Maris, 2020, EuroImmun Medical Laboratory Diagnostics da Epitome Diagnostics sun sami amincewa daga ƙungiyar Turai don kayan gwajin su, wanda zai iya gano IgG da IgA antibodies a cikin jini a bayan bayanan kwayar cutar.
Wannan gwajin yana da ƙarfin cewa za a iya gwada ɗaruruwan samfurori a cikin sa'o'i kaɗan, kuma saboda haka wannan gwajin ya fi saurin PCR na gargajiya na RNA na kwayar cutar sau da yawa.
A cikin kwanaki 14 bayan kamuwa da cutar, ana iya gano maganin rigakafi.A farkon watan Afrilu, Ingila ba ta sami ɗayan kayan gwajin maganin rigakafin da ta saya don amfani da su ba.
Hong Kong ta tsara shirin da zai ba marasa lafiya da ake zargi damar zama a gida, "sashen gaggawa zai ba da bututun samfurin ga mai haƙuri", su yi ta da shi, su mayar da shi, kuma a wani lokaci za su sami sakamakon gwajin. NHS na Burtaniya ta sanar da cewa suna nazarin shirin farko na gwajin marasa lafiya a gida, wanda zai kawar da haɗarin kamuwa da cuta ga wasu idan sun isa asibiti ko kuma ba sa buƙatar kashe ƙwayoyin cuta idan an yi amfani da motar asibiti.
Cibiyoyin tafiye-tafiye sun taimaka wa Koriya ta Kudu don yin gwaje-gwaje mafi sauri, mafi girma fiye da kowace ƙasa.A Jamus, a ranar 2 ga Maris, Associationungiyar Likitocin Inshorar Kiwon Lafiya ta Tarayya ta ba da rahoton cewa suna da damar yin gwaje-gwaje kusan 12,000 a rana a cikin tsarin motsi, sama da mutane 10,700 da aka gwada a makon da ya gabata.
Idan likitan ya nemi a yi gwajin, ana biyan kudin ta ta hanyar inshorar lafiya.
A cewar shugaban cibiyar Robert Koch, Jamus tana da damar yin gwaje-gwaje 1,60,000 a kowane mako.
An ba da gwajin tuki a manyan birane har zuwa 19 ga Maris.
Har zuwa 26 ga Maris, 2020, ba a san adadin gwaje-gwajen da aka yi a Jamus ba, saboda an ba da rahoton sakamako mai kyau kawai.
Binciken farko a dakin gwaje-gwaje ya nuna cewa aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla 4,83,295 an gwada su har zuwa makon 12/2020 na kalandar da kuma makon 12/2020, kuma aƙalla 33,491 (6.9%) sun tabbatar da tabbatacce ga SARS-CoV-2.Masu bincike a Isra'ila a Technion da Rambam Hospital sun haɓaka kuma sun yi amfani da hanyar don bincika samfuran marasa lafiya 64 a lokaci guda, wanda a ciki aka tattara dukkan samfuran kuma kawai ana ci gaba da gwada su idan an sami samfurin mai kyau.A ranar 5 ga Fabrairu, 2020, BI ta buɗe dakin gwaje-gwaje na gaggawa na 2000 g a Wuhan da ake kira "O-YAN" (Cinese: ko Ingilishi "Gy Fire"), wanda zai iya bincika samfuran sama da 10,000 a cikin kwanaki biyu.
An gina shi a cikin kwanaki 5 a ƙarƙashin kulawar Wanda ya kafa BGI, Wang Jian, kuma wannan ƙirar ta nuna cewa da a ce ba a fara wannan ƙarfin gwajin ba a kan lokaci, da Hubei ta sami ƙarin kashi 47% kuma farashin kula da keɓewa ya ninka sau biyu.
Labarin Wuhan ya biyo baya da sauri ta hanyar HuO-Yan Labs a cikin birane 12 na kasar Sin, Shenzhen, Tianjin, Beijing da Shanghai.
A ranar 4 ga Maris, 2020, yawan gwajin yau da kullun ya kai 50,000 a rana. Tsarin buɗe ido na Multiplex wanda Origami Essays ya buga, zai iya gwada samfurori 1122 na marasa lafiya don COVID-19 ta amfani da gwaje-gwaje 93 kawai.
Har zuwa watan Maris, karancin masu maganin da kuma karancin su sun kasance cikas ga gwaji mai yawa a EU, UK da Amurka.
Wannan ya sa wasu marubuta suka fara gwadawa ta amfani da tsarin shirya samfurin wanda ya hada da dumama samfuran zuwa 98 ° C (208 ° F) na mintuna 5 don sakin kwayoyin halittar RNA don ƙarin gwaji.A ranar 31 ga Maris, an ba da sanarwar cewa UAE yanzu tana yin gwaji ga mutane da yawa don cutar coronavirus a cikin yawanta fiye da kowace ƙasa kuma tana kan hanyar ɗaga matakan gwaji don isa ga yawancin jama'a.
Wannan ya kasance ne ta hanyar haɗuwa da ƙarfin tuki da siyan ɗakunan gwaje-gwaje masu yawa daga Group42 da BGI (wanda ya dogara da "Huo-Yan" dakunan gwaje-gwajen gaggawa na gaggawa a China).
An gina wannan dakin gwaje-gwaje ne cikin kwanaki 14 kuma yana iya yin dubban gwaje-gwaje na RT-PCR a rana, kuma shi ne na farko a duniya da aka yi a waje da kasar Sin.
An samar da ayyukan gwaji daban-daban da ke niyya ga sassa daban-daban na bayanan kwayoyin cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta dauki matakin Jamus na tura kayan aiki ga kasashe masu karamin karfi wadanda ba su da albarkatun kera nasu.
An buga aikin Jamus a ranar 17 ga Janairun 2020; yarjejeniyar da Cibiyar Kula da Cututtuka ta Amurka ta haɓaka ba ta samuwa ba har zuwa 28 ga Janairu, wanda ya sa gwajin da ke akwai a Amurka ya tsaya. A farkon lokacin barkewar cutar, China da Amurka suna da matsaloli game da amincin kayan gwajin, kuma waɗannan ƙasashe da Australia, buƙata da masana kiwon lafiya ba za su iya samar da isassun kayan gwaji don biyan shawarwarin gwaji ba.
Akasin haka, yawan gwajin da ake samu a Koriya ta Kudu ya taimaka wajen rage yaduwar cutar coronavirus.
Gwamnatin Koriya ta Kudu ta gina manyan wuraren gwaji a dakunan gwaje-gwaje na kamfanoni masu zaman kansu a cikin shekaru da yawa.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta ba da umarnin tsawaita shirin gwaji a matsayin hanya mafi kyau don rage yaduwar cutar COVID-19. Babban yaduwar kwayar cutar ya haifar da buƙatar gwaji mai yawa wanda ya haifar da ragowar ɗaruruwan gwaje-gwaje a dakunan gwaje-gwaje masu zaman kansu a Amurka da kuma ƙarancin wadataccen swab da reagent na sinadarai.
A watan Maris na shekarar 2020, kasar Sin ta bayar da rahoton matsalolin daidaito a cikin kayan gwajin su.
A Amurka, kayan gwajin da CDC ta haɓaka suna da "kurakurai"; daga baya gwamnati ta kawar da shingen da ke hana gwajin masu zaman kansu.
Kamfanin ya bayyana cewa rashin nasarar tattara samfuran ko amfani da kayan aikin da ya dace na iya haifar da sakamakon da ba daidai ba.
Ma'aikatar ta Spain ta ce za ta mayar da kayan gwajin da aka bayar da sakamakon da ba daidai ba kuma za ta ba da wasu kayan gwajin da Shenzhen Bioscience ta samar a maimakon haka.Jamhuriyar Czech ta ba da sakamakon 80% na kayan gwajin da ta saya daga China.Slovakia ta sayi kayan gwaji miliyan 1.2 daga China wanda aka gano yana da lahani.
Firayim Minista Matovic ya ba da shawarar a zubar da kit ɗin a Danube.Ates Kara na Ma'aikatar Lafiya ta Turkiyya ya ce Turkiyya ta sayi kit ɗin daga China "yana da manyan kurakurai" kuma "ba ta yi amfani da su ba".
Gwajin, sannan keɓe marasa lafiya da suka kamu da cutar da kuma bin diddigin waɗanda suka haɗu da mutanen da ke da cutar SARS-CoV-2, sun ba da sakamako mai kyau.
Masu bincike a birnin Vigo, Italiya, inda aka fara samun mutuwar mutum daga COVID-19, sun yi gwaje-gwaje biyu a kan mutane 3,400 a cikin kwanaki goma.
Kimanin rabin mutanen da suka kamu da cutar ba su da wata alama kuma an killace wadanda aka gano.
Ta hanyar rage tafiye-tafiye a rayuwar jama'a, an kawar da sabon kamuwa da cuta gaba daya.
Tare da bin diddigin lamba mai karfi, takunkumin tafiye-tafiye na cikin gida, gwaji da keɓewa, yaduwar cutar coronavirus ta 2020 a Singapore ta yi jinkiri sosai fiye da sauran ƙasashe masu tasowa, kuma ba a buƙatar sanya takunkumi masu ƙarfi kamar rufe gidajen abinci da wuraren sayar da kayayyaki.
An soke abubuwa da yawa kuma tun daga ranar 28 ga Maris, Singapore ta fara ba da shawarar 'yan ƙasa su zauna a gida, amma makarantu sun sake buɗewa a ranar 23 ga Maris a lokacin da aka tsara bayan lokacin hutu.
Wasu ƙasashe da yawa kamar Iceland da Koriya ta Kudu sun gudanar da annobar ta hanyar bin diddigin lamba, hana tafiye-tafiye na cikin gida, gwaji da keɓewa, amma tare da kulle-kulle masu saurin shiga.
Binciken kididdiga ya nuna cewa ƙasashe da ke da yawan gwajin da ke da alaƙa da yawan mutuwar suna da ƙananan mutuwar, saboda waɗannan ƙasashe suna iya gano mutane masu sauƙi ko marasa alamun cutar.
WHO ta ba da shawarar cewa ƙasashe waɗanda ba su da ƙarfin gwaji kuma dakunan gwaje-gwaje na ƙasa suna da ƙarancin gogewa game da COVID-19 su aika da samfuran COVID-19 biyar na farko da na farko da na farko 10 don tabbatarwa a ɗaya daga cikin dakunan gwaje-gwaje 16 da WHO ta ambata.
Daga cikin dakunan gwaje-gwaje 16 da aka ambata, 7 suna cikin Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amurka, da 1 a Ostiraliya.
A cikin teburin da ke ƙasa, "Kashi na gwajin da aka yi" yana nuna tasirin manufofin gwaji na ƙasar.
Duk da haka, idan aka kwatanta da wata ƙasa da ke gwada duk 'yan ƙasa, waɗanda ke gwada waɗanda ke asibiti kawai, za a sami kashi sama da 100 cikin ɗari na masu gwajin da ke nuna alamun cutar ko a'a.
Wanke hannu (ko wanke hannu), wanda kuma ake kira tsabtace hannu, shine aikin wanke hannuwan mutum don kawar da datti, man shafawa, ƙwayoyin cuta ko wasu abubuwan da ba'a so.
Wanke hannu a wasu "lokaci masu mahimmanci" a cikin rana yana hana yaduwar cututtuka da yawa, kamar zawo da plaque, waɗanda ke yaduwa ta hanyar hannayen da ke cikin bakina.
Mutane na iya kamuwa da cututtukan numfashi kamar mura ko sanyi, misali, idan ba su wanke hannayensu ba kafin su taɓa idanunsu, hanci, ko bakinsu (watau, mucous membrane).
Sau biyar na musamman na rana da wanke hannu da sabulu ke da muhimmanci sune: kafin da bayan bayan bayan bayan bayan bayan wankewa ko canza diaper, kafin shayar da jariri, kafin cin abinci da dafa abinci da bayan ko kafin da bayan sarrafa nama, kifi ko kaji.
Idan sabulu da ruwa ba su samuwa, za a iya wanke hannaye da laushi, Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannuwanku a lokutan:
Kafin a dafa abinci, sa'ad da ake dafa abinci, da kuma bayan an gama.
Kafin ka kula da marar lafiya da kuma bayan ka kula da shi.
Bayan an canja tufafin jaririn ko kuma bayan an wanke jakar jaririn da ya je asibiti.
Bayan yin fitsari, tari ko hancinsa.
Bayan sun taɓa dabba, abincin dabba, ko ƙwan dabba.
Tsabtace hannu na likita shine al'adar tsabtace hannu da ke da alaƙa da ayyukan likita.
Wanke hannu kafin a ba da magani ko kula da lafiya yana hana ko rage yaduwar cutar.
Babban manufar wanke hannu a fannin kiwon lafiya shi ne wanke hannu daga abubuwa masu cutarwa (kwayoyin cuta, ƙwayoyin cuta ko wasu ƙwayoyin cuta) da kuma sunadarai masu cutarwa ko masu cutarwa.
Wannan yana da mahimmanci ga mutanen da ke sarrafa abinci ko kuma waɗanda ke aiki a fannin kiwon lafiya, amma yana da mahimmanci ga jama'a.
Wanke hannu yana da fa'idodi masu yawa na kiwon lafiya, gami da rage yaduwar mura, coronavirus da sauran cututtukan cututtuka; hana cututtukan cututtukan gudawa; rage kamuwa da cututtukan numfashi;
Kuma hakan ya haɗa da rage yawan mutuwar yara a gida.
Wani bincike da aka yi a 2013 ya nuna cewa ingantaccen wanke hannu zai iya kawo wasu ƙananan ci gaba a cikin tsayin yara 'yan kasa da shekara biyar.
A ƙasashe masu tasowa, ana iya rage yawan mutuwar yara da ke tattare da cututtukan numfashi da gudawa ta hanyar fara sauye-sauyen sauye-sauye kamar wanke hannu da sabulu.
Wannan mataki mai sauki zai iya rage mutuwar mutane da kusan kashi 50 cikin dari.
Matakan da ke karfafa wanke hannu na iya rage yawan cutar guda uku, kuma yana da kama da samar da ruwa mai tsafta ga masu karamin karfi.
Rage kashi 48 cikin dari na cututtukan gudawa na iya danganta shi da wanke hannu da sabulu. Yin wanke hannu da sabulu a gidaje, makarantu da al'ummomi a duk duniya shine hanya mafi inganci da rahusa don hana gudawa da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututut
Cutar huhu, babbar hanyar cutar ARI, ita ce babbar hanyar mutuwa a cikin yara 'yan kasa da shekaru biyar, wanda ke kashe kimanin yara miliyan 18 a kowace shekara.
An kiyasta cewa yara miliyan 35 ne ke mutuwa a kowace shekara sakamakon zazzabin cizon sauro da kuma cutar huhu.
A cewar UNICEF, wanke hannu da sabulu kafin cin abinci da bayan bayan bayan gida na iya ceton rayuka fiye da kowane allurar rigakafi ko kuma maganin likita, yana rage mutuwar da zazzabi ya haifar da kusan rabi da mutuwar cututtukan numfashi mai tsanani da kashi ɗaya cikin huɗu.
Sau da yawa ana haɗa wanke hannu tare da sauran ayyukan tsabtace jiki a matsayin ɓangare na shirye-shiryen ruwa, tsaftacewa da tsaftacewa (wash).
Wanke hannu yana karewa daga kamuwa da cutar da ake yadawa ta hanyar saduwa ta kai tsaye.
Wani sakamako mai illa na wanke hannu shine wanke hannu akai-akai na iya haifar da bushewar fata da lalacewar fata.
Wani bincike da aka yi a Denmark a shekara ta 2012 ya nuna cewa yawan wanke hannuwa na iya haifar da yanayin fata kamar ƙaiƙayi da ɓarna a hannu da ake kira cututtukan fata, musamman ma a tsakanin ma'aikatan kiwon lafiya.
Ana kuma ganin yawan wanke hannu a matsayin wata alama ta OCD.
Akwai lokuta guda biyar a rana da hannuwan hannu ke da muhimmanci don rage yaduwar cututtuka: bayan zuwa gidan wanka (yin fitsari, bayan gida), bayan wanke bayan jariri (canza tufafi), kafin a shayar da jariri, kafin cin abinci da kuma kafin / bayan dafa abinci ko kafin / bayan sarrafa nama, kifi ko kaji.
A wasu lokatai, wanke hannu da kyau zai taimaka wajen hana yaduwar cuta, kamar kafin da kuma bayan kula da raunuka ko kuma raunuka; bayan yin atishawa, tari ko kuma shan iska; bayan taɓa ƙurar dabba ko dabba, da kuma bayan taɓa shara.
A yawancin ƙasashe, wanke hannu da sabulu yana da wuya.
A cikin binciken da aka yi a cikin ƙasashe 54 a cikin 2015, an gano cewa a matsakaita kashi 38.7% na gidaje suna wanke hannayensu da sabulu. Wani binciken da aka yi a cikin 2014 ya nuna cewa Saudi Arabiya tana da mafi girman adadin wanke hannu da kashi 95%, kusan kashi 77% a Amurka, kuma mafi ƙarancin kashi 23% a China. Wasu canje-canjen ayyuka yanzu suna nuna cewa wanke hannu da sabulu yana ƙaruwa a lokuta masu mahimmanci.
Shirin Kula da Lafiya na Wajibi wanda Ma'aikatar Ilimi ta Philippines ta aiwatar, misali ne na auna ayyukan da za a yi don inganta lafiyar yara da ilimin su.
Kashe kwari sau biyu a shekara, tare da wanke hannuwanku da sabulu kowace rana, goge haƙoranku da fluoride, babban ɓangare ne na shirin ƙasa.
An yi nasarar aiwatar da wannan a Indonesia.
Ana iya inganta cire ƙwayoyin cuta daga fata ta hanyar amfani da sabulu ko kayan wanki tare da ruwa.
Babban aikin sabulu da kayan wanki shine rage hana narkewa da kara narkewa.
Ruwa kadai bai isa ya wanke fata ba domin kitse da furotin da ke cikin ƙasa ba sa narkewa cikin ruwa nan take.
Duk da haka, ana yin tsarkakewa ta hanyar ruwa mai kyau.
Saboda yanayin sake amfani da mu, sabulu mai kauri yana iya ƙunsar ƙwayoyin cuta daga amfani da shi a baya.
Wasu nazarin da aka yi game da ƙaurawar ƙwayoyin cuta ta hanyar sabulu mai ƙazantawa sun nuna cewa ƙwayoyin cuta ba za su iya yin ƙaura ba saboda kumfa ta kashe su.
CDC har yanzu tana cewa "Ana son sabulu mai ruwa wanda ba a taɓa shi da hannu".
An inganta sabulu mai maganin rigakafi sosai tsakanin masu kula da lafiyar jiki.
Zuwa yau, babu wata hujja da ta nuna cewa ana amfani da maganin kashe kwayoyin cuta ko kuma maganin kashe kwayoyin cuta don maganin rigakafin kwayoyin cuta.
Koyaya, sabulu na maganin rigakafi suna ƙunshe da abubuwan maganin rigakafi na yau da kullun kamar trichlosan, wanda ke da jerin jerin ƙwayoyin cuta masu jurewa.
Saboda haka, ba a zaɓi maganin hana hana ƙwayoyin cuta don sabulu na kashe ƙwayoyin cuta ba, amma ba zai iya zama mai tasiri kamar yadda aka ambata ba.
Baya ga surfactants da masu kare fata, masu sarrafa pH kamar su acid (acetic acid ascorbic acid, lactic acid), masu maganin cututtuka masu aiki benzoic acid, da sauran masu kula da fata (ruwan amarya, bitamin, menthol, tsire-tsire masu tsire-tsire). Wani bincike mai zurfi da Jami'ar Oregon School of Public Health ta yi ya nuna cewa sabulu na yau da kullun suna da tasiri sosai wajen cirewa da hana kwari kamar sabulu na trichlosaccharides na yau da kullun.
Ruwan zafi da ke da kyau don wanke hannuwanku bai isa ya kashe ƙwayoyin cuta ba.
Kwayoyin cuta suna girma sosai a zafin jiki (37 digiri C).
Koyaya, ruwan dumi ya fi ruwan sanyi mai sanyi tasiri wajen cire ƙurar da ƙwayoyin cuta daga man fetur na halitta.
Duk da haka, akasin yarda da yarda, nazarin kimiyya ya nuna cewa ruwan dumi ba shi da tasiri wajen rage nauyin ƙwayoyin cuta daga hannaye.
Sanitizer na hannu ko maganin kashe ƙwayoyin cuta na hannu shine mai tsabtace hannu wanda ba shi da tushen ruwa.
A ƙarshen 1990s da farkon karni na 21, masu tsabtace hannu marasa ruwa (wanda aka fi sani da rubs na hannu na giya, rubs na antiseptic ko masu tsabtace hannu) sun fara zama sananne.
Yawancin su suna cikin gel tare da wakili mai kauri kamar carbomer (polymer na acrylic acid) tare da isopropyl alcohol ko ethanol da aka hada, ko kuma a cikin ruwa mai laushi kamar glycerin, ko kuma a cikin kumfa don sauƙaƙe amfani da kuma rage tasirin bushewar barasa.
Mai sauƙin hydrogen peroxide yana haɓaka aikin maganin rigakafi. Aƙalla kashi 60 zuwa 90 cikin ɗari na barasa a cikin tsabtace hannu yana kashe ƙwayoyin cuta.
Alcohol rub yana kashe ƙwayoyin cuta masu tsabtace jiki, ƙwayoyin cuta masu ƙarancin magani (MRSA da VRE), tarin fuka da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, vaccinia, influenza da hepatitis) da fungi
Alcohol rub sanitizer yana da kashi 70% na barasa kuma yana kashe 99.97% (rage 3.5 logs wanda yayi daidai da raguwa na decibels 35) a hannaye a cikin sakan 30 bayan amfani da shi kuma 99.99% zuwa 99.99% (rage 4 zuwa 5 logs) bayan minti 1 na amfani.
Sanitiser na hannu na barasa ba shi da tasiri sosai game da ƙwayoyin cuta kamar norovirus (ko norwalk), wanda shine mafi yawan sanadin cututtukan cututtukan gastroenteritis. Ya kamata a yi amfani da maganin kashe cuta mai yawa ko rub na giya don tsabtace hannaye biyu.
A gaban hannu biyu da baya da kuma tsakanin yatsunsu, shafa ruwan, kumfa ko gel har sai an bushe shi na kimanin dakika 30.
Ka wanke yatsun hannu da kuma yatsun hannu biyu. Cibiyar Kula da Cututtuka ta Amirka ta ce idan ka ga cewa hannunka yana da datti, ka wanke hannunka da tsabtace hannu.
Ana samun karuwar amfani da wadannan wakilai saboda sauƙin amfani da kuma saurin kashe ƙwayoyin cuta, amma bai kamata su zama madadin wanke hannu da kyau ba idan sabulu da ruwa basu da wadata.
A cikin wannan yanayin, ana iya amfani da kayan shafawa na fata da / ko moisturizer don tsabtace fata.
Ana iya rage ko kawar da tasirin bushewar barasa ta hanyar ƙara glycerin da / ko wasu kayan shafawa na fata a cikin wannan dabara.
A cikin gwajin asibiti, masu tsabtace hannu masu amfani da giya tare da emollients sun rage ƙonewa da bushewar fata fiye da sabulu ko kayan shafawa na maganin rigakafi.
Alergy mai haɗari da cututtukan fata, cututtukan gallbladder, ko rashin lafiyar giya ko kuma abin da ke cikin rubs na hannu.
A cikin binciken, an gano cewa haɗuwa da abubuwa masu saurin damuwa suna haifar da cututtukan fata fiye da wanke hannu da sabulu da ruwa.
Duk da ingancinsu, wakilai marasa ruwa ba sa wanke hannuwan kayan aiki, amma suna kashe su ne kawai.
Wannan shine dalilin da yasa tsabtace hannu ba shi da tasiri kamar sabulu da ruwa don hana yaduwar cututtuka saboda cututtukan suna kan hannu.
Ingancin tsabtace hannu mara shan giya ya dogara da abubuwa da yawa da kuma tsari kuma a tarihi ya fi na giya da giya da yawa.
Kwanan nan, abubuwan da aka yi amfani da su na amfani da benzalkonium chloride sun nuna ci gaba da aiki na maganin rigakafi, sabanin barasa, inda aka gano cewa an rage ingancin bayan amfani da shi sau da yawa, mai yiwuwa saboda ci gaba da mummunan halayen fata.
Mutane da yawa da ke cikin ƙananan al'umma ba za su iya sayen sabulu ba, kuma suna amfani da toka da laka.
Ash da laka suna iya zama masu tasiri fiye da ruwa amma ba su da tasiri kamar sabulu.
Wani abin damuwa shi ne idan ƙasa ko toka ta kamu da ƙwayoyin cuta, hakan zai kara yaduwar cutar maimakon rage ta.
Kamar sabulu, ƙasa tana kashe ƙwayoyin cuta domin idan ta haɗu da ruwa, tana samar da ruwa mai ƙanshi.
WHO ta ba da shawarar yin amfani da toka ko yashi a matsayin madadin lokacin da sabulu ba shi da samuwa.
Tsarin wanke hannu daidai wanda Cibiyar Kula da Cututtuka ta Amurka ta ba da shawarar don hana yaduwar cutar ya haɗa da waɗannan matakan:
Ruwa mai zafi ko ruwan da ke gudana yana sa hannuwanka su yi rigar.
Ana ba da shawarar ruwan da ke gudana saboda tafkunan da ke tsaye suna iya zama masu gurɓataccen abu, kuma ba a sami bambanci sosai a yanayin zafin ruwan ba.
Ka yi amfani da sabulu mai yawa, ka shafa hannayenka, ka shafa su a bayan hannayenka, tsakanin yatsunsu, ƙarƙashin ƙusoshinka, ka yi masa kumfa.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannayensu sosai idan ana amfani da sabulu fiye da ruwa.
Ka wanke hannayenka na akalla dakika 20.
Gogewa yana sa a yi taushi, kuma hakan yana kawar da ƙwayoyin cuta daga fata.
Wanke hannuwanku a ƙarƙashin ruwa mai gudana.
Wanke hannu a cikin kwandon ruwa zai iya sake gurɓata hannayen.
Ka share hannayenka da tawul mai tsabta ko kuma ka bar su su bushe.
Hannun hannu masu danshi da rigar suna sake gurɓatawa da sauri. Yatsun hannu, wuyan hannu, tsakanin yatsun hannu, da kuma ƙarƙashin ƙusa sune wuraren da aka fi wanke hannu.
Ƙwaƙwalwar ƙusa da kuma goge ƙusa da aka yi da ƙusa suna iya sa ƙwayoyin cuta su shiga cikin ƙwayoyin cuta.
Sau da yawa ana ba da shawarar yin amfani da ruwan shafa don hana hannayen bushewa; bushewar fata na iya lalata fata wanda zai iya ƙara haɗarin kamuwa da cuta.
Akwai wasu zaɓuɓɓuka masu rahusa don sauƙaƙe wanke hannu a wuraren da babu ruwan famfo da / ko sabulu. Misali, idan ya cancanta a cikin ƙasashe masu tasowa, zuba ruwa da / ko toka daga rataye jerikan ko kabewa tare da ramuka masu dacewa idan ya cancanta. Akwai zaɓuɓɓukan kiyaye ruwa a cikin yanayin iyakancewar samar da ruwa (kamar makarantu ko yankunan karkara a cikin ƙasashe masu tasowa), kamar "tippies taps" da sauran zaɓuɓɓukan da ba su da tsada.
Tape tap fasaha ce mai sauƙi da ke ɗaure gwangwani da igiya don zuba ruwa kaɗan a hannu da sabulu da kuma lever da za a iya motsawa da ƙafa.
Drying hannu yadda yakamata wani bangare ne na aikin tsabtace jiki, amma akwai ɗan muhawara game da mafi ingancin bushewa a cikin wanka na jama'a.
Bincike da yawa ya nuna cewa tawul ɗin takarda sun fi na lantarki tsabtace hannu fiye da na wanka da yawa.
A shekara ta 2008, Jami'ar Westminster London da kuma masana'antar takarda ta Turai sun shirya wani bincike da aka yi don kwatanta matakan tsabtace jiki da takarda tawul, na'urar busar da hannu da ke amfani da iska mai zafi da na'urar busar da hannu ta zamani.
Bayan wanke hannuwanku da bushewa da iska mai zafi, an sami ƙaruwa na kwayoyin cuta a yatsunsu da kashi 194 cikin ɗari, kuma a ƙasan hannu da kashi 254 cikin ɗari.
Bayan an bushe su da jet air dryer, adadin kwayoyin cuta a yatsunsu ya karu da kashi 42 cikin dari, kuma a kasa da kashi 15 cikin dari.
Bayan wanke hannu da bushewa da tawul ɗin takarda, jimlar ƙwayoyin cuta a yatsunsu ya ragu da kashi 76% kuma a kan ƙafar hannu ya ragu da kashi 77%. Masana kimiyya sun yi gwaje-gwaje don bincika ko kowane nau'in bushewa yana iya gurɓata sauran masu amfani da gidan wanka da yanayin gidan wanka.
Jet Air Dryer wanda ke fitar da iska daga cikin na'urar a saurin mita 180 a kowane dakika (kilomita 650 / h; 400 mph), yana iya busa ƙwayoyin cuta daga hannaye da na'urar kuma yana gurɓata masu amfani da gidan wanka da yanayin wanka har zuwa mita 2.
Ta amfani da na'urar busar iska mai zafi, ƙwayoyin cuta suna iya yaduwa zuwa nisan mita 0.25 daga na'urar busar.
Babu wani yaduwar da aka nuna saboda tawul ɗin takarda. A cikin binciken da TUV Produkt und Umwelt ya yi a shekara ta 2005, an kimanta hanyoyin juya hannaye daban-daban.
Bayan bushe hannu, an nuna canje-canje a cikin ƙwayoyin cuta kamar haka:
Akwai masana'antun bushewa da yawa, kuma an kwatanta su da bushewa da tawul ɗin takarda.
A lokacin tafiya, lokacin da sabulu da ruwa ba su samuwa, tsabtace hannu yana da zaɓi na wanke hannu.
Ya kamata a sanya tsabtace hannu da ke dauke da barasa a cikin akalla kashi 60 cikin dari.
Wanke hannu na likita ya zama tilas bayan likitan Hungary Ignaz Semmelweis ya gano ingancinsa don hana cututtuka a cikin yanayin asibiti (a cikin 1846).
Akwai na'urorin lantarki da ke tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani bincike ya nuna cewa amfani da su ya rage yawan kamuwa da cutar.
Wanke hannu na likita yana da tsawon akalla dakika 15, wanda ya ƙunshi amfani da sabulu da ruwa ko gel mai yawa don wanke hannu da kuma wanke kowane ɓangaren hannu.
Dole ne a shafa hannaye a cikin juna.
Idan akwai datti a cikin ƙusa, za a iya amfani da goga don cire shi.
Yana da mahimmanci a wanke hannuwanku da kuma goge su da tawul mai tsabta saboda ƙwayoyin cuta na iya zama a cikin ruwan hannu.
Bayan ya bushe, ka yi amfani da tawul don rufe ruwan (kuma ka buɗe ƙofar fita idan kana so)
Wannan zai hana hannayenku sake gurɓatawa daga waɗannan wurare.
A cikin kiwon lafiya, manufar wanke hannu shine kawar da ƙwayoyin cuta masu cutarwa ("kwayoyin cuta") da hana su yaduwa.
Jaridar New England Journal of Medicine ta ruwaito cewa rashin wanke hannu ya kasance a matakin da ba za a iya karɓa ba a yawancin wuraren kiwon lafiya, inda yawancin likitoci da ma'aikatan jinya ke mantawa da wanke hannu kafin su taɓa marasa lafiya, wanda ke haifar da kamuwa da ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da wasu hanyoyi masu sauki na iya rage kamuwa da cutar da ke tattare da jini da kashi 66 cikin dari. Hukumar Lafiya ta Duniya ta wallafa takarda mai dauke da ka'idojin wanke hannu da wanke hannu a bangaren kiwon lafiya.
Ana kuma iya samun jagororin da aka tsara na kula da tsabtace hannu a shafin yanar gizon kungiyar don yin tsokaci ga jama'a.
Whitby da sauransu sun tsara wannan bita.
Idan ana buƙatar nuna bin doka, kayan aikin ƙwararru na iya auna da kuma daidaita tsabtace hannu.
Hukumar Lafiya ta Duniya ta ba da "Lokaci Biyar" game da wanke hannu:
Idan ya zo cikin jini/ruwan jiki
Kafin a yi aikin kashe kwayoyin cuta,
Bayan kula da mai haƙuri. Idan sabulu ya ƙunshi sunadarai masu kashe ƙwayoyin cuta ("magunguna" ko "sassafawa" sabulu), wanke hannu yana haifar da kisa.
Ana iya buƙatar kashewa kafin tiyata ko a wuraren da kwayoyin cuta masu jurewa sun fi yawa, don motsa aikin tiyata ana buƙatar bututun da za'a iya kunnawa da kashewa ba tare da taɓa hannu ba, chlorhexidine ko iodine wash, tawul mai tsabta don bushewa bayan wanke hannu da goga mai tsabta don shafawa da kuma wani kayan aikin tsabtace hannu don tsabtace ƙusa.
Dole ne a cire duk kayan ado.
Don wannan aikin, ana buƙatar wanke hannu da wuyan hannu daga kusurwa zuwa kusurwa na tsawon minti 2-6.
Ba ma bukatar mu shafe lokaci mai tsawo (minti 10) muna shafawa.
Lokacin wankewa, ya kamata a guji ruwa daga wuyan hannu zuwa kusurwa ya koma baya akan hannu.
Bayan an gama wanke hannu, ana bushe hannaye da zane mai kashe kwayoyin cuta kuma ana sanya rigar tiyata a jiki.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannu kafin da bayan kula da mai rashin lafiya ko amfani da maganin kashe ƙwayoyin cuta.
Don kula da cututtukan staph a asibiti, an gano cewa mafi girman fa'idar wanke hannu yana zuwa ne daga farkon kashi 20 cikin ɗari na wanke hannu, kuma an sami fa'idodi kaɗan lokacin da aka ƙara yawan wanke hannu sama da kashi 35 cikin ɗari.
Wanke hannu da sabulu mai tsabta yana da sau uku mafi yawan cututtukan cututtukan cututtuka a cikin abinci. Idan aka kwatanta da wanke hannu da sabulu mai tsabta, kamar 30 seconds a lokaci, wanke hannu da sabulu mai tsabta ya rage kamuwa da kwayoyin cuta da kashi 26 cikin dari.
Amma sabulu da ruwa sun fi tasiri fiye da ruwan wanke hannu na barasa don kawar da cutar H1N1 da kuma ƙwayar cuta mai wuya na Clostridium. Matsaloli don inganta lafiyar hannu a cikin yanayin kiwon lafiya na iya haɗawa da horar da ma'aikata kan wanke hannu, samar da ƙarin ruwan wanke hannu na barasa, da kuma ba ma'aikata takardun tunatarwa na rubutu da na magana.
Ana buƙatar ƙarin bincike kan waɗanne daga cikin waɗannan maganganun ne suka fi tasiri a cikin saitunan kiwon lafiya daban-daban.
A cikin ƙasashe masu tasowa, wanke hannu da sabulu ana ɗaukarsa mai arha kuma hanya ce mai mahimmanci don samun lafiya da abinci mai gina jiki.
Amma rashin ingantaccen ruwan sha da rashin sabulu ko wuraren wanke hannu a gidajen mutane, makarantu da wuraren aiki ya zama ƙalubale don cimma halin wanke hannu a duniya.
Misali, duk da cewa akwai wasu hanyoyin da ba su da tsada don gina wuraren wanke hannu a yawancin yankunan karkara na Afirka, akwai karancin bututun wanke hannu kusa da kowane gidan wanka na jama'a ko na masu zaman kansu.
Koyaya, rashin wanke hannu na iya zama sakamakon ƙarancin kayan wanke hannu fiye da rashin sabulu ko ruwa.
Ingantawa da kuma ba da lada ga wanke hannu da sabulu na iya tasiri kan yanke shawara na manufofi, wayar da kan jama'a game da fa'idodin wanke hannu da kuma canza halayen al'umma na dogon lokaci.
Don aiwatar da shi yadda ya kamata, dole ne a sanya ido da kimantawa.
Binciken da aka yi na nazari 70 ya gano cewa hanyoyin da ke da alaƙa da al'umma suna da tasiri sosai wajen haɓaka yawan wanke hannu a cikin LMIC, yayin da ayyukan tallan zamantakewar ba su da tasiri sosai. Misali ɗaya na ƙarfafa wanke hannu a makarantu shine "Hanyar tauraro uku" ta UNICEF wanda ke ƙarfafa makarantu don samar da sauƙi, hanyoyin da ba su da tsada don tabbatar da ɗalibai suna wanke hannayensu da sabulu, tare da sauran bukatun tsafta.
Idan aka cimma mafi karancin ka'idoji, makarantu za su iya tafiya daga tauraro daya zuwa uku.
Samar da wuraren wanke hannu na iya zama wani ɓangare na ayyukan da ake yi don inganta wanke hannu don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya ita ce wani misali na kokarin wayar da kan jama'a game da sauya dabi'u. A sakamakon annobar cutar coronavirus a shekarar 2019-20, UNICEF ta yi kamfen don karɓar emojis na wanke hannu.
Wasu nazarin sun yi la'akari da tasirin kuɗin wanke hannu a cikin ƙasashe masu tasowa dangane da rage yawan kuɗin da ake samu.
Amma, wani bincike ya nuna cewa inganta wanke hannu da sabulu ya fi rahusa fiye da ruwa mai guba da sauran hanyoyin tsabtace jiki.
Ga mutanen da ke cikin mawuyacin yanayi, musamman mata masu haihuwa ko sojoji da suka ji rauni a asibitoci - a farkon tsakiyar karni na 19 manyan mutane biyu da ke aiki kan tsabtace hannu sun fahimci mahimmancin wanke hannu don lafiyar ɗan adam: likitan Hungary Ignaz Segmelweis da ke aiki a Vienna, Austria da Florence Nightingale, "mai kafa Turanci na aikin jinya na zamani".
A lokacin, mutane da yawa sun gaskata cewa miyau yana haifar da cututtuka.
A cikin shekarun 1980, cibiyoyin Kula da Cututtuka da Cututtuka a Amurka sun ƙara ƙarfafa wanke hannu a matsayin muhimmin mataki na hana yaduwar kamuwa da cuta sakamakon barkewar cututtukan abinci da cututtukan da ke tattare da kiwon lafiya.
Cutar mura ta 2009 da annobar COVID-19 a shekarar 2020 sun haifar da wayar da kan mutane a kasashe da dama kan mahimmancin wanke hannu da sabulu don kare kansu daga irin wannan cututtukan.
Alal misali, a Jamus, an saka zane-zane a bayan wankin wanke hannu a bayan gidajen wanke hannu na jama'a da gine-ginen ofis da kuma bayan gidajen wanke jirgin sama.
Wanke hannuwan mutum a wani lokaci yana nufin rashin son ɗaukar alhakin wani abu ko kuma raba abubuwan da ke tattare da shi.
Wannan ya samo asali ne daga wani nassi na Littafi Mai Tsarki a cikin Matta inda Pontius Bilatus ya wanke hannunsa game da shawarar da ya yanke na gicciye Yesu Kristi, amma a wasu al'ummomin Ingilishi, wannan magana ta zo tare da amfani da yawa.
A cikin Shakespeare's Macbeth, Lady Macbeth tana nuna ta laifi ga laifukan da ta aikata kuma mijinta ya aikata, yana ƙoƙarin wanke ta da gangan don wanke ta.
An kuma gano cewa idan mutane suka tuna ko kuma sun yi tunanin yin lalata, suna yawan wanke hannayensu kuma suna mai da hankali ga kayan wanke hannu.
Hakanan, waɗanda aka ba su damar wanke hannayensu bayan irin wannan tunani ba su da saurin shiga cikin wasu ayyukan da ke biyan kuɗin "tsabtace" kamar aikin sa kai.
Ana buƙatar wanke hannu a cikin addinai don dalilai na tsabta da alama. Amfani da ruwa don wanke hannu, amma ba amfani da sabulu ba don wanke hannu na alama, wani ɓangare ne na al'adar wanke hannu, wanda ya haɗa da Baha'u'llah, Hindu, Tevilah da Na'ila a addinin Yahudanci, La'ababo a addinin Kirista, da Wudu a addinin Islama.
A addinin Hindu, Yahudanci da Musulunci, wanke hannu bayan zuwa bayan gida wajibi ne.
Kuma a cikin addinin Hindu, Buddha, Sikh, Yahudanci da Musulunci, wanke hannu kafin da kuma bayan kowane abinci wajibi ne.
Kula da haɗarin aikin da ke tattare da COVID-19
Kula da haɗarin aikin da ke haifar da COVID-19 shine aikace-aikacen tsarin lafiya da kiwon lafiya na sana'a don sarrafa haɗarin don hana cutar coronavirus 2019 (COVID-19).
Kula da haɗarin aiki da kyau ya dogara da wurin aiki da yanayin aiki, wanda ya dogara da tushen kamuwa da cuta, tsananin cutar a cikin al'umma da kuma abubuwan haɗarin kowane ma'aikaci wanda zai iya zama mai rauni game da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), ayyukan da ke da ƙananan haɗarin kamuwa da cuta suna da iyakantaccen hulɗa da mutane da sauran abokan aiki, wanda ke ba da shawarar matakan rigakafin kamuwa da cuta, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida yayin da suke rashin lafiya, ladabi na numfashi, da tsaftacewa da tsabtace wurin aiki a kai a kai.
Ayyukan da ke da matsakaicin haɗarin kamuwa da cuta sun haɗa da ayyukan da ke buƙatar haɗuwa ko kusanci da waɗanda ba a san su ba ko kuma waɗanda ba a yi tsammanin suna da cutar COVID-19, amma waɗanda ke da alaƙa da kamuwa da cutar ta al'umma ko kuma ta hanyar balaguron ƙasa da ƙasa.
Wannan ya hada da ma'aikatan da ke hulɗa da jama'a, kamar a makarantu, wuraren aiki masu yawan jama'a da kuma manyan wuraren sayar da kayayyaki.
Baya ga matakan rigakafin kamuwa da cuta, kula da haɗarin ga wannan rukunin ya haɗa da yin amfani da iska mai ƙarfi ta amfani da matattarar iska, amfani da masu kare hanci da kuma samun kayan kariya na mutum idan mutum ya kamu da COVID-19.
OSHO ta ɗauki ma'aikatan kiwon lafiya da ma'aikatan gidan gawa da suka haɗu da sanannen ko wanda ake zargi da kamuwa da COVID-19 a matsayin masu haɗarin kamuwa da cutar, wanda ya ƙunshi ma'aikaci da ke yin aikin samar da aerosol ko tattara ko sarrafa samfuran sanannen ko wanda ake zargi da kamuwa da COVID-19 wanda ke haifar da haɗarin kamuwa da cutar sosai.
Kula da haɗari da suka dace da waɗannan ma'aikata sun haɗa da sarrafa injiniyoyi kamar ɗakunan iska mai matsin lamba da kayan aikin kariya na mutum wanda ya dace da aikin.
Cutar COVID-19 na iya haifar da tasiri mai yawa a wuraren aiki.
Ma'aikata na iya yin rashin aiki saboda rashin lafiya, buƙatar kula da wasu, ko tsoron yiwuwar kamuwa da cuta.
A cikin ma'anar abin da ake buƙata da kuma yadda ake samun waɗannan kayayyaki, tsarin kasuwanci na iya canzawa (kamar sayen lokacin da ba a cika yawan jama'a ba ko sayen ta hanyar rarrabawa ko sabis na tuki).
A ƙarshe, za a iya katse shigo da kaya daga yankunan da ke fama da cutar ta COVID-19. Za a iya amfani da shirye-shiryen kamuwa da cuta da kuma shirin mayar da martani don ɗaukar matakan kariya.
Tsarin matakan haɗari da ke tattare da wurare daban-daban da ayyuka, wanda ya haɗa da tushen kamuwa da cuta, abubuwan haɗari da ke faruwa a cikin gida da zamantakewar jama'a da abubuwan haɗari na kowane ma'aikaci, kamar tsufa ko tsofaffin yanayin kiwon lafiya.
Hakanan suna tsara abubuwan da ake buƙata don magance waɗannan haɗarin da kuma tsarin ba da agaji don yanayin da ɓarkewar za ta iya haifar.
Shirye-shiryen cututtuka da shirye-shiryen amsawa na iya zama batun shawarwari na ƙasa ko na ƙasa.
Manufofin da za a bi don magance barkewar cutar sun hada da rage yaduwar cutar ga ma'aikata, kare mutanen da ke cikin haɗarin kamuwa da cututtukan da ba su dace ba, kiyaye ayyukan kasuwanci da rage tasirin tasirin abubuwa a cikin sarkar samar da su.
Matsanancin cutar yana shafar yadda jama'a ke amsawa a wuraren da kasuwancin yake.
Tsarin tsari na matakan haɗari wanda aka yi amfani dashi sosai a cikin lafiya da lafiya don rarraba ƙungiyoyi bisa ga tasirin tasirin haɗarin.
Inda ba za a iya kawar da haɗarin COVID-19 gaba ɗaya ba, mafi ingantattun sarrafawa sune sarrafa injiniya, sannan sarrafawa na gudanarwa kuma a ƙarshe kayan aikin kariya na mutum.
Gudanar da aikin injiniya ya ƙunshi ware ma'aikata daga haɗarin da ke tattare da aiki ba tare da dogaro da halayyar ma'aikaci ba kuma yana iya zama mafi kyawun hanyar aiwatar da shi.
Kulawa na gudanarwa shine sauyawa cikin manufofi ko hanyoyin aiki wanda ke buƙatar ma'aikaci ko mai aiki suyi aiki.
Kayan aikin kare kai (PPE) ba su da tasiri sosai kamar na injiniya da sarrafawa, amma suna iya taimakawa wajen hana wasu cututtuka.
Dukkanin PPE dole ne a zaba bisa ga haɗarin da ma'aikaci zai iya fuskanta, ya dace da amfani (misali masu numfashi) kuma a saka su yadda ya kamata, a bincika su akai-akai, a kula da su kuma a maye gurbinsu kamar yadda ya cancanta, kuma a cire su da kyau, a tsabtace su kuma a adana su ko kuma a zubar da su yadda ya kamata don hana kamuwa da cuta.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHO), ayyukan da ke da ƙananan haɗarin kamuwa da cuta suna da iyakantaccen hulɗa da jama'a da sauran abokan aiki.
Ana ba da shawarar yin amfani da matakan rigakafin kamuwa da cuta na asali ga kowane irin wurin aiki, gami da wanke hannaye sosai da kyau, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, bin ƙa'idodin numfashi, gami da rufe fuska yayin tari da hancin, samar da buckets don zubar da takarda da shara, kasancewa a shirye don sadarwa ko shirya canje-canje idan ya cancanta, hana ma'aikata amfani da kayan aiki da kayan aiki na wasu, da tsaftacewa da tsabtace wuraren aiki a kai a kai.
Gano da kuma ware mutanen da ke da cutar a cikin lokaci yana da mahimmanci don kare ma'aikata, abokan ciniki, baƙi da sauransu a wuraren aiki.
Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka (CDC) sun ba da shawarar cewa ma'aikatan da ke nuna alamun rashin lafiyar numfashi mai tsanani su zauna a gida na aƙalla awanni 24 ba tare da shan zazzabi ba ko wasu magunguna masu rage zazzabi ko kuma alamun cutar ba, har sai sun sami zazzabi, rashin zazzabi da sauran alamun, kuma manufofin hutun rashin lafiya suna da sassauƙa, wanda ke ba ma'aikata damar zama a gida don kula da wani daga cikin dangin su mara lafiya kuma ma'aikata sun san manufofin.
A cewar OSHA, matsakaicin haɗarin kamuwa da cuta ya haɗa da ayyukan da ke buƙatar mutane su kasance a cikin kusanci na ƙafa shida (1.8 m) daga mutanen da ba a san ko ake zargin suna da cutar COVID-19 ba, amma saboda yaduwar al'umma da ke faruwa a kusa da yankin kasuwancin ko kuma mutumin ya yi balaguron ƙasa da ƙasa kwanan nan zuwa wuraren da cutar ta COVID-19 ta yadu.
Wannan ya hada da shigar da matattarar iska mai inganci a cikin sarrafawar injiniya don su da kuma kungiyoyin masu haɗari, ƙara yawan iska mai iska, buƙatar takunkumin jiki kamar masu tsaron iska na filastik mai haske da kuma sanya taga mai tsayi don sabis na abokin ciniki. Wannan ya haɗa da samar da kayan aiki na gida don kula da ayyukan gida ga ƙungiyoyin masu haɗari da ƙananan ƙungiyoyi masu haɗari, samar da kayan aiki na ainihi don masu kula da gida da ƙananan ƙungiyoyi, samar da dandamali na musamman don masu kula da gida, samar da dandamali na yau da kullun don sadarwa ta hanyar sadarwa ta hanyar sadarwa, shigar da kayan aiki na yau da kullun, samar da matakan tsaro na musamman, rufe wuraren da ke da haɗari ga masu amfani da COVID-19, samar da dandamali na gaggawa don kula da tsabtace hannayen jama'a, da kuma samar da horo da horo ga masu aiki da ke da halin yanzu, da kuma samar da matakan kariya na musamman da ke da mahimmanci don magance COVID-19.
Ma'aikata a cikin wannan rukunin haɗarin ba sa yawan buƙatar yin amfani da na'urar numfashi.
Idan wani ya kamu da rashin lafiya a cikin jirgin sama, matakan da suka dace don kare ma'aikata da sauran fasinjoji sun haɗa da nisantar da mutumin da ƙafa 6 daga sauran mutane, sanya memba na ma'aikata don kula da mutumin da ke rashin lafiya da ba da abin rufe fuska ga mutumin da ke rashin lafiya ko kuma gaya wa mutumin da ke rashin lafiya ya rufe bakinsa da hancinsa da takardar nama yayin tari ko hancinsa.
Lokacin da kuke yiwa matafiya marasa lafiya hidima ko taɓa ruwan jikin su ko kuma abubuwan da ke iya kamuwa da cutar, dole ne a sanya safar hannu ta likita da za a iya amfani da ita, kuma idan matafiya marasa lafiya suna da zazzabi, tari ko wahalar numfashi, ma'aikatan gidan jirgin za su sa ƙarin kayan kariya na sirri.
Dole ne a zubar da safofin hannu da sauran kayan da za a iya zubar da su a cikin jakar da ke da haɗari, sannan a tsabtace da kuma kashe ƙwayoyin cuta a wuraren da ke da cutar. Ga jiragen ruwa na kasuwanci, ciki har da jiragen ruwa da sauran jiragen ruwa, kula da haɗari ya haɗa da jinkirta tafiya yayin da ba su da lafiya da kuma keɓewa idan sun kamu da zazzabi ko wasu alamun cutar yayin da suke cikin jirgin da kuma sanar da cibiyar kiwon lafiya a jirgin nan da nan.
Ainihin, ana buƙatar bin likita a cikin ɗakin mutum da aka ware. CDC ta ba da shawarar rufewa na ɗan lokaci don tsabtace da kashe ƙwayoyin cuta idan an sami mai cutar a makarantu da cibiyoyin kula da yara, ko da kuwa akwai yaduwar al'umma ko a'a.
Inda akwai aƙalla matsakaiciyar yaduwar al'umma, ana iya ɗaukar manufofin nisantar zamantakewa, kamar yin tafiye-tafiye, taron jama'a da sauran manyan tarurruka, gami da horo na jiki ko azuzuwan addu'a ko cin abinci a gidajen abinci, ƙara nesa tsakanin tebur, sauya lokutan isowa da fita, iyakance baƙi marasa mahimmanci da kafa wuraren kiwon lafiya daban don yara masu alamun mura.
Idan akwai manyan kamuwa da cuta a cikin al'ummomin gida, makarantu na iya yin la'akari da rufewa na tsawon lokaci, tare da dabarun nisantar da jama'a. Ma'aikatan tilasta yin doka waɗanda ke yin ayyukansu na yau da kullun, CDC ta ɗauka suna da ƙarancin haɗarin lafiya na gaggawa.
Jami'an tilasta yin doka da ke buƙatar hulɗa da wasu mutane da ke da cutar ko kuma waɗanda ake zargi da kamuwa da cutar COVID-19 ana ba da shawarar su bi ƙa'idodin tare da kayan kariya na mutum masu dacewa kamar yadda masu aikin likita na gaggawa suke yi.
Idan akwai kusanci a lokacin kulawa, ma'aikata su tsabtace da kashe ƙwayoyin cuta ta amfani da fesa tsabtace gida ko gogewa kafin sake amfani da bel ɗin aiki da kayan aiki da kuma bin ƙa'idodin aiki don zubar da PPE da aka yi amfani da su, ware tufafi da wankewa.
OSHA ta yi la'akari da cewa wasu ma'aikatan kiwon lafiya da ma'aikatan gidan gawa suna da haɗarin kamuwa da cuta.
Ayyukan da ke da haɗarin kamuwa da cutar sun haɗa da masu ba da kiwon lafiya, masu ba da agaji, ma'aikatan dakin gwaje-gwaje da masu jigilar kayayyakin likita waɗanda ke fuskantar sanannun ko masu cutar COVID-19.
Ma'aikata suna da haɗarin kamuwa da cutar idan suna yin aikin samar da aerosol ko tattara ko sarrafa samfurori daga sanannun ko waɗanda ake zargi da cutar COVID-19.
Tsarin samar da aerosol ya hada da intubation, tsarin shigar da cuff, bronchoscopy, wasu tsarin hakori da gwaji ko karɓar samfurin mai kaifi.
Ayyukan da ke da haɗarin kamuwa da cutar sun haɗa da ma'aikatan da ke aiki don shirya gawawwakin mutanen da aka sani ko ake zargi da cutar COVID-19 a lokacin mutuwa; idan sun yi autopsy, suna fuskantar haɗarin kamuwa da cutar. Waɗannan rukunin haɗarin sun haɗa da ɗakunan keɓewa don mutanen da aka sani ko ake zargi da cutar COVID-19, gami da aiwatar da aikin samar da aerosol a cikin ƙarin sarrafa injiniya.
A wasu wuraren kiwon lafiya da kuma gidajen gawa, ana iya amfani da iska mai ƙarancin iska.
Za a sarrafa samfurori tare da matakan biosafety na 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa idan akwai wasu marasa lafiya da ake zargi da cutar COVID-19, to a kebe su a cikin ɗakunan jira daban. Tare da sauran PPE, OSHA ta ba da shawarar cewa ma'aikatan da ke aiki a cikin ƙafa 6 daga masu cutar SARS-CoV-2 da aka sani ko ake zargi da cutar da kuma sarrafa aerosol su yi amfani da injin numfashi.
A cikin Amurka, NIOSH ya amince da N95 respirator ko mafi kyawun respirator don amfani a cikin mahallin cikakken tsari, rubutaccen tsarin kariya na numfashi, gami da gwajin dacewa, horo, da gwajin likita.
Sauran nau'ikan masu kare numfashi na iya samar da kariya mafi kyau kuma su sa ma'aikata su sami kwanciyar hankali. WHO ba ta ba da shawarar kare jiki gaba ɗaya ba, saboda COVID-19 cuta ce ta numfashi, ba ta yaduwa ta sauran ɓoyayyen jiki.
WHO ta ba da shawarar cewa ma'aikatan da ke binciken wuraren shiga ne kawai za su sa abin rufe fuska na tiyata.
Ga ma'aikatan da ke tattara, kula da ko jigilar samfurori na numfashi na marasa lafiya da ke fuskantar COVID-19 ba tare da aiwatar da aikin samar da iska ba, WHO ta ba da shawarar yin amfani da abin rufe fuska, tabarau ko rufe fuska, riguna da safar hannu.
Idan an yi amfani da aikin samar da aerosol, to sai a yi amfani da kayan N95 ko FFP2 a maimakon abin rufe fuska.
Saboda karancin kayan PPE a duniya, WHO ta ba da shawarar cewa a yi amfani da shingayen jiki kamar su telemedicine, tsabtace windows, wanda ke ba da damar masu kula da lafiya kai tsaye su shiga ɗakunan da ke dauke da marasa lafiya na COVID-19 ta amfani da kayan PPE da ake buƙata don takamaiman aiki, rage buƙatar su na amfani da PPE, amfani da abin rufe fuska guda ɗaya ba tare da ɓoyewa ba yayin kula da marasa lafiya da yawa tare da ganewar asali iri ɗaya, kula da daidaitaccen sarkar samar da PPE, da kuma ba da shawarar amfani da abin rufe fuska ga waɗanda ba su da masks.
Daga: Katherine Meher, Wikimedia Foundation, Shugaba
Daga: Dukan ma'aikatan Wikimedia Foundation
Jigo: [COVID-19] Rage nauyi da shirya don gaba
An aika kwanan wata / lokaci: 14 ga Maris, 2020, 00:24 UTC
Lasisi: CC0: Babu haƙƙoƙin haƙƙin mallaka
A wannan watan mun sami kanmu cikin yanayi mai mahimmanci.
Cutar ta COVID-19 ta zama wani abu da ke nuna alakar da ke tsakanin dan adam da kuma nauyin da muke da shi ga juna.
Ba mu da irin wannan kalubale, amma mun san cewa mafi kyawun amsarmu ta dogara ne akan jinƙai na duniya, haɗin kai da kuma ginin ƙungiya wanda shine zuciyar ƙungiyar ku.
Wani tabbaci mai ban mamaki na yadda muke da sa'a mu yi aiki tare da mutane masu ban mamaki shine kyakkyawar ma'amala da kulawa da muke gani a cikin imel, waya da hira da abokan aikinmu.
Ba zan iya zama mai godiya da alfahari da kiran ku abokan aikina ba.
A makon da ya gabata, wani ya yaba mini a kan aikin da nake yi.
Ya tunatar da ni game da muhimmancin da ake da shi a duniya a wannan lokacin da ake karanta Wikipedia da kuma yadda wannan muhimmin kayan aiki yake da iko a kan layi kuma kowa yana iya samunsa.
Ko kuna ci gaba da sabunta wannan shafin ko kuna biyan abokan aikinmu ko kuna kiyaye al'ummarku, aikinku ne ya sa hakan ya yiwu.
Duniya tana bukatar bayanin da Wikipedia ke bayarwa fiye da yadda ta ke bukata a yanzu.
Wannan shine lokacin da ba kawai abin da muke yi ba amma yadda muke yi zai shafi duniya.
Muhimmancin wannan kamfen da rawar da kuke takawa a ciki, zai kawo wasu canje-canje masu mahimmanci a yadda muke aiki tare, wanda zai fara a mako mai zuwa.
Idan muka yi hakan, za mu iya canja salon rayuwarmu.
Kamar yadda Robin ya ambata a baya, C-Team ya haɗu a daren jiya don tattauna ra'ayoyinmu da jadawalinmu a cikin kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun tattauna yadda za mu amsa abin da muke fuskanta da kuma yadda za mu ci gaba da ci gaba da ci gaba da ci gaba da ci gaba a wannan lokaci.
Muna son kawar da damuwa da kuma taimakawa aikinmu na dogon lokaci.
Idan kana son ka sake yin waya, ba matsala.
Ga dukkan ma'aikata, yan kwangila da ma'aikatan kwangila:
Muna sa ran aikinmu na yau da kullun zai kasance kusan awanni 4 a rana ko awa 20 a mako har sai an ba da sanarwa.
Ba za mu ba da hutu ba - idan za ku iya yin aiki a cikin sa'o'i na yau da kullun, za a iya amfani da ku a cikin wannan kamfen.
Amma a yau, duniya ba za a iya hango ta ba, kuma ko kuna son kula da ƙaunatattunku, ko kuna son kawo kayan abinci ko kuna son zuwa wurin likita, lafiyar ku ita ce fifiko.
Ba ma bin sahun lokacinku.
Idan kana rashin lafiya, kada ka yi aiki.
Ba lallai ne mu faɗi wannan ba, amma muna faɗin haka.
Babu bukatar hutu na rashin lafiya ko PTO - kawai ka gaya wa manajanka kuma ka taimaka wa ƙungiyarka ta daidaita kalandar da jadawalin don tabbatar da cewa an kammala mahimman sassan aikin.
(Idan an gano cewa kun kasance masu cutar COVID-19, da fatan za a sanar da Brian a T&C Ops, don T&C ta iya tallafa muku kuma ta tabbatar da cewa an kula da yanayinku ta hanyar gudanarwa).
Za a biya ma'aikata cikakken albashi idan sun yi aiki a kan sa'o'i.
Mun riga mun faɗi kuma mun sake tabbatar da alƙawarinmu na girmama alƙawarinmu ga masu ba da sabis ɗinmu da abokan aikinmu waɗanda ke aiki akan sa'o'i.
Kowa zai sami albashi daidai da sa'ar aikin da ya yi a cikin al'adarsa ta yau da kullun.
Wannan ya haɗa da rashin lafiya da rashin iya aiki.
Idan kana son yin aiki, za mu taimaka maka.
Mutane da yawa suna amfani da aikinsu don su rage yawan damuwa da suke yi game da duniyar da ke kewaye da su.
Musamman ma a wannan lokacin, duk abin da za mu iya yi zai kawo sakamako mai ban mamaki.
Kuma wannan kuma game da kula da kanka ne.
Abin da muke bukata shi ne ku tattauna da shugabanninku don mu san abin da za mu yi tsammani kuma mu yi gyara.
Wasu ayyuka suna da muhimmanci.
Akwai wasu abubuwa da ya kamata mu ci gaba da yi.
SRE, HR Ops, Trust & Safety da kuma ƙungiyar tara kuɗi (daga cikin wasu) suna yin ayyuka masu mahimmanci waɗanda zasu iya buƙatar ƙarin taimako.
Za mu fara aiki tare da dukkan sassanmu don tantance manufofinmu na yanzu kuma mu mai da hankali kan tallafawa abubuwan da ke da mahimmanci ga aikinmu.
Akwai aiki da yawa da za mu yi a gare mu duka, bari mu mai da hankali ne kawai kan manyan ayyukan.
Idan ka yi aiki a hankali yanzu, ba za ka yi asara ba daga baya.
Da zarar annobar ta ƙare, ba mu da shirin "aiki sau biyu don kammala aikin".
Ba za a bukaci ka yi aiki na tsawon lokaci don ka bi tsarin aiki da ba za ka iya cim ma ba.
Mun yarda cewa yanayi ya canza kuma za mu yi aiki don saita sabbin manufofi da jadawalin lokacin da ya dace.
Mene ne APP yake nufi?
Yayin da muke daidaita sabbin abubuwan da muke tsammani na yau da kullun da kuma lokutan aiki, muna da niyyar daidaita lokacin isar da shirinmu na shekara-shekara na 2020-2021.
Muna da niyyar gabatar da shawarwari don fadada shirinmu na 2019-2020, wanda zai ba ma'aikata karin lokaci don tsara kasafin kudi don fifita mahimman ayyuka, kula da kansu da kula da ƙaunatattun su, yayin da muke haɗa waɗanda ke buƙatar yin aiki a cikin makonni masu zuwa ko waɗanda ke son yin aiki na ɗan gajeren lokaci.
Wannan tsawaita lokacin zai rage yawan aiki da damuwa a cikin kungiyar gaba daya.
Za mu gabatar da shawarwarinmu ga kwamitin a mako mai zuwa kuma za mu sanar da wakilanmu da kungiyoyinmu game da abin da za mu yi nan gaba da zarar an tabbatar da hakan.
Na gode wa ƙungiyar APP don jagorancinku a cikin wannan.
Kasancewa a ofishin, kamuwa da cuta da kuma tsabtace wurin.
A makon da ya gabata ne muka sami labarin cewa wani ma'aikaci a yankinmu na SF yana da yiwuwar kamuwa da cutar COVID-19.
Duk da haka, a matsayin mai kiyayewa, mun sanya ƙungiyar tsabtace ƙwayoyin cuta don kashe ƙwayoyin cuta a duk wuraren da muke aiki a ofisoshinmu na San Francisco.
Suna amfani da maganin kashe ƙwayoyin cuta na musamman da ake amfani da su a asibiti don kashe ƙwayoyin cuta a kowane wuri da kuma a harabar gidanmu da kuma gefen lif ɗin da ke hawa bene.
Ginin yana amfani da kayayyakin da ke kiyaye lafiyar mazaunansa.
Muna farin ciki da cewa a lokacin da muka yanke shawarar dawowa, ofisoshin za su kasance a shirye don aiki.
Ofishinmu na DC yana cikin yankunan WeWork, inda aka raba matakan COVID-19 tare da mu da sauran ma'aikatan yankin DC.
A makon da ya gabata, ofishinmu na DC ya canza zuwa cikakken nesa, bin ƙa'idodin da aka raba tare da San Francisco.
Kamar yadda wasu abokan aikinmu a yankin New York suka sani, muna tattaunawa game da haya a Brooklyn.
Ana ci gaba da tattaunawar, amma za mu iya jinkirta wannan.
Wasu daga cikin abokan aikinmu suna aiki daga nesa a karon farko.
Abokan aiki da suka daɗe suna aiki a nesa sun san cewa wannan gyara ne kawai, kuma suna so su ba ku wasu shawarwari:
Ka rage lokacin taronka zuwa awa ɗaya ko biyu.
Idan kuna bukatar zaman da ya fi haka tsawo, ku yi tunanin yadda za ku iya raba su cikin kwanaki da yawa.
Ka bayyana musu dalla-dalla abin da za a yi a taron kuma ka aika musu da littattafan da za su taimaka musu.
Don sa haɗin kai da kuma haɗin kai na ainihi, ka sa wannan bidiyon ya zama na asali ta hanyar kayan aiki kamar Google Docs da Zoom.
Don yin kowane taro da sauƙi, ka sa wani ya yi ja-gora, ya lura da tambayoyin da ake yi a cikin hira, ya bincika jerin masu magana, kuma ka sa wani ya taimaka maka ka yi rubutu (ko kuma ka yi rubutu tare).
Idan kana son wata lasifika mai amfani, ka aika da imel zuwa ga mai ba da taimako.
Ku yi amfani da kuɗin da kuka ba da don ku ci abincin da kuke ci.
Shiga cikin tashar #Remotize akan Slack don tattaunawa da abokan aikin ku game da aikin da aka ba ku.
HR Operations Team suna neman 'Webinar-Based Ergonomics' don taimakawa haɓaka aikin da aka rarraba a cikin ƙungiyar.
A makon da ya gabata mun nemi duk masu ba da gudummawar al'umma da su dakatar da taron jama'a da aka ba da tallafin Wikimedia kamar "Editathon" har sai WHO ta ayyana ƙarshen annobar.
Mun gaya musu cewa mun fahimci cewa buƙatarmu don dakatar da sauran ƙuntatawa zai sa ba zai yiwu ba su kammala ayyukan tallafin da suka amince da su, kuma mun kuma gaya musu cewa ba za a hukunta kowa ba don jinkirin da ya canza wannan burin.
A mako mai zuwa za mu ci gaba da bin ƙarin jagororin da aka bayar don Wikimedia da sauran taron yanki da na al'ada.
A cikin al'umma ta duniya, akwai wani abu da ke nuna cewa muna bakin ciki game da wannan rikice-rikice amma muna farin ciki game da wannan bayyananniyar da kuma ikonmu na mayar da hankali ga al'ummominmu, Wikimedia da sauransu.
A ci gaba, CRT tana aiki don kafa shafi a kan Meta-Wiki don samar da sarari ga al'ummomi don lura da wannan tasirin da kuma bin hanyoyin sadarwa tare da su.
Kasancewa cikin hulɗa da batutuwan da suka shafi COVID-19.
Za mu aika da gayyata zuwa kalandarku don taron ma'aikata na musamman da za a yi a ranar Alhamis mai zuwa, 14: 00 UTC/ 07: 00 PT.
Za mu yi amfani da wannan lokacin don raba ƙarin sabuntawa, amsa tambayoyinku, da kuma ɗan fahimtar juna.
Muna tare da ku kuma muna shirye mu taimaka muku ta kowace hanya.
A halin yanzu, ci gaba da samun bayanai ta hanyar imel da sauran mahimman bayanai game da COVID-19 a kan Office-Wiki.
CRT za ta ci gaba da sabunta shafukan kuma ta ajiye duk bayanan a wuri guda.
Muna kuma aiki don ci gaba da sadarwa tare da ma'aikatanmu waɗanda ke zaune a ƙasashen da ke fama da mummunan rauni.
Idan kuna da tambayoyi game da tafiya, taron, babban aiki, ko ƙalubalen da kuke tunani, ko kuma kuna buƙatar taimako game da wani abu, kada ku yi jinkirin sanar da CRT kuma kuyi aiki tare da su.
Muna nan don taimakawa da kuma hadin kai da kuma kafa alaka idan ya cancanta.
Idan kana da wani abu mai sirri ko mai mahimmanci, don Allah aika imel zuwa ga Brian Juden, Daraktan Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dandalin Dand Dandalin Dand Dand Dandalin Dand Dand Dand Dand Dand Dand Dand Dand D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D
Babu wani daga cikin waɗannan canje-canjen da za a yi la'akari da su a matsayin watsi da aikinmu.
Maimakon haka, sun amince da cewa a wannan lokacin za mu ɗauki aikinmu da alhakinmu kamar yadda ba mu taɓa yi ba.
Waɗannan su ne matakan da muke ganin ya kamata mu ɗauka don mu ci gaba da aiki tare don mu ci gaba da aiki, mu biya bukatunsu, kuma mu ba su ayyukan da suke dogara da su.
A lokacin da lokaci ya yi, ayyukan da muka tsara za su taimaka mana.
A yanzu, lokaci ya yi da za mu hada kai tare da samar da sarari don muhimman ayyuka, waɗanda za su faru a mako mai zuwa da wata mai yiwuwa.
Muna bukatar ku duka don yin hakan, don haka kuna buƙatar kula da kanku da danginku don ku iya ba da mafi kyawunku lokacin da ake buƙata.
Yanzu, don Allah, ku wanke hannuwanku kuma kada ku taɓa fuskarku!
A cikin wannan rukunin, akwai wasu 'yan'uwa maza da mata da suka yi hidima a matsayin masu kula da ikilisiya da kuma masu kula da ikilisiya.
B'Angiotensin-converting enzyme 2 ((ACE2)) wani enzyme ne wanda ke da alaƙa da ƙwayoyin ƙwayoyin cuta (ƙwayoyin cuta) a cikin huhu, jijiyoyin jini, zuciya, koda da hanji.
Ta hanyar rage yawan angiotensin-II da kuma kara yawan Ang ((1-7) ACE2 yana hana aikin enzymes masu canza angiotensin (ACE) kuma saboda haka magani ne mai mahimmanci don magance cututtukan zuciya da jijiyoyin jini.
An kira kwayar halitta ta mutum na enzyme hACE2.
Angiotensin-converting enzyme 2 wani sinadarin zinc ne wanda yake kan farfajiyar endothelial da sauran kwayoyin halitta.
ACE2 yana da wani nau'i na N-terminal peptidase M2 da kuma C-terminal collectorin na renal amino acid transporter domain.
ACE2 shine nau'in kwayar halitta mai nau'in guda ɗaya wanda ke aiki ta hanyar aikin enzyme a kan ƙwayoyin halitta a cikin huhu da sauran kyallen takarda.
Ana fitar da ƙarin ƙwayoyin halitta na ACE2 ta hanyar wani transmembrane na biyu da ake kira shades, kuma sakamakon haka ana fitar da furotin mai narkewa cikin jini kuma a ƙarshe ya narke cikin fitsari.
ACE2 yana cikin kusan dukkan gabobin jiki: yana da alaƙa da ƙwayoyin alveolar cell na nau'in II a cikin huhu, enterocytes a cikin ƙananan hanji, ƙwayoyin endothelial na jijiyoyi da jijiyoyi, da kuma tsokoki masu laushi na jijiyoyi a yawancin gabobin jiki.
Ana kuma samun ACE2 mRNA a cikin ƙwayar kwakwalwa, stratum, hypothalamus da kuma kwakwalwar kwakwalwa.
Babban aikin ACE2 shine yin aiki a matsayin mai hana ACE.
ACE yana ba da damar hormone angiotensin I zuwa angiotensin II mai ƙuntataccen jijiya.
ACE2 ya karya amino acid na carboxyl-terminal daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma ya canza shi zuwa hydrolyzed zuwa angiotensin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
[des-Arg9]-Bradykinin, apelin, neurotensin, dinorphine A da ghrelin da sauran peptides da yawa zasu iya karya ACE2.
ACE2 kuma yana daidaita motsi na allon mai jigilar amino acid mai tsaka tsaki SLC6A19 kuma yana da alaƙa da cututtukan zuciya.
A matsayin furotin mai wucewa, ACE2 yana aiki a matsayin babban hanyar shiga cikin sel don wasu coronaviruses, gami da HCoV-NL63;SARS-CoV (wanda ke haifar da SARS); da SARS-CoV-2 (wanda ke haifar da COVID-19).
Musamman, ɗaurewar enzymatic domain na ACE2 zuwa SARS-CoV da furotin S1 na SARS-CoV2 a saman sel yana haifar da endocytosis, kuma canja wurin duka ƙwayoyin cuta da enzymes zuwa endosomes da ke cikin sel.
Hakanan ana buƙatar mai watsa shiri serine protease TMPRSS2 don yin amfani da furotin S don aiwatar da shigarwa, wanda hanawa a halin yanzu ana gudanar da bincike a matsayin magani mai yiwuwa. Wannan ya sa wasu suka yanke shawarar cewa rage matakan ACE2 a cikin sel zai taimaka wajen magance kamuwa da cuta.
Koyaya, ƙungiyoyi da ƙungiyoyi masu yawa na ƙwararru da ƙungiyoyi masu tsarawa sun ba da shawarar ci gaba da daidaitaccen ACE mai hanawa da maganin ARB.
Binciken da aka yi da kuma nazarin meta da aka buga a ranar 11 ga Yuli, 2012 ya gano cewa "amfani da masu hana ACE yana da alaƙa da rage haɗarin cutar nimoniya da 34% idan aka kwatanta da sarrafawa".
Bugu da ƙari, marasa lafiya da ke da haɗarin kamuwa da cutar nimoniya, musamman waɗanda ke fama da bugun jini da kuma ciwon zuciya, sun sami raguwar haɗarin cutar bayan an yi musu maganin hana ACE.
Kodayake tasirin ACE inhibitor bai da ƙarfi sosai fiye da haɗarin cutar nimoniya gaba ɗaya, amfani da ACE yana da alaƙa da rage yawan mutuwar da ke da alaƙa da cutar nimoniya.
Ana tsammanin sake haɗuwa da ɗan adam ACE 2 (rhACE2) magani ne na sabon abu don raunin huhu mai tsanani kuma an nuna cewa ya inganta haemodynamics na huhu da kuma oxygen saturation a cikin 'yan alade da ke fama da cutar ta cututtukan huhu mai tsanani.
A cikin ɗan adam, rabin rayuwar rhACE2 kusan awanni 10 ne kuma yana ɗaukar mintuna 30 don fara aiki kuma yana ɗaukar awanni 24.
Yawancin binciken sun nuna cewa rhACE2 na iya zama magani mai ban sha'awa ga waɗanda ke da rashin haƙuri ga masu hana tsarin renin-angiotensin (RAS inhibitors) na gargajiya ko cututtukan da ke da babban matakin rashin daidaituwa na angiotensin. An kimanta rhACE2 da aka zubo a cikin gwaji na asibiti don magance cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Aikace-aikacen b-COVID-19 aikace-aikacen software ne a kan wayoyin hannu, waɗanda aka tsara don taimakawa wajen tuntuɓar mutum a cikin martani ga cutar coronavirus ta 2019-20, watau, aiwatar da gano mutumin da ya taɓa tuntuɓar mai kamuwa da cutar ("Saduwa").
An haɓaka da kuma ba da shawarar aikace-aikace da yawa tare da tallafin gwamnati a wasu larduna da yankuna.
An samar da wasu tsarin samar da manhajojin gano lamba.
Musamman a cikin tsarin da ke bin diddigin yanayin masu amfani da manhajar, an nuna damuwa game da sirrin sirri.
Wasu zaɓuɓɓuka marasa amfani sun haɗa da amfani da siginar Blue Tooth don yin rajistar hulɗar mai amfani da sauran wayoyin salula.
A ranar 10 ga Afrilu, 2020, Google da Apple sun ba da sanarwar cewa za a haɗa waɗannan ƙa'idodin ƙa'idodin tushen BlueTooth don tallafawa aiki kai tsaye a cikin tsarin aiki na Android da iOS.
A cikin China, tare da haɗin gwiwar AliPay, gwamnatin kasar Sin ta samar da wata manhaja don tabbatar da cewa 'yan ƙasa sun kasance tare da mutanen da ke da cutar COVID-19.
Ana amfani da manhajar a birane sama da 200 na kasar Sin, a Singapore kuma ana amfani da manhajar da ake kira Trace Together.
An kirkiro manhajar ne daga wata kungiyar IT ta gida kuma an samar da ita a matsayin tushen budewa kuma za a mika ta ga gwamnati. Arewacin Macedonia ta ƙaddamar da manhajar da ke da tushen Blue Tooth mai suna "Tsaya Corona" don tuntuɓar mutanen da ke da yiwuwar kamuwa da cutar da kuma ba da amsa mai sauri ga jami'an kiwon lafiya.
Ma'aikatar sadarwa da fasaha da ma'aikatar lafiya ne suka samar da manhajar.
A ranar 14 ga Afrilu, 2020, aikace-aikacen suna jiran amincewa daga Google Play Store da Apple App Store.
Gwamnati ta ce a ranar 12 ga Afrilu, 2020, cewa aikace-aikacen yana cikin wani mataki na ci gaba kuma zai kasance a cikin 'yan makonni. An shirya irin wannan aikace-aikacen a Ireland da Faransa ("Tsaya COVID").
Australia da New Zealand duk suna la'akari da aikace-aikacen da suka danganci Singapore's Trace Together da Blue Tooth Protocol. Rasha na da niyyar gabatar da aikace-aikacen geofencing don marasa lafiya da ke da cutar COVID-19 da ke zaune a Moscow, waɗanda aka tsara don tabbatar da cewa ba za su bar gida ba.
Ross Anderson, Farfesa a fannin injiniyan tsaro a Jami'ar Cambridge, ya lissafa matsaloli masu yawa na aiki a cikin tsarin tushen APIs, gami da kuskuren kuskure da ƙarancin yiwuwar tasiri idan amfani da APIs ya iyakance ga ƙananan adadin jama'a.
Da yake nuna damuwa game da yaduwar aikace-aikacen "Covid-19" masu ɓatarwa ko cutarwa, Apple ya sanya iyaka kan irin nau'ikan kungiyoyin da za su iya ƙara aikace-aikacen da suka shafi cutar coronavirus a cikin Shagon su, suna iyakance ga "hukuma" ko kuma wasu kamfanoni masu martaba.
Google da Amazon sun sanya irin wannan takunkumin.
Masu fafutukar kare sirrin sun nuna damuwa game da tasirin sa ido mai yawa ta amfani da aikace-aikacen coronavirus, musamman game da ko za a lalata kayan aikin sa ido da aka tsara don magance cutar coronavirus.
Amnesty International da wasu kungiyoyi 100 sun yi kira da a kawo karshen irin wannan sa ido a cikin wata sanarwa.
Kungiyoyi sun bayyana sharudda guda takwas don ayyukan gwamnati:
Kulawa dole ne ta kasance "doka, dole kuma daidaitacce";
Za a sami ƙarin shinge na kulawa da kulawa da sunset clauses;
Dole ne a iyakance amfani da bayanai don dalilai na COVID-19;
Dole ne a tabbatar da tsaro da rashin sani, kuma a nuna cewa an kiyaye shi bisa ga samarwa;
Kulawa ta dijital tana buƙatar kauce wa nuna bambanci da watsi;
Za a bayyana musayar bayanai tare da wasu kamfanoni a cikin doka;
Hakkin 'yan ƙasa na karewa daga cin zarafi da kuma amsawa ga cin zarafi;
Ana buƙatar sa hannun ma'ana na duk "masu ruwa da tsaki" ciki har da masana kiwon lafiyar jama'a da ƙungiyoyin da ba a kula da su ba.Kungiyar Kwamfuta ta Chaos ta Jamus (CCC) da kuma 'Yan Jarida ba tare da Iyaka (Reporters ohne Grenzen) (RSF) sun kuma ba da jerin abubuwan dubawa.
Manufar da aka gabatar ta Google/Apple ita ce magance matsalar cire kayan sa ido daga tsarin aiki na na'urarsu har abada da zarar sun daina buƙatar tsarin sa ido.
Wasu ƙasashe suna amfani da hanyar sadarwar wurin da ke cikin hanyar sadarwa maimakon aikace-aikacen da ke buƙatar saukar da aikace-aikacen da ke kawar da ikon kauce wa bin sawu.
An amince da bin hanyar sadarwa a Isra'ila.
Hanyoyin sadarwa da ke da damar yin amfani da bayanan wuri na asali suna da mahimman matsalolin sirri.
Koyaya, ba duk tsarin da ke da sabar uwar garke bane ke buƙatar samun damar bayanan wurin mutum; an ƙirƙiri tsarin kariya na sirri da yawa waɗanda ke amfani da sabar uwar garke kawai don sadarwa.
An yi amfani da tsarin da ba na manhajar ba don gabatar da ganowa a Koriya ta Kudu.
Maimakon amfani da ƙa'idodin sadaukarwa, tsarin ya haɗa bayanan sa ido daban-daban, gami da bayanan sa ido na na'urar hannu da bayanan ma'amala na katin, kuma ya haɗa su don samar da sanarwa ta hanyar saƙon rubutu ga mutanen da ke da cutar.
Baya ga amfani da wannan bayanin don faɗakar da yiwuwar tuntuɓar, gwamnati ta ba da bayanan wurin a bainar jama'a, saboda canje-canje masu nisa a cikin dokar sirrin bayanai bayan barkewar MERS a ƙasar, an ba da izinin wani abu.
Wasu kasashe, ciki har da Jamus, sun yi tunanin tsarin da ke da tsakiya da kuma tsare sirri.
Babu wani bayani da aka bayyana har zuwa 6 ga Afrilu, 2020.
Sirri - Tsare-tsaren tuntuɓar sirri shine ingantaccen ra'ayi, tare da takaddun bincike tun aƙalla 2013. Har zuwa 7 ga Afrilu 2020, sama da ƙwararrun ƙwararrun masana suna aiki akan hanyoyin da za su dace da sirrin sirri, kamar amfani da Bluetooth Low Energy (BLE) don shiga kusanci da sauran wayoyin salula.
Koyaya, PEPP-PT ƙoƙari ne na haɗin gwiwa wanda ke da hanyoyin da aka rarraba da kuma rarraba su kuma babu yarjejeniya guda ɗaya. Tsarin yarjejeniya ya haɗa da bayanan sirri na sirri - gano kusanci (DP-PPT/DP-3T), lambobin tuntuɓar wucin gadi (TCN, fka Contact Event Numbers, CEN), ladabi na sirri da kuma tsarin don bin diddigin tuntuɓar wayar hannu (PACT) da sauransu.
A cikin waɗannan ladabi, bayanan da za a iya ganowa ba sa barin na'urar kuma duk abin da aka haɗa yana kan na'urar.
Rukunin sirri a MIT Media Lab suna haɓaka SafePath, wani dandamali don amfani da fasahohin tsare sirri yayin tattarawa ko amfani da wuri ko hanyar haɗuwa don bin diddigin yaduwar COVID-19.
Wannan ya dogara ne akan binciken da aka buga a cikin watan Maris na 2020 a cikin farar takarda mai taken "Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic". Wani irin wannan yunƙurin shine SafeTrace, kamfanin haɓaka fasahar sirri wanda Enigma MPC ya kirkira, wanda aka kafa a MIT Media Lab.
SafeTrace yana amfani da fasaha mai amfani da kayan aiki na kayan aiki don ba da damar mai amfani don raba wuri mai mahimmanci da bayanan kiwon lafiya tare da sauran masu amfani da hukumomi ba tare da yin sulhu akan sirrin bayanan ba.
A ranar 5 ga Afrilu, 2020, an kafa ƙungiyar TCN ta Duniya ta ƙungiyoyi waɗanda suka haɗu a kusa da irin wannan ra'ayi da kuma manyan ladabi da ke kan gaba, kuma suna da nufin rage rarrabuwa, haɓaka da haɓaka ƙwarewar aikace-aikacen faɗakarwa, wanda shine babban mahimmancin tallafi.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta buɗe tushen yarjejeniyar BlueTrace da aka yi amfani da ita ta hanyar aikace-aikacen hukuma.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa dandamali na Android da iOS, sun ba da sanarwar wani shiri don gano lamba bisa haɗin haɗin fasahar Bluetooth mai ƙarancin makamashi da kuma sirrin sirri, wanda suke da'awar zai kiyaye sirrin.
Ya kuma bayyana fasalulluka na fasahar da aka yi amfani da ita a cikin tsarin.
A cewar Apple da Google, tsarin zai iya zama matakai uku:
Sanya kayan aiki don bawa gwamnatoci damar samar da sirrin gwamnati - Kare aikace-aikacen gano kwayar cutar Corona.
Haɗuwa da wannan aikin kai tsaye zuwa iOS, Android, Google da Apple yana shirin magance matsalolin sa ido na yau da kullun ta hanyar rarraba tsarin ta hanyar sabunta tsarin aiki da farko da kuma kawar da shi ta hanyar da ta dace bayan an kawar da barazanar.
B'drug repositioning ((wanda kuma ake kira sake fasalin magani, sake fasalin, sake fasalin ko sauya magani)) shine amfani da magani wanda aka amince dashi don cutar ko cuta don magance wata cuta.
Wannan shine nau'in binciken kimiyya na farko wanda ake gudanarwa yanzu don haɓaka ingantaccen magani mai lafiya don COVID-19.
Kwayar cutar plasma don allurar rigakafi da sake warkewa. SARS-CoV-2 tana da furotin 66 da za a iya cirewa, kowannensu yana da wurare masu alaƙa da yawa.
Binciken irin wannan wurin da aka yi amfani da shi ya ba da damar samar da maganin rigakafi mai tasiri ga furotin na COVID-19.
Muhimman sunadaran da SARS-CoV-2 ke niyya sune sunadarai kamar su papane, RNA-daidaitaccen RNA polymerase, helicase, S protein, da kuma ADP ribophosphate.
Hussain AA da sauransu sun yi nazarin wasu magungunan da aka zaba don gano kamanceceniya tsakanin su da irin wannan magani da aka amince da shi, sannan suka bincika shi don samar da magani mai cutar SARS-CoV-2 a cikin karatun su na farko don ba da shawarar a cikin tsarin binciken asibiti.
Chloroquine magani ne na hana sanyi wanda ake amfani dashi don magance wasu cututtukan autoimmune.
A ranar 18 ga Maris, WHO ta sanar da cewa magungunan huɗu da za a yi nazari a matsayin ɓangare na gwajin asibiti na Solidarity za su ƙunshi chloroquine da hydroxychloroquine mai alaƙa.
Gwamnan New York Andrew Cuomo ya sanar da cewa za a fara gwajin jihar New York akan chloroquine da hydroxychloroquine daga ranar 24 ga Maris.A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate a ƙarƙashin izinin Amfani da Gaggawa (EUA).
Ba a sami amincewa ga wannan magani ta hanyar tsarin gwajin asibiti na FDA ba kuma an ba shi izini a ƙarƙashin EUA don yin gwaji ne kawai ga marasa lafiya da ke asibiti amma ba za su iya karɓar magani a ƙarƙashin gwajin asibiti ba.
CDC ta ce "ba a tabbatar da amfani da Hydroxychloroquine ba, sashi, ko tsawon lokacin amfani da shi don rigakafi ko maganin kamuwa da cutar SARS-CoV-2 ba".
Likitoci sun ce ana amfani da wannan magani ne idan "babu wani zaɓi".
Wani karamin bincike da kungiyar bincike ta Turkiyya da ke Istanbul ta gudanar ya nuna cewa ana amfani da chloroquine tare da zinc, bitamin A, bitamin C da bitamin D.
Akwai manyan bincike da ake yi a jami'ar Duke da Oxford.
Jami'ar NYU Langone Medical School tana gwada amincin da ingancin hydroxychloroquine a matsayin magani na rigakafi.
Gwaje-gwajen asibiti na kasar Sin a Wuhan da Shenzhen sun yi iƙirarin cewa favipirvir yana da "cikakken tasiri".
A Shenzhen, an samu mutane 35 da suka yi gwajin ba su da lafiya a cikin kwanaki 4 yayin da 45 da ba su samu ba sun yi rashin lafiya na kwanaki 11.
A wani bincike da aka yi kan marasa lafiya 240 da ke fama da cutar huhu a birnin Wuhan, rabin marasa lafiyar sun karɓi favipirvir, rabin kuma suka karɓi umiphenvir.
Hukumar Pharma ta Italiya ta tunatar da jama'a cewa adadin da ake da shi a halin yanzu don tallafawa maganin bai isa ba kuma na farko ne.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don adana shi, tare da taimakon sojoji don rarraba shi ga asibitocin jami'a, inda za a yi amfani da shi don kula da marasa lafiya na COVID-19.
A cewar jaridar South China Morning Post, Shinzo Abe ya tattauna da gwamnatin Trump game da sayan maganin, wanda zai iya zama da karancin tasiri ga marasa lafiya masu fama da cutar saboda cutar ta riga ta kara yawa a can.
Wannan ba zai zama mai lafiya ba ga mata masu ciki ko mata masu ƙoƙarin yin ciki.
Wani bincike akan lopinavir/ritonavir (Caletra) wanda ya hada maganin rigakafin cutar lopinavir da ritonavir ya kammala cewa "babu wani amfani".
An tsara magungunan don hana kwayar cutar ta HIV ta hanyar ɗaure ta da ƙwayoyin cuta.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin inganta waɗannan magungunan don gano mahaɗan da ke ɗaure da furotin na SARS-CoV-2.
WHO ta haɗa Lopinavir/Ritonavir a cikin gwajin haɗin kai.
Gilead Sciences ta kirkiro da kuma bunkasa Remdesivir don magance cutar Ebola da Marburg. Gilead Sciences ta gano cewa Remdesivir yana da tasirin anti-viral na ciki da ke hana cutar filalo, pneumonia, paramyxovirus, da coronavirus.
Wata matsala da maganin rigakafi ke fuskanta ita ce, tsayayya da kwayoyin halitta wanda ke haifar da cututtuka da kamuwa da cuta.
Wasu nazarin farko na gwaji sun nuna cewa remdesivir na iya samun babban ƙwayar cuta don juriya. Wasu gwaji na asibiti suna gudana, biyu daga cikinsu suna gudana a Asibitin Jami'ar Cleveland; ɗaya ga mutanen da ke da rashin lafiya mai sauƙi ɗayan kuma ga mutanen da ke da mummunan cuta.
Ana gudanar da gwaji uku na asibiti na shan bitamin C a cikin jijiyoyin jini ga marasa lafiya masu fama da cutar COVID-19 da aka kwantar a asibiti; biyu masu sarrafa wuribo ((China, Kanada) da ɗaya mara sarrafawa ((Italiya).
Jihar New York ta fara gwajin maganin Azithromycin a ranar 24 ga Maris.
Cibiyar Kula da Lafiya da Magunguna ta Duniya ta Japan (NCGM) ta shirya gwajin asibiti na alvesco (cyclosonide) na Tijin, corticosteroid na numfashi don cutar asma don kula da marasa lafiya masu alamun cutar coronavirus.
Ana gudanar da gwajin Mataki na II na Angiotensin-Conversion Vicar 2 wanda zai hada da marasa lafiya 200 daga cikin marasa lafiya masu fama da cutar a asibitoci a Denmark, Jamus, da Austria.
Masu bincike a Cibiyar Zuciya ta Montreal, Kanada, a halin yanzu suna nazarin rawar da calcium ke takawa wajen rage kumburi da rikitarwa na huhu a cikin marasa lafiya da ke da alamun COVID-19.
Ana daukar manya 6000 masu shekaru 40 zuwa sama, wadanda aka gano suna da cutar COVID-19 kuma ba sa bukatar asibiti don binciken da ake kira Colcorona.
Mata masu ciki ko masu shayarwa da kuma matan da ba su da amfani da maganin hana haihuwa ba su cancanci.
Ana gwada wasu magungunan rigakafin sutura a Italiya.
Ana amfani da ƙananan nauyin kwayoyin halitta na heparin don kula da marasa lafiya, wanda ke ƙarfafa cibiyoyin kiwon lafiya a Italiya don buga jagororin.
Italiya ta sanar a ranar 14 ga Afrilu cewa za ta fara nazarin marasa lafiya 300 don nazarin maganin rigakafi da maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin.
Saboda SARS-CoV-2 kwayar cuta ce, ana mai da hankali kan amfani da maganin rigakafin cutar da aka amince da shi a baya a cikin MERS, SARS, da cutar West Nile don sababbin dalilai.
Ribavirin: An ba da shawarar ribavirin don maganin COVID-19 a cikin Shafin 7 na Jagororin China.
Yumiphenovir: An ba da shawarar Yumiphenovir don maganin COVID-19 a cikin Shafin 7 na Jagororin China.
An gano cewa wasu kwayoyin cutar sun dace da amfani da su don sabon manufar maganin COVID-19:
Tosylzumab ((IL-6-Anti-Receptor): An amince da shi daga China
Ka kuma duba gwajin da aka yi a China da Italiya da Tocilizumab#COVID-19.
b'A COVID 19 allurar rigakafi ne na rigakafin cutar coronavirus ta 2019 ((COVID-19).
Duk da cewa babu wani allurar rigakafi da aka kammala gwajin asibiti, akwai wasu ƙoƙarin da ake yi don samar da irin wannan allurar.
A karshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba a sa ran samun allurar rigakafin cutar SARS-CoV-2 ba kafin watanni 18.
A watan Afrilu, an gudanar da binciken aminci na Mataki na I kan 'yan takarar allurar rigakafi biyar.
An gano COVID-19 a watan Disamba na 2019.
Cutar da ta barke a duniya a shekarar 2020 ta haifar da zuba jari da bincike mai yawa don samar da allurar rigakafi.
Kungiyoyi da yawa suna amfani da bayanan da aka buga don samar da allurar rigakafin SARS-CoV-2.
Abubuwan da ke da muhimmanci ga shirin CEPI don samar da allurar rigakafi kamar yadda aka sanar a watan Afrilu sune saurin, ƙarfin samarwa, tsara sikelin da kuma isar da duniya.
A watan Afrilu, masana kimiyya na CEPI sun sami bayanai cewa a farkon shekarar 2020, ana gudanar da bincike da ci gaba a dandamali daban-daban na fasaha 10 don samar da allurar rigakafi mai tasiri kan COVID-19.
Babban manufofin dandamali a cikin Nazarin Tsaro na Farko sune:
Kwayar nucleic ((DNA da RNA)) (Tsarin I Masu haɓakawa da mai neman allurar rigakafi: Moderna, mRNA-1273)
Kwayar cuta (Tsarin I mai haɓaka da mai neman allurar rigakafi:Cancino Biologics, adenovirus type 5 vector)
A cikin watan Afrilu, a cewar bayanan da masana kimiyya na CEPI suka samu, a total an samu 'yan takarar allurar rigakafi 115 a farkon matakan ci gaba, tare da tabbatar da cewa akwai ayyukan 78 da ke gudana (a cewar Cibiyar Milken 79) da kuma wasu 37 da aka sanar da kadan da aka bayyana a fili (a zaton akwai shirin ko kuma ana shirin).
Gwaje-gwaje na farko da na biyu suna da farko don tantance aminci da ƙarfin antigen kuma galibi ana yin su ne ta hanyar bazuwar, sarrafawa da wuribo da wurare da yawa don tantance ainihin, ingantattun allurai.
Gwaje-gwaje na Phase III yawanci suna da mutane da yawa, wanda ya haɗa da rukunin sarrafawa, don tantance ingancin allurar rigakafin don hana cutar da kuma lura da tasirin sakamako bayan an ba da isasshen allurai.
Daga cikin alluran rigakafi 79 da ke cikin ci gaba (kamar yadda aka tabbatar a farkon Afrilu 2020), har yanzu ba a tantance alluran rigakafi 74 a cikin ɗan adam ba (har yanzu ana gudanar da "binciken farko").
A ranar 24 ga Janairun 2020, a Ostiraliya, Jami'ar Queensland ta ba da sanarwar cewa suna binciken yiwuwar allurar rigakafin kwayar cuta wanda zai haifar da amsawar rigakafi ta hanyar gyaran kwayoyin halittar ƙwayoyin cuta.
A ranar 24 ga Janairun 2020, a Kanada, Cibiyar allurar rigakafin kasa da kasa (VIDEO-INTERVAC) a Jami'ar Saskatchewan ta sanar da cewa ta fara aiki kan allurar rigakafin, wanda aka ce za a fara gwajin mutum a 2021.
Cibiyar Kula da Cututtuka ta kasar Sin ta sanar da shirin samar da allurar rigakafi don magance cututtuka a ranar 26 ga Janairu, 2020 da kuma Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairun 2020, kamfanin Janssen Pharmaceutical, wanda Hannek Skytmaker ya jagoranta, ya sanar da cewa yana aiki kan samar da allurar rigakafi.
Janssen tana haɓaka allurar rigakafin baki tare da abokin aikinta na fasahar halittu, Vaxart.
A ranar 18 ga Maris, 2020, Emergent Biosolutions ta sanar da haɗin gwiwar samar da kayayyaki tare da Vaxart don haɓaka allurar rigakafi.
A ranar 8 ga Fabrairun 2020, Oncogene Laboratory a Romania ta buga takarda game da tsarin samar da allurar rigakafi mai kama da fasahar da ake amfani da ita a maganin rigakafin cutar kansa.
A ranar 25 ga Maris, shugabannin cibiyar bincike sun sanar da cewa sun yanke shawarar hada allurar rigakafi kuma sun fara gwaji.
A ranar 27 ga Fabrairun 2020, kamfanin Genrex, NuGenrex Immuno-Oncology, ya sanar da cewa ya fara aikin allurar rigakafi don samar da allurar rigakafin COVID-19 Li-Key peptide.
Suna son samar da allurar rigakafin da za a iya gwadawa a cikin mutane cikin "kwanaki 90".
A ranar 5 ga Maris, 2020, Jami'ar Washington da ke St. Louis ta sanar da shirinta na samar da allurar rigakafi.
Cibiyar Nazarin Likitocin Sojojin Amurka da Kwamandan Kayan aiki a Fort Detrick da Cibiyar Sojojin Walter Reed da ke Silver Spring, dukansu suna cikin yammacin Maryland, sun ba da sanarwar cewa suna aiki a kan allurar rigakafi a ranar 5 ga Maris, 2020.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa tana aiki tare da Novavax Inc.
Don samar da allurar rigakafi.
Abokan hulɗar sun ba da sanarwar yin gwajin farko na asibiti da gwaji na asibiti na farko a watan Yulin 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta ba da sanarwar cewa tana aiki a kan keɓaɓɓu 11 kuma zai ɗauki kusan shekaru 1.5 zuwa 2 don haɓaka allurar rigakafi duk da saurin aiki.
Kamfanin Medico, wani kamfanin fasahar zamani da ke birnin Quebec, Quebec, ya sanar a ranar 12 ga Maris, 2020 cewa ya samar da kwayar cutar coronavirus, tare da samun kudade daga Cibiyar Nazarin Lafiya ta Kanada.
Ana gudanar da bincike a dakin gwaje-gwaje kan dan takarar rigakafin, kuma ana shirin fara gwajin mutum a watan Yuli ko Agusta 2020.
A farkon wannan makon, The Guardian ta ruwaito cewa Shugaban Majalisar Dinkin Duniya Donald Trump ya nuna shirye-shiryen biyan Curevac "babban kuɗi don samun izinin rigakafin COVID-19 na musamman", wanda gwamnatin Jamus ta nuna rashin amincewa da shi.
A ranar 17 ga Maris, 2020, kamfanin harhada magunguna na Amurka Pfizer ya sanar da cewa ya yi haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin mRNA tare.
A halin yanzu ana gudanar da gwajin farko na rigakafin rigakafin mRNA-BNT162 wanda ake sa ran a fara gwajin asibiti a watan Afrilu 2020.
A Italiya a ranar 17 ga Maris, 2020, kamfanin nazarin halittu na Italiya, Takez Biotech, ya sanar da cewa za su sami sakamakon gwajin farko na asibiti a watan Afrilu na 2020, sannan za a fara gwajin mutum na ɗan takarar allurar rigakafin.
A ranar 19 ga Maris, 2020, Coalition for Epidemic Prepardiness Innovations (CEPI) na Faransa ya ba da sanarwar saka hannun jari na US$4.9 ga ƙungiyar tallafi ta binciken allurar rigakafin COVID-19 tare da taimakon Cibiyar Pasteur, Themis Biosciences (Vienna, Austria) da Jami'ar Pittsburgh, wanda ya kawo jimlar saka hannun jari na CEPI don haɓaka allurar rigakafin COVID-19 zuwa US$29.
Abokan haɗin gwiwar saka hannun jari na CEPI don haɓaka allurar COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
Hukumomin kiwon lafiya na Rasha sun sanar a ranar 20 ga Maris, 2020 cewa masana kimiyya sun fara gwajin dabbobi akan wasu takarar allurar rigakafi guda shida.
Masu bincike a Kwalejin Imperial ta London sun sanar a ranar 20 ga Maris, 2020 cewa suna haɓaka allurar rigakafin RNA mai haɓaka kanta don COVID-19.
An samar da dan takarar allurar rigakafi a cikin kwanaki 14 bayan karbar umarni daga China.
Gwamnatin Kanada ta sanar da tallafin dala miliyan 275 na C$ 96 don ayyukan maganin COVID-19 a ƙarshen Maris, wanda ya haɗa da kamfanoni da jami'o'i a Kanada da dama da ke neman allurar rigakafi, kamar su Medicaidgo da Saskatchewan Initiative.
A kusan lokaci guda, Gwamnatin Kanada ta ba da sanarwar C$192 miliyan don haɓaka allurar rigakafi musamman don COVID-19, wanda ya haɗa da shirin kafa "Bankin allurar rigakafi" na ƙasa don amfani da shi idan cutar ta sake barkewa.
A ranar 2 ga Afrilu, 2020, Jami'ar Pittsburgh School of Medicine ta sanar da cewa tana yin gwajin yiwuwar allurar COVID-19, Pitkovak, a cikin beraye, ta ba da rahoton cewa "An gwada tasirin antigen-specific antibody reaction [a cikin beraye] na SARS-CoV-2 S1 subunit vaccine da MNA ta bayar wanda ya fara bayyana makonni 2 bayan allurar".
A ranar 16 ga Afrilu, 2020, Jami'ar Waterloo School of Medicine a Kanada ta sanar da shirin samar da takarar rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rig
Za a yi amfani da mai cin kwayar cuta don ƙirƙirar DNA wanda zai iya yin kwafi a cikin kwayar cutar ɗan adam don samar da ƙwayoyin cuta marasa lahani, wanda zai motsa tsarin rigakafi don samar da ƙwayoyin cuta ga SARS-CoV-2.
A watan Maris na 2020, gwamnatin Majalisar Dinkin Duniya, masana'antu da jami'o'i uku, tare da Haylett Packard Enterprise's Cloud Computing Resources, Amazon, Microsoft da Google, sun yi amfani da albarkatu don samun damar kwamfutar IBM.
Wasu alluran rigakafi suna haifar da sakamako mai ban mamaki, wanda za a iya kira sakamako mara kyau.
Wannan yana nufin cewa akwai wasu fa'idodi da za a iya samu daga wannan magani ban da magance cutar.
A gaba, za a yi amfani da ma'aikatan kiwon lafiya 4,170 don gwajin bazuwar a Ostiraliya.
Ana iya ganin cewa alluran rigakafin da ake samarwa ba su da lafiya ko tasiri.
Binciken da aka yi a baya don kimanta ingancin allurar rigakafin COVID-19 a cikin wasu dabbobi kamar su berayen ACE2-transgenic, da sauran dabbobin dakin gwaje-gwaje da kuma dabbobi masu kama da dabbobi ba tare da ɗan adam ba, ya nuna cewa akwai buƙatar haɗin gwiwar ƙasa da ƙasa don tabbatar da matakan kula da matakin 3 na biosafety da daidaitaccen tsarin aminci don sarrafa ƙwayoyin cuta masu rai.
An gwada alluran rigakafin SARS da MERS a kan dabbobi ban da mutane.
Har zuwa 2020, babu maganin SARS ko allurar rigakafi da ke da aminci da tasiri ga ɗan adam.
A cewar takardun bincike da aka buga a 2005 da 2006, ganowa da kuma bunkasa sabbin alluran rigakafi da magunguna don magance SARS sun kasance babban fifiko ga gwamnatoci da cibiyoyin kiwon lafiya a duniya.
Lokacin da MERS ya zama mafi rinjaye, ana tsammanin cewa binciken da ake yi a kan SARS zai ba da samfurin da zai taimaka wajen gano allurar rigakafi da magunguna don kamuwa da cutar MERS-CoV.
A watan Maris na 2020, an kammala gwajin asibiti na farko a cikin ɗan adam don maganin MERS na tushen DNA, kuma ana aiki akan wasu alluran rigakafi guda uku, dukansu alluran rigakafi ne na kwayar cuta, biyu adenoviral-vectored (ChAdOx1-MERS, BFRS-Gamvac), da MVA-vectored (MVA-MERS-S).
An fara tattaunawa kan makirci ne sakamakon wani rubutu a shafukan sada zumunta da ke nuna cewa an san kwayar cutar da ke haifar da COVID-19 kuma an riga an samu allurar rigakafi.
Takaddun shaida da aka samo daga rubuce-rubuce daban-daban a shafukan sada zumunta suna nufin takaddun shaida da ke akwai don tsarin jinsi da allurar rigakafin wasu nau'ikan kwayar cutar coronavirus kamar SARS coronavirus.
Cutar Coronavirus ta 2019 (COVID-19) cuta ce mai saurin yaduwa wacce ke haifar da Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar C.
Cutar zazzabi, tari da wahalar numfashi sune alamun da aka saba gani.
Wasu daga cikin alamun da za su iya faruwa su ne gajiya, rashin jin daɗi, gudawa, ciwon makogwaro, ƙanshin ƙanshi, da ciwon ciki.
Yawanci lokaci ne na bayyanar cututtuka daga toshewa zuwa kwanaki biyar amma zai iya zama daga kwana biyu zuwa 14.
Yawancin marasa lafiya suna da alamun rashin lafiya, yayin da wasu marasa lafiya ke ci gaba da cutar, wanda ke haifar da cutar nimoniya da raunin gabobin jiki.
Ya zuwa ranar 17 ga Afrilu, 2020, an samu sama da mutane miliyan 2.24 da suka kamu da cutar a kasashe da yankuna 210, inda aka samu mutuwar mutane 153,000.
Sama da mutane 5,68,000 ne suka warke daga cutar, kuma ana yada kwayar cutar ne ta hanyar hulɗa ta kai tsaye da mutane, galibi ta tari, hancin baki ko kuma magana.
Sa'ad da mutum ya numfasa, ana fitar da wannan ruwan kuma yana sauka a ƙasa ko kuma ƙasa, ba ya ɗauke da cututtuka a nesa.
Mutane na iya kamuwa da cutar ta hanyar taɓa idanu, hanci da baki da kuma shafa abubuwa masu gurbatawa.
Kwayar cutar tana rayuwa a kowane wuri har tsawon sa'o'i 72.
Ana iya kamuwa da cutar a cikin kwanaki uku na farko bayan bayyanar cututtuka, amma ana iya yaduwa a cikin pre- da post-symptomatic. Real-time reverse transcription polymerase chain reaction (rRT-PCR) na nasopharyngeal fluid shine hanyar daidaitaccen bincike.
Ana ba da shawarar cewa duk wanda ake zargi da kamuwa da cutar da kuma duk wanda ke kula da shi ya sanya abin rufe fuska.
Ana ba da shawarwari daban-daban game da amfani da abin rufe fuska daga jama'a, wasu jami'ai suna adawa da amfani da abin rufe fuska, wasu suna ba da shawarar amfani da shi, wasu kuma suna cewa dole ne a yi amfani da shi.
A halin yanzu babu takamaiman maganin rigakafi ko rigakafi don COVID-19.
Yawancin ƙasashe a duk yankuna shida na WHO sun ba da rahoton yaduwar cutar a cikin gida.
A wasu lokuta marasa lafiya da ke fama da cutar ba su da alamun cutar ko kuma suna da alamun mura kamar zazzabi, tari, gajiya da wahalar numfashi.
Alamomin da suka faru ba zato ba tsammani sune wahalar numfashi, ci gaba da ciwo ko damuwa a kirji, rikicewa, wahalar tafiya da launin shuɗi a fuska da lebe. Ana ba da shawarar zuwa asibiti nan da nan idan an gano waɗannan alamun.
Alamu masu laushi na iya zama alamun numfashi kamar atishawa, hanci mai narkewa ko ciwon makogwaro.
Wasu marasa lafiya sun nuna alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Wasu marasa lafiya a China sun fara nuna alamun ciwon kirji da bugun zuciya.
Wasu marasa lafiya sun sami ci gaba zuwa ciwon huhu, raunin gabobin jiki da mutuwa.
Wannan shi ake kira lokacin incubation.
Lokacin incubation na COVID-19 yawanci kwanaki biyar zuwa shida ne, amma a wasu mutane zai iya zama kwanaki biyu zuwa 14.
97.5% na marasa lafiya da suka kamu da cutar sun kamu da cutar a cikin kwanaki 11.5 bayan kamuwa da cutar. Rahotanni sun nuna cewa ba duk marasa lafiyar da ke kamuwa da cutar ba ne ke kamuwa da cutar.
Har yanzu ba a bayyana rawar da waɗannan masu ɗaukar hoto ba ke takawa a cikin kamuwa da cuta ba; duk da haka, ana tsammanin cewa suna da hannu wajen yada cutar daga farkon allurai.
Har yanzu ba a san adadin marasa lafiya da ke fama da cutar ba kuma ana ci gaba da nazarin su, yayin da Cibiyoyin Kula da Cututtuka na Koriya (KCDC) suka ba da rahoton cewa kashi 20 cikin dari na marasa lafiya da aka tabbatar ba su da alamun cutar har sai an kwantar da su a asibiti.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara hada marasa lafiya marasa alamun cutar a cikin adadin marasa lafiya na yau da kullun daga ranar 1 ga Afrilu; daga cikin mutane 166 da suka kamu da cutar da aka gano a wannan ranar, 130 (78%) marasa lafiya ba su da alamun cutar a lokacin gwajin.
Dukansu, tofa da kuma leɓen ruwa suna ɗauke da ƙwayoyin cuta masu yawa.
Yin magana da ƙarfi yana sa mu yi sanyin jiki fiye da yin magana da baki.
Wani bincike da aka yi a Singapore ya nuna cewa tari da ba a rufe baki ba zai iya sa ƙanƙara ta kai tsawon kafa 15 zuwa mita 4.5.
Ko da yake cutar ba ta samo asali daga iska ba, amma Kwalejin Kimiyya ta Kasa ta yi hasashen yiwuwar watsa kwayar halitta, kuma an gano RNA mai cutar a cikin samfurori da aka karɓa daga masu karɓar iska a waje da gidajen mutane.
Wasu hanyoyin kiwon lafiya, kamar saka bututu a jiki da kuma sake dawo da zuciya da jijiyoyin jini, na iya haifar da ɓarkewar ɓarkewar iska ta hanyar iska.
Idan aka damu da yaduwar cutar ta hanyar fitsari, ana ganin cewa ba ta da haɗari. Mutane da ke da alamun cutar sun fi kamuwa da cutar.
Ko da yake ba a san yadda cutar ke yaduwa ba tukuna, amma mutum ɗaya zai iya kamuwa da mutane biyu zuwa uku, kuma ƙwayoyin cuta na iya rayuwa a farfajiyoyi na awanni zuwa kwanaki, in ji Cibiyar Kula da Cututtuka ta Turai (ECDC).
A zahiri, an gano cewa kwayar cutar ta kasance a kan takarda na kwana daya, a kan filastik da ƙarfe (AISI 304) har tsawon kwana uku, kuma a kan farfajiyar da ke da jan ƙarfe kashi 99 cikin ɗari har tsawon awanni huɗu.
Koyaya, ya dogara da yanayin zafin jiki da zafi kuma yana canzawa daidai.
Sabulu da kayan wanki suna iya zama masu tasiri idan aka yi amfani da su yadda ya kamata; kayayyakin sabulu suna lalata, hana, da kuma ware kwayar cutar daga fata da sauran farfajiya.
Sauran magungunan, kamar su benzaconium chloride da chlorhexidine gluconate (wani nau'in maganin kashe kwayoyin cuta na tiyata) ba su da tasiri sosai. A cikin binciken da aka yi a Hong Kong, an ɗauki samfurin haushi a cikin kwanaki biyu bayan shigar da shi asibiti.
A cikin marasa lafiya biyar daga cikin shida, samfurin farko ya sami mafi yawan ƙwayoyin cuta, kuma a cikin mutum na shida, an sami mafi yawan ƙwayoyin cuta a gwajin da aka yi a rana ta gaba.
Cutar coronavirus mai saurin kamuwa da cutar 2 (SARS-CoV-2) wata sabuwar cuta ce da ke nuna alamun cututtukan numfashi mai tsanani. An fara keɓe ta daga marasa lafiya uku da ke fama da cutar huhu a Cibiyar Kula da Cututtukan Naƙasa na numfashi a Wuhan.
Dukkanin halaye na sabon SARS-CoV-2 sun bayyana a cikin kwayar cutar Corona da ke cikin yanayi.
A waje da jikin mutum, ana kashe kwayar cutar ta sabulu na gida wanda ke samar da kumfa mai kariya. Tushen SARS-CoV-2 yana da alaƙa da SARS-CoV.
COVID-19 yana da tasiri sosai a cikin huhu, saboda kwayar cutar tana isa ga ƙwayoyin asali ta hanyar enzyme angiotensin-converting enzyme 2 (ACE2), wanda ke da yawa a cikin wasu nau'ikan ƙwayoyin ƙwayoyin cuta na iska a cikin huhu.
Kwayar cutar tana amfani da glycoprotein na musamman wanda ake kira spike don haɗawa da ACE2 da kuma shiga cikin ƙwayoyin asali.
Kashi 12 cikin dari na marasa lafiya da ke asibiti a Wuhan, China, sun sami ciwon zuciya mai tsanani kuma ana samun su sau da yawa a cikin cututtuka masu tsanani.
A lokacin yaduwar cutar, cututtukan zuciya masu tsanani suna da yawa saboda halayen kumburi na jiki da lalacewar rigakafi, amma mummunan rauni na jijiyoyin zuciya na iya kasancewa da alaƙa da abubuwan da ke karɓar ACE2 a cikin zuciya.
Abubuwan da ke karɓar ACE2 suna da yawa a cikin zuciya kuma suna da hannu cikin aikin zuciya.
Misalai na jini na jini (31%) da jini na jini a cikin jijiyoyi (25%) an gano su a cikin manyan marasa lafiya na COVID-19. Wataƙila suna da alaƙa da rashin ganewar asali.
Kodayake SARS-COVID-2 yana da halayen kamuwa da ƙwayoyin cuta tare da ƙwayoyin cuta na numfashi don ACE2, alamun hawan jini suna bayyana a cikin marasa lafiya masu tsanani na COVID-19.
Musamman, an gano cewa kwayoyin halittar GM-CSF-secretory T-cell suna da alaƙa da sanya IL-6-secretory monocytes masu kumburi da kuma ciwon huhu mai tsanani a cikin waɗannan marasa lafiyar COVID-19.
An kuma gano cewa an samu wasu ƙwayoyin cutar a jikin mutum.
Hukumar Lafiya ta Duniya ta wallafa wasu ka'idoji don gwada cutar.
Hanyar gwajin da aka yarda da ita ita ce ainihin lokacin juyawa juyawa polymerase chain reaction.
Ana yawan gwadawa akan samfurori na numfashi da aka samo daga cikin makogwaro; amma ana iya amfani da samfurori na numfashi ko kuma tofa.
Sakamakon gwajin yakan kasance cikin sa'o'i kadan ko kwana biyu.
Ana iya yin gwajin jini, amma yana buƙatar samfuran jini biyu da aka ɗauka a tsakanin makonni biyu kuma sakamakon ba shi da ƙimar nan take.
Masana kimiyya na kasar Sin sun iya ware kwayar cutar da kuma buga jerin kwayoyin halittar ta, wanda ya baiwa dakunan gwaje-gwaje a duniya damar samar da gwaje-gwajen polymerase chain reaction (PCR) da ke gano kamuwa da cutar.
Har zuwa 4 ga Afrilu, 2020, ana ci gaba da gwajin maganin rigakafi (wanda zai iya gano kamuwa da cuta a yanzu kuma ya gaya wa mutum ko ya kamu da cutar a baya) amma ba a yi amfani da su sosai ba.
Kwarewar gwajin a China ya nuna cewa daidaito ya kai kashi 60 zuwa 70 cikin dari.
FDA a Amurka ta amince da gwajin farko na Point of Care a ranar 21 ga Maris, 2020 don amfani a ƙarshen wannan watan. Jagororin bincike da asibitin Zhongnan na Jami'ar Wuhan ya bayar sun ba da shawarar hanyoyin gano kamuwa da cuta bisa ga halaye na sinadarai da haɗarin yanayin cuta.
A cikin farkon kamuwa da cuta, ɓarna mai yawa na filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen
A yayin da cutar ke ci gaba, ana iya samun rinjaye na subpliural, ɓarna mai ban mamaki (ƙarancin ƙwayar ƙwayar ƙwayar cuta tare da canzawar alveolar fillings) da kuma ƙuƙwalwa.
Akwai ɗan bayani game da ilimin lissafi da ƙananan raunuka na COVID-19.
Wasu muhimman bayanai game da cututtukan da aka gano a cikin autopsies sune:
Abubuwan da za a iya gani da idanu: kumburi na huhu, ciwon zuciya, ƙuƙwalwar huhu, da kumburi na huhu
An lura da nau'ikan cutar nimoniya guda huɗu masu tsanani:
Ciwon huhu mai sauƙi: ƙonewar huhu, ƙwayoyin ƙwayoyin cuta a cikin huhu, ƙwayoyin cuta masu girma a cikin huhu, ƙwayoyin cuta tare da shiga cikin ƙwayoyin fararen fata, da kuma samar da ƙwayoyin cuta masu yawa.
Ciwon huhu mai tsanani: Rashin ciwon huhu da kuma zubar da jini daga cikin huhu
Cutar cutar ta cutar da cutar ta haifar da ciwon numfashi mai tsanani da kuma rashin iskar oxygen.
Ciwon huhu mai warkewa: tarin abubuwan da ba a sarrafawa a cikin ƙoshin huhu da kuma fibrosis na interstitial a cikin huhu.
Jini: Ƙarƙashin jini da ke cikin jijiyoyi (ƙarancin ƙwayar jini); halayen leukocytotrophic
Matakan da za a dauka don rage yiwuwar kamuwa da cutar sun hada da zama a gida, kauce wa wuraren da jama'a ke taruwa, wanke hannuwanka da sabulu da ruwa akai-akai na akalla dakika 20, kiyaye iska mai tsafta, da kuma kauce wa taba idanu, hanci ko baki da hannayen da ba a wanke ba.
CDC ta ba da shawarar sanya tawul a gaban hanci da baki lokacin da kake tari ko hancinka. Idan ba ka da tawul, rufe hanci da gefen hannu.
An shawarci masu amfani da maganin bayan duk wani tari ko hancin da suka yi.
CDC ta ba da shawarar sanya abin rufe fuska a wuraren jama'a don iyakance yaduwar cutar daga mutanen da ba su da alamun cutar.Domin rage hulɗa da mutane da yawa, an rufe makarantu da ofisoshi, an sanya takunkumin tafiya da kuma hana taron jama'a.
A cikin sharuddan nisantawa, an ce mutane su kasance aƙalla ƙafa 6 daga juna.
Ba a san ko akwai maganin rigakafin COVID-19 ba. Ko da yake ba a yi hasashen cewa za a samu rigakafin ba kafin 2021, a halin yanzu, babban ɓangare na gudanar da COVID-19 shine sarrafa cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu akai-akai da sabulu da ruwa na aƙalla dakika 20, musamman bayan sun je bayan gida ko idan hannayensu sun lalace, kafin cin abinci da bayan taɓa hanci, da kuma bayan tari ko hancin.
CDC ta kuma ba da shawarar amfani da maganin wanke hannu mai dauke da barasa wanda ya ƙunshi kashi 60 cikin ɗari na barasa, amma a yi amfani da shi ne kawai idan sabulu da ruwa ba su da yawa.
A cikin waɗannan ƙwayoyin, maganin rigakafi yana haifar da ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don hana ƙwayoyin cuta girma a cikin giya; ba 'wani abu mai aiki ba ne don kashe ƙwayoyin cuta na hannu.'
An haɗa glycerol a matsayin mai riƙe danshi.
Ana kula da marasa lafiya ta hanyar kula da taimako, wanda ya haɗa da ba da iskar oxygen, maganin ruwa da sauran abubuwan da suka shafi gabobin da suka shafi.
CDC ta ba da shawarar cewa duk wanda ake zargi da dauke da kwayar cutar ya sanya abin rufe fuska.
An yi amfani da maganin oxygen daga waje don magance matsalar rashin numfashi, amma har yanzu ba a san amfanin ba.
An ba da shawarar tsabtace jiki da salon rayuwa mai kyau da abinci don haɓaka rigakafi.
Magungunan tallafi na iya amfani da su ga waɗanda ke da alamun cutar a farkon lokacin kamuwa da cutar.WHO da Hukumar Lafiya ta Kasa ta China sun buga shawarwari don kula da marasa lafiya na COVID-19 da aka kwantar a asibiti.
Masana cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Har zuwa watan Afrilu, 2020, babu wani takamaiman magani da aka gano don COVID-19.
Wasu likitoci sun ba da shawarar yin amfani da paracetamol a farkon lokaci maimakon ibuprofen saboda alamun.
Don rage haɗarin yaduwar kwayar cutar, dole ne a ɗauki matakan kariya, musamman lokacin da ake amfani da kayan aikin likita waɗanda ke haifar da ɓarkewar ruwa a cikin iska, kamar shigar da bututun jiki ko iska ta hannu.
CDC ta ba da shawarar cewa ma'aikatan kiwon lafiya da ke kula da marasa lafiya da ke fama da COVID-19 su kiyaye su a cikin ɗakunan keɓewa na iska (AIIR) tare da kiyaye su da kiyayewa na yau da kullun, kula da hulɗa da kuma kula da yaduwar iska.
Ana ba da shawarar kayan kariya don shiri: rigar PPE, mashin numfashi ko abin rufe fuska, kariya ta ido da safar hannu na likita. Idan akwai, za a fi son injin numfashi maimakon abin rufe fuska.
Ko da yake an amince da na'urar N95 don masana'antu, FDA ta amince da amfani da masks a ƙarƙashin izinin Amfani da Gaggawa (EUA).
An tsara su don karewa daga ƙurar iska, amma ba za a iya tabbatar da tasirin su akan takamaiman matsakaiciyar halitta ba a wasu aikace-aikace.
Idan babu abin rufe fuska, za a iya amfani da abin rufe fuska ko kuma abin rufe fuska na gida a matsayin makomar ƙarshe, kamar yadda CDC ta ba da shawarar.
Yawancin marasa lafiyar COVID-19 ba su da tsanani da za su buƙaci iska ta likita ko wani zaɓi, amma akwai ƙananan adadin marasa lafiya.
Ana ci gaba da nazarin irin kayan aikin numfashi na likita da marasa lafiya ke samu saboda matsalar numfashi ta COVID-19 ga mutanen da ke asibiti. Ana iya hana shigar da bututu a cikin jiki ta hanyar bututun mai zurfi ta hanci ko kuma matsin lamba mai kyau na iska.
Ba a san ko ɗayan waɗannan yana da amfani iri ɗaya ga marasa lafiya masu ciwo mai tsanani ba.
Wasu likitoci sun fi son maganin iska mai ƙarfi kamar iska mai ƙarfi idan akwai, saboda yana iyakance yaduwar ƙwayoyin cuta a cikin iska fiye da shigar da bututun iska mai ƙarfi.
Ko da a kasashe masu tasowa, babu isassun gadajen asibiti a kan kowane mutum, don haka karuwar gaggawa na yawan masu fama da cutar COVID-19 na iya iyakance ikon tsarin kiwon lafiya wajen kula da shigar da su asibiti.
Wani bincike da aka yi a kasar Sin ya nuna cewa kashi 5 cikin 100 na marasa lafiya da ke cikin ICU, kashi 2.3 cikin 100 na marasa lafiya da ke bukatar taimakon fasahar iska ta waje, da kuma kashi 1.4 cikin 100 na marasa lafiya da suka mutu.
Kimanin kashi 30 cikin dari na masu cutar COVID-19 da aka kwantar a asibiti a China sun kasance a cikin ICU.
A yayin da marasa lafiya da ke fama da cutar COVID-19 ke samun mummunan cututtukan numfashi (ARDS), samun iska mai ƙarfi yana da wahala kuma yana da wahala.
Ana buƙatar masu ba da iska masu ƙarfi da kuma PEEP mai ƙarfi don rage haɗarin cutar huhu da kuma cutar huhu ta hanyar iska yayin da ake ba da iskar oxygen.
Ba za a iya samun PEEP mai ƙarfi a kan tsofaffin masu ba da iska ba.
An fara binciken yiwuwar maganin cutar a watan Janairun 2020, kuma an fara gwajin kwayoyin cutar da yawa.
Remdesivir ya zama mafi alkawurra a cikin waɗannan.
Ko da yake za a ɗauki lokaci kafin a samar da sababbin magunguna a shekarar 2021, yawancin magungunan da aka gwada sun sami izini don amfani da su ko kuma suna cikin ƙarin gwaji.
Za a iya gwada maganin rigakafi a cikin marasa lafiya masu tsanani.
Masu aikin sa kai da Hukumar Lafiya ta Duniya ta ba da shawarar su shiga cikin gwaji don nazarin tasirin da amincin waɗannan magungunan. FDA ta ba da izinin gwaji na ɗan lokaci don maganin plasma mai haɗari a matsayin magani na gwaji a cikin marasa lafiya masu haɗari.
Ba su shiga gwajin sunadarai ba don tabbatar da cewa suna da tasiri da lafiya a maganin cutar.
A watan Fabrairun 2020, kasar Sin ta kaddamar da wata manhajar wayar hannu don magance cutar.
Ana tambayar masu amfani da su su sanya sunayensu da lambar ID.
Ta hanyar bayanan da aka lura, wannan app zai iya nuna 'kusa da kusanci' kuma ya fahimci yiwuwar kamuwa da cutar.
Kowane mai amfani zai iya duba matsayin wasu masu amfani uku.
Idan akwai wata barazana, wannan app din yana ba da shawarar keɓe kai, kuma yana sanar da hukumomin kiwon lafiya na gida. Ana amfani da manyan bayanai na nazarin bayanan wayar salula, fasahar gano fuska, bin diddigin wayar salula da hankali na wucin gadi don lura da marasa lafiya da waɗanda suka kamu da cutar da kuma abokan hulɗarsu a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba hukumomin tsaro damar bincika bayanan wayar salula na mutanen da ke da yiwuwar kamuwa da cutar coronavirus.
An dauki matakan killacewa da kare wadanda za su iya saduwa da mutanen da suka kamu da cutar.
A watan Maris na shekarar 2020, Deutsche Telecom ta ba da bayanan bayanan da aka tattara na wuraren waya ga cibiyar gwamnatin tarayya ta Jamus, Robert Koch Institute, don amfani da su don hana yaduwar kwayar cutar da kuma bincike.
Rasha ta kafa fasahar gano fuska don gano mutanen da suka karya dokar killacewa.
Kwamishinan kiwon lafiya na yankin Italiya, Julio Gallari, ya ce yana samun bayanai ta wayar salula.
Gwamnatin Jamus ta shirya taron Hackathon na tsawon awanni 48 a karshen mako tare da abokan hulɗa sama da 42,000.
Shugaba Kirsti Karluliud na Estonia ya yi kira ga duniya da ta dauki wasu matakai na musamman don dakile yaduwar cutar.
Mutane na iya jin tsoro saboda keɓewa, ƙuntatawa na tafiya, sakamakon rashin lafiya ko tsoron kamuwa da cuta.
"Ƙaruwar warewar jama'a, kaɗaici, damuwa game da lafiyar jiki, damuwa, da kuma rashin kuɗi, su ne ainihin abubuwan da ke jawo haɗari ga lafiyar mutane da kuma lafiyarsu", in ji BBC, kamar yadda Rory O'Connor ya ambata.
Wannan cuta tana iya zama da alamomi kaɗan ko babu alamomi, kuma tana kama da cututtukan numfashi kamar sanyi da tari.
Sau da yawa, a cikin makonni biyu, masu saurin warkewa sukan warke, amma a cikin makonni uku zuwa shida, masu ciwo mai tsanani sukan warke.
Bisa ga bayanan da aka samu game da wasu irin waɗannan ƙwayoyin cuta kamar SARS, MERS, ana iya cewa mata masu juna biyu da ke fama da cutar COVID-19 suna da haɗari, amma babu bayanai game da COVID-19. A wasu mutane, COVID-19 na iya shafar huhu, wanda ke haifar da cutar huhu.
A cikin mutanen da cutar ta shafa sosai, COVID-19 na iya haifar da cutar rashin ƙarfi ta numfashi (ARDS), wanda zai haifar da rashin ƙarfi na numfashi, harin septic ko raunin gabobin jiki da yawa, da sauransu.
Matsaloli da ke tattare da COVID-19 sun hada da sepsis, ƙwayoyin jini da ba su dace ba da kuma lalacewar zuciya, koda da hanta, da sauransu.
Kashi 6% na mutanen da aka kwantar a asibiti saboda COVID-19 sun sami ciwo na ƙwayoyin jini, ƙaruwar lokacin prothrombin, kuma kashi 4% na waɗannan rukunin sun sami cutar koda.
Kimanin kashi 20-30% na mutanen da ke da COVID-19 an gano suna da ƙwayoyin enzyme na hanta.
Rahoton ya ce, tsawon lokaci tsakanin bayyanar cututtuka da mutuwa ya kai kwanaki 10, daga cikinsu 5 na asibiti.
Amma, marasa lafiya da aka kwantar a dakunan jinya suna cikin asibiti kuma matsakaicin lokacin mutuwar su kwana bakwai ne.
A farkon binciken da aka yi, an gano cewa matsakaicin lokacin bayyanar cututtuka daga bayyanar cututtuka zuwa mutuwa ya kasance kwanaki 14.
Wani bincike da Hukumar Lafiya ta Kasa ta kasar Sin ta gudanar ya nuna cewa mace mace tana mutuwa da kashi 2.8 cikin dari, yayin da mace ke mutuwa da kashi 1.7 cikin dari.
Binciken cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
An gano canjin kwayar cutar a cikin kwayoyin cutar.
Hoton na huhu yana da alaƙa da ciwon damuwa na numfashi (ARDS).
11.8% na mutuwar da Hukumar Lafiya ta Kasa ta kasar Sin ta ruwaito sun nuna cewa akwai matakan troponin ko kuma ciwon zuciya.
Rahoton watan Maris na Amurka ya nuna cewa kashi 89% na mutanen da aka kwantar da su a asibiti suna da wasu gunaguni. Samun albarkatun kiwon lafiya da yanayin zamantakewar tattalin arziki na yankin ma suna shafar mutuwar.
Bambancin yanki yana haifar da canjin hasashen mutuwar a cikin wannan yanayin, amma kuma yana haifar da matsalolin tsarin.
Rage adadin masu cutar zai iya haifar da ƙarin mutuwar.
Koyaya, gaskiyar cewa waɗannan mutuwar sakamakon haɗuwa ne da lokuta na baya, na iya nufin cewa ƙididdigar yawan mutuwar yanzu ba ta da kyau.
Masu shan sigari sun fi saurin kamuwa da cututtukan COVID-19 sau 1.4 fiye da marasa shan sigari kuma sun fi saurin buƙatar kulawa mai tsanani ko mutuwa sau 2.4 fiye da marasa shan sigari.
Jami'an asibiti a Hong Kong sun gano cewa wasu mutane da suka warke daga cutar sun rasa kashi 20 zuwa 30 cikin dari na ƙarfin huhu, kuma hotunan huhu sun nuna cewa akwai lalacewar gabobin jiki.
Wannan yana iya haifar da ciwon bayan-ciki-ciki bayan warkewa.
Har zuwa Maris 2020, ba a san ko kamuwa da cutar da ta gabata ta samar da ingantacciyar rigakafi mai ɗorewa a cikin mutanen da suka warke daga cutar ba.
Idan aka yi la'akari da yadda sauran cututtukan coronavirus ke aiki, za a iya cewa akwai yiwuwar rigakafi, amma an ba da rahoton cewa an sami sakamako mai kyau na COVID-19 a cikin kwanaki masu zuwa bayan warkewa daga COVID-19.
Ana ganin cewa a irin waɗannan lokuta, ana iya samun kamuwa da cuta mai tsawo maimakon sake kamuwa da cuta.
Ana ganin cewa kwayar cutar ta halitta ce kuma ta samo asali ne daga dabba kuma ana yada ta ta hanyar kamuwa da cuta.
Ba a san ainihin asalinsa ba, amma har zuwa Disamba 2019, kamuwa da cutar ta kasance ta hanyar kamuwa da cutar daga mutum zuwa mutum.
Nazarin da aka yi kan mutane 41 da suka kamu da cutar COVID-19 da aka buga a cikin mujallar The Lancet a watan Janairu ya nuna cewa ranar 1 ga Disamba 2019 ita ce ranar da aka fi saurin fara bayyanar da alamun cutar.
A cikin sanarwar da WHO ta fitar, an bayyana ranar 8 ga Disamba 2019 a matsayin ranar da za a fara bayyanar da alamun cutar.
Ana amfani da hanyoyi daban-daban don lissafin mutuwar.
Waɗannan lambobi sun bambanta tsakanin yankuna da kuma zamani kuma ana shafar su ta yawan gwaje-gwaje, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tsawon lokacin da ya wuce tun farkon barkewar cutar da kuma yanayin yawan jama'a kamar shekaru, jinsi da lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta ba da lambar gaggawa ta ICD-10 U07.1 ga mutuwar da aka tabbatar da gwaji daga kamuwa da cutar SARS-CoV-2, da kuma cutar U07.1 ga mutuwar da ba a tabbatar da cutar SARS-CoV-2 ba ta hanyar gwaji ko kuma cutar ta COVID-19.
Bayanai daga Jami'ar Johns Hopkins sun nuna cewa yawan mace-mace a duniya ya kai kashi 6.9 cikin dari.
Wannan adadi ya bambanta ta yanki. Sauran matakan sun hada da Case Mortality Rate (CFR), wanda ke nuna yawan mutanen da aka gano da cutar da suka mutu daga wata cuta, da kuma 'Infection Mortality Rate (IFR), wanda ke nuna yawan mutanen da ke dauke da cutar (masu cutar da marasa lafiya) da suka mutu daga wata cuta.
Waɗannan ƙididdigar ba su da iyakance lokaci kuma suna ɗaukar takamaiman yawan mutanen da ke fama da cutar ta hanyar yawan lokuta.
Ba duk mutane da suka kamu da cutar ba ne ke samun rigakafi, kuma kasancewar rigakafi na iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A cikin Italiya, a cikin wani ƙaramin gari mai suna Castelliglione d'Adda, cibiyar barkewar cutar, mutane 4,600,80 (1.7%) sun mutu zuwa yanzu.
A Ganglet, an fara yaduwar cutar ne ta hanyar bikin Carnival kuma an fara yaduwa tsakanin matasa, wanda hakan ya haifar da ƙananan mace-mace kuma mai yiwuwa ba duka mutuwar da ke da alaƙa da COVID-19 za a iya rarraba su ta wannan hanyar ba.
Bugu da ƙari, tsarin kiwon lafiya na Jamus ba shi da nauyi sosai.
A cikin Netherlands, kusan kashi 3 cikin ɗari na mutane na iya samun ƙwayoyin cuta, kamar yadda aka samu daga mai bayar da jini.
An tabbatar da mutuwar mutane 69 (kashi 0.004 cikin dari na yawan jama'a) daga COVID-19.
Sakamakon wannan annoba da kuma yawan mace-mace sun bambanta ga mata da maza.
Nazarin da aka yi a China da Italiya ya nuna cewa maza sun fi mutuwa.
Maza da suka kai shekara hamsin suna cikin haɗarin mutuwa, kuma a shekarun 1990 ne aka fi samun raguwar mace da namiji.
A kasar Sin, mace-macen maza sun kai kashi 2.8 cikin dari, mata kuma sun kai kashi 1.7 cikin dari.
Ba a san ainihin dalilin da ya sa ake samun wannan bambancin tsakanin jinsi ba, amma yana iya kasancewa na asali ne ko kuma na al'ada.
Rashin daidaiton rigakafi na jinsi, ƙarancin shan sigari a cikin mata, da kuma ci gaban yanayin rashin lafiya kamar hawan jini a cikin ƙaramin shekaru fiye da mata, duk suna iya haifar da yawan mutuwar maza.
A Turai, maza sun kai kashi 57% na mutanen da suka kamu da cutar, kuma maza sun kai kashi 72% na mutanen da suka mutu sakamakon COVID-19.
Har zuwa Afrilu 2020, gwamnatin Amurka ba ta da bayanan bambancin jinsi tsakanin mutanen da ke da cutar COVID-19.
Binciken ya nuna cewa cututtukan da ke tattare da kwayar cuta kamar su Ebola, HIV, mura da SARS suna shafar maza da mata daban.
Ma'aikatan kiwon lafiya da yawa, musamman ma ma'aikatan jinya mata ne, kuma suna cikin haɗarin kamuwa da cutar.
A ranar 11 ga Fabrairun 2020, WHO ta sanar da cewa sunan cutar "COVID-19".
Shugaban WHO, Tedros Adhanom Ghebreyesus ya ce CO na nufin Corona, VI yana nufin Virus, D yana nufin cuta kuma 19 shine shekarar da cutar ta fara bulla: 31 ga Disamba, 2019.
An ba da wannan sunan ne don kauce wa yin magana game da wani yanki na musamman (kamar, China), nau'in dabba, ko rukuni na mutane, wanda ya bi shawarar duniya game da sanya suna, kuma an yi hakan ne don kauce wa ɓata sunan kowa. An ba da sunan cutar da ke haifar da COVID-19 mai suna Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2).
A cikin sadarwar jama'a, WHO tana amfani da "Covid-19 virus" da "Covid-19 responsible virus" ban da "Covid-19 virus".
Ana kiran cutar da kwayar cutar "coronavirus".
A lokacin barkewar cutar a Wuhan, China, an kira cutar da cutar da "coronavirus" da kuma "Wuhan coronavirus".
A watan Janairun 2020, WHO ta ba da shawarar 2019-nCoV da 2019-nCoV Acute Respiratory Disease a matsayin sunayen wucin gadi don cutar da cutar, daidai da jagorar 2015 game da amfani da wuri a cikin sunayen cututtuka da ƙwayoyin cuta.
An ba da sunayen hukuma COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar iya aiki a cikin daidaitattun jerin abubuwan da ba a cika ba, wasu masana'antun dijital suna buga kayan kula da lafiya a matsayin swabs na hanci da sassan iska.
Misali, a wani asibiti a Italiya, lokacin da ake buƙatar bawul ɗin iska da gaggawa kuma mai ba da kaya bai iya samar da shi a kan lokaci ba, wani kamfani na gida ya sake yin aikin injiniya kuma ya buga bawul 100 a cikin dare.
Bayan barkewar cutar COVID-19, an samar da bayanai marasa kyau da kuma karkatattun bayanai game da asali, girman cutar, magani da sauran batutuwan da suka shafi cutar.
An gano cewa mutane suna iya yada wannan kwayar cutar ga wasu dabbobi.
Wannan binciken bai sami wata hujja ba cewa akwai kwayar cutar a aladu, ducks da kaji.
Babu wani magani ko allurar rigakafi da aka amince da shi don magance cutar.
Gwamnati na ci gaba da binciken duniya kan allurar rigakafi da magani na COVID-19.
A watan Maris, WHO ta fara gwajin "haɗin kai" don tantance tasirin maganin maganin cutar ta hanyar maganin rigakafin cutar guda huɗu da ke aiki sosai.
Duk da cewa babu riga-kafi a halin yanzu, hukumomi daban-daban suna aiki sosai don samar da 'yan takarar allurar rigakafi.
Ana amfani da binciken da aka yi a baya akan SARS-CoV-2, saboda duka SARS-CoV da SARS-CoV-2 suna amfani da ƙwayoyin cuta na ACE2 don shiga cikin ƙwayoyin ɗan adam.
Ya zuwa yanzu, an gano dabarun allurar rigakafi guda uku.
Na farko, masu binciken suna da burin samar da cikakkiyar rigakafin cutar.
Manufar amfani da irin wannan kwayar cutar, ko ta kasance mai aiki ko kuma ta mutu, shine samar da sabuwar cuta tare da COVID-19 a cikin saurin rigakafin jikin mutum.
Wata dabara ita ce alluran rigakafin subunit, wanda ke nufin samar da allurar rigakafi, wanda ke sa tsarin garkuwar jiki ya zama mai saukin kamuwa da cutar zuwa wani yanki na kwayar cutar.
A game da SARS-CoV-2, irin wannan aikin ya mai da hankali ne kan furotin na S-spike wanda ke taimaka wa kwayar cutar ta shiga cikin ƙwayoyin cuta na enzyme ACE2.
Dabara ta uku ita ce game da allurar rigakafin nucleic acid (DNA ko RNA allurar rigakafi, fasaha mai ban mamaki don samar da allurar rigakafi).
Kowane ɗayan waɗannan dabarun uku yana buƙatar gwajin gwaji don aminci da inganci.A Seattle a ranar 16 ga Maris, 2020, an fara gwajin asibiti na rigakafi tare da masu sa kai huɗu.
Wannan allurar rigakafin tana da lambar halittar da ba ta da haɗari, wanda aka sake yin kwafinta daga kwayar cutar da ke haifar da cutar. An ba da shawarar haɓaka tushen rigakafi a matsayin ƙalubalen da za a iya fuskanta don haɓaka allurar rigakafi don SARS-CoV-2, amma wannan yana da rikice-rikice.
Rahotanni sun nuna cewa a watan Afrilu na shekarar 2020, an gudanar da gwaji sama da 300.
An yi nazarin gwaje-gwaje bakwai daga cikin magungunan da aka riga aka amince da su don zazzabin cizon sauro, gami da bincike huɗu akan hydroxychloroquine ko chloroquine.
Yawancin binciken da aka yi a China sun shafi magungunan rigakafin cutar rigakafi masu amfani da yawa, wanda ya haɗa da gwaji tara na Mataki na III akan Remdesivir a ƙasashe da yawa, kamar yadda aka bayar a ƙarshen Afrilu.
Rahoton na Afrilu 2020 ya nuna cewa, akwai wani bincike mai zurfi game da ci gaban likitanci don allurar rigakafi da magungunan rigakafi na COVID-19. An tantance magungunan rigakafin cutar da ke akwai don magance COVID-19, gami da remdesivir, chloroquine da hydroxychloroquine, lopinavir/rytonavir da interferon beta da lopinavir/rytonavir.
Rahoton na Maris 2020 ya nuna cewa akwai wasu shaidu na farko na tasirin Remdesivir.
Marasa lafiya da aka yi wa magani da Remdesivir sun sami ci gaba a yanayin lafiyarsu.
Ana gudanar da gwaji na asibiti na Mataki na III a Amurka, China da Italiya.An yi nazarin chloroquine, wanda a baya ake amfani da shi don cutar zazzabin cizon sauro, a cikin China a watan Fabrairun 2020, tare da sakamakon farko.
Duk da haka, wannan bincike yana bukatar bita na jama'a.
Hukumomin kiwon lafiya na Koriya da China sun ba da shawarar amfani da chloroquine.
Koyaya, Cibiyar Nazarin Kwayoyin Cutar Wuhan ta ba da shawarar auna gram ɗaya a rana, ta lura cewa kashi biyu na cutar yana da haɗari sosai kuma yana iya haifar da mutuwa.
FDA ta ba da izinin amfani da gaggawa na hydroxychloroquine da chloroquine a ranar 28 ga Maris, 2020, bisa ga shawarar likitocin da ke kula da marasa lafiya da COVID-19. Jagorar ta bakwai ta kasar Sin ta kuma haɗa da interferon, raibavirin ko umiphenovir don amfani da su akan CORONA-19.
Bayanai na farko sun nuna cewa ana buƙatar yin amfani da ribavirin mai yawa don hana SARS-CoV-2 a cikin gwaji.
An ba da shawarar yin ƙarin gwaji tare da nitasoxanide bayan an nuna ƙarancin ƙwayar cuta na SARS-CoV-2. Nazarin ya nuna cewa ana buƙatar farkon furotin mai ƙarancin furotin ta hanyar transmembrane protease serine 2 (TMPRSS2) don shigar da SARS-CoV-2 ta hanyar hulɗa tare da ACE-2 makamashi.
Akwai matsaloli masu yawa a cikin nazarin chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba wanda ya hana ƙungiyar likitoci yin amfani da waɗannan magungunan ba tare da ƙarin bincike ba. Oseltamivir bai hana SARS-CoV-2 a cikin gwaji ba kuma ba a gano wani sanannen rawar da zai taka a maganin COVID-19.
Cytokine Storm na iya zama mai rikitarwa a cikin matakai na gaba na COVID-19 mai tsanani.
Wannan ya nuna cewa hydroxychloroquine na iya samun kaddarorin anti-cytokine storm. Bayan wani karamin bincike, Hukumar Lafiya ta Kasa ta kasar Sin ta hada tosalizumab a cikin jagororin magani.
Ana gudanar da gwaji na kasa-kasa na biyu a Italiya bayan an ga sakamako mai kyau a cikin mutanen da ke fama da cututtuka masu tsanani.
Idan aka haɗa da gwajin jini na ferritin don gano guguwar cytokine, yana nufin hana ci gaban da ake tsammani yana haifar da mutuwa a cikin wasu mutane masu kamuwa da cutar.
A cikin 2017, FDA ta amince da interleukin-6 neurotransmitter antagonist bisa ga binciken farko don maganin cutar mai ƙarancin ƙwayar cuta mai ƙarancin ƙwayar cuta mai suna CAR T cell therapy, wanda ya haifar da cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta cutar ta hanyar cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar.
Har zuwa yau, babu wata hujja ta bazuwar, da aka sarrafa cewa tosalizumab magani ne mai tasiri don CRS.
Ana ci gaba da bincike kan hanyar ba da allurar rigakafi ta hanyar canja wurin rigakafi da aka tsabtace da kuma ƙididdigar rigakafi da tsarin rigakafin mutane da suka warke daga COVID-19 ya samar ga waɗanda ke buƙatarsa.
An yi amfani da wannan dabarar a lokacin SARS, amma ba ta da wani sakamako mai kyau.
Neutralization na kwayar cuta shine tsarin aikin da ake so, wanda zai iya magance cutar SARS-CoV-2.
Duk da haka, wasu fasahohi, kamar su kwayar halitta mai ƙwayoyin cuta da / ko phagocytes, na iya yiwuwa.
Ana ci gaba da wasu nau'ikan maganin rigakafin rigakafi, misali, ta amfani da rigakafin monoclonal da aka yi.
Za a iya kara yawan samar da maganin cutar, wanda ya kunshi sunadarai masu ruwa daga jinin marasa lafiya da suka warke, kuma ya kunshi kwayoyin rigakafi na musamman ga wannan kwayar cutar, don bunkasa su cikin sauri.
Cutar coronavirus, wata ƙungiya ce ta cututtuka masu alaƙa da juna.
Li Wenliang, wani likita a asibitin tsakiya na Wuhan, ya kamu da COVID-19 kuma ya mutu bayan ya ba da sanarwar yaduwar cutar.
